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RIASSUNTO 
La mia tesi di dottorato approfondisce aspetti relativi all‟analisi proteomica in gel 
bidimensionale: il lavoro svolto si e‟ proposto di apportare da un lato un contributo al 
miglioramento dei metodi di pre-frazionamento del campione, finalizzato al raggiungimento 
di un alto livello di risoluzione, ad una selezione di popolazioni di proteine più omogenee per 
la separazione su gel, e ad una migliore riproducibilità delle mappe proteiche, e dall‟altro 
l‟impiego dei protocolli messi a punto nella prima fase della ricerca e‟ stato 
immediatamente trasferito e messo alla prova su due problematiche specifiche e 
selezionate di ambito sia microbiologico, che biomedico. L‟applicazione dei protocolli di pre-
frazionamento unitamente ad un disegno sperimentale di proteomica differenziale ha 
permesso di ricavare importanti informazioni biochimico-cellulari e di operare correlazioni 
stimolo-effetto. 
Gli obiettivi della tesi sono stati: 
1) messa a punto di protocolli efficaci per la eliminazione di contaminanti (acidi nucleici e 
polisaccaridi) dal campione proteico per 2-DE; 
2) indagine proteomica differenziale per delucidare i meccanismi molecolari dell‟acido-
resistenza di Ga. hansenii AAB0248; 
3) messa a punto di protocolli di frazionamento del campione in: proteine di membrana, del 
citosol e proteine associate alle membrane; 
4) indagine sull‟omeostasi del ferro nei macrofagi con approccio di proteomica differenziale: 
effetti della stimolazione con ferro ionico; 
5) indagine sull‟omeostasi del ferro nei macrofagi con approccio di proteomica differenziale: 
effetti della stimolazione con eritrociti senescenti. 
 
Proteomica microbiologica 
In collaborazione con il Dott. Giacomo Zapparoli, laboratorio di microbiologia, Dipartimento 
di Biotecnologie, Università di Verona e con il Prof. Paolo Giudici, Dipartimento di Scienze 
Agrarie, Università degli Studi di Modena e Reggio Emilia.  
 
Ga. hansenii AAB0248 appartiene ai batteri acetici, è stato isolato dall‟aceto ed è di sicuro 
interesse scientifico in quanto riesce a sopravvivere in un ambiente non solo acido, ma 
anche contenente acido acetico, molecola citotossica per la maggior parte delle specie 
microbiche. E‟ stata quindi pianificata un‟analisi di proteomica differenziale per indagare i 
meccanismi molecolari coinvolti nell‟acido-resistenza di questo peculiare batterio.  
Tuttavia le prime mappe bidimensionali della popolazione delle proteine totali espresse da 
questi batteri, ottenute con i classici metodi di preparazione del campione (impiego di 
soluzione di solubilizzazione, trattamento con l‟1% di anfoline 3-10, trattamento con 
fenolo:cloroformio:isoamilico), mostrano gravi problemi di focalizzazione, soprattutto nella 
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parte acida del gel, probabilmente dovuti alla presenza massiccia di DNA e polisaccaridi che 
complessandosi tra loro tendono a bloccare i pori delle IPGs e ad ostacolare l‟entrata delle 
proteine. Per questi motivi è stato necessario, prima di procedere alla vera e propria analisi 
di proteomica differenziale, mettere a punto un metodo efficace per la preparazione del 
campione. Il protocollo che abbiamo concepito viene ampiamente descritto nel capitolo 1 
della sessione 2 e si basa essenzialmente sull‟utilizzo del CTAB. Il detergente anionico CTAB 
è comunemente usato dai genetisti per liberare gli acidi nucleici totali dai polisaccaridi. 
L‟azione del CTAB si esplica nella sua capacità di formare complessi insolubili con acidi 
nucleici e/o polisaccaridi. Quando la concentrazione iniziale di NaCl è maggiore di 0.7 M, il 
CTAB resta in soluzione, se invece la concentrazione di NaCl si abbassa al di sotto di 0.7 M, 
il CTAB diventa insolubile e risulta nella formazione di una medusa costituita dal detergente 
stesso e da tutto ciò che ha legato. Gli altri componenti della cellula sono invece 
efficacemente allontanati nel supernatante, perché in tali condizioni essi non precipitano. 
Questo concetto è stato quindi sfruttato per mettere a punto un nuovo protocollo. I risultati 
ottenuti applicando al campione questo trattamento sono stati oltre modo incoraggianti: 
infatti sono stati eliminati tutti i problemi di strisciamento orizzontale nella zona acida dovuti 
a DNA e polisaccaridi e di focalizzazione e, contemporaneamente è stato recuperato un 
grande numero di proteine. Esperimenti di controllo hanno evidenziato l‟effettiva rimozione 
di DNA e polisaccaridi da parte del detergente. 
Il trattamento con CTAB è stato successivamente applicato a campioni di lisato batterico di 
Ga. hansenii AAB0248 sottoposti a condizioni di stress indotto dalla presenza di acido 
acetico e comparati con lisati controllo. Sono state trovate variate nella loro espressione a 
seguito dello stimolo 79 proteine (45 sotto-espresse e 34 sovra-espresse). Sono state 
identificate 94 singole catene polipeptidiche, appartenenti a proteine coinvolte nella totalità 
dei processi cellulari: infatti il 14% sono proteine della trascrizione, il 7.5% esplica la glicolisi 
ed il ciclo di Krebs, l‟8.5% appartiene agli enzimi della traduzione ed il 7.5% è coinvolto nel 
ripiegamento delle proteine. Inoltre il 6.5% prende parte alla biosintesi degli acidi grassi, il 
17% al metabolismo dei nucleotidi e degli amminoacidi, il 3% alla regolazione del ciclo 
cellulare, ed un altro 3% è adibito alla chemiotassi e al movimento cellulare. Il rimanente 
33% è coinvolto nel trasporto di ioni attraverso le membrane, in reazioni di ossidazione e 
riduzione, nella fosforilazione, nella proteolisi, ed in molti altri processi cellulari.  
I risultati suggeriscono come la presenza di acido acetico nel mezzo di crescita, porti ad un 
cambiamento globale a livello di espressione proteica nelle cellule batteriche: pressoché 
tutti i processi metabolici e non che si svolgono all‟interno di questi batteri sembrano essere 
interessati dalla presenza di acido acetico, molecola citotossica per la maggior parte degli 
organismi viventi. E‟ interessante notare come tutti gli enzimi coinvolti nel processo 
glicolitico siano aumentati, mentre tutti quelli coinvolti nel ciclo di Krebs (siano diminuiti, 
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così come risulta sottoespresso anche la piruvate dehydrogenase, enzima che trasforma il 
piruvato in acetil-CoA. 
E‟ interessante osservare il bilancio tra le variazioni di glicolisi e ciclo di Krebs risulta in una 
aumentata produzione di piruvato. Si può ipotizzare un ruolo chiave di questo aumento del 
piruvato nella sintesi di biomassa cellulosica. E‟ stato infatti ampiamente dimostrato che i 
batteri acetici, fatti crescere in opportuni terreni, sono in grado di produrre cellulosa 
partendo dal piruvato. É possibile perciò ipotizzare che questo ceppo in presenza di acido 
acetico, subisca una rinnovata spinta metabolica verso la produzione di cellulosa e che 
l‟aumento nella biosintesi di cellulosa che probabilmente conferisce al batterio un certo 
vantaggio ecologico. Inoltre, sono trovate variate nelle cellule cresciute in presenza di acido 
acetico numerose proteine coinvolte nel macchinario di ripiegamento e turn-over, in grado 
cioè‟ di permettere l‟adattamento alle condizioni di stress. 
Questi risultati possono avere applicazioni in futuro, specialmente nelle biotecnologie, per 
esempio per la produzione di una cellulosa estremamente pura per uso medico, oppure da 
utilizzare semplicemente come biocombustibile.  
Proteomica biomedica 
In collaborazione con la Dott.ssa Annalisa Castagna e il Dott. Domenico Girelli, Dipartimento 
di Medicina Clinica e Sperimentale, Unità di Medicina Interna B, Università di Verona, con la 
Dott.ssa Ivana De Domenico, Division of Hematology, Department of Medicine, School of 
Medicine, University of Utah, ed il Prof. Jerry Kaplan, Department of Pathology, School of 
Medicine, University of Utah.  
 
Questa parte della tesi e‟ stata rivolta alla messa a punto di metodi di frazionamento delle 
proteine cellulari in popolazioni omogenee di proteine di membrana, del citosol e di proteine 
associate alle membrane, con il conseguente vantaggio di separare su un medesimo gel 
bidimensionale proteine con una comune localizzazione cellulare. 
Nel caso presente si e‟ lavorato su colture di monociti/macrofagi ed e‟ stato messo a punto 
un metodo di frazionamento delle proteine che ponesse particolare attenzione al recupero 
delle proteine di membrana.  
Le proteine di membrana e le proteine associate alle membrane sono state estratte 
sfruttando le peculiari caratteristiche un detergente non ionico: il Triton X-114. Questo 
detergente cambia la sua solubilità in una soluzione acquosa, a seconda della temperatura: 
infatti a 0°C il Triton X-114 è completamente solubile, mentre a 23°C diventa insolubile e 
precipita. E‟ stata quindi utilizzata questa sua proprietà per l‟estrazione e la precipitazione 
delle proteine di membrana. In particolare si formano due fasi, una fase acquosa superiore, 
contenente le proteine idrofiliche associate alle membrane, ed una fase inferiore, 
contenente le proteine idrofobiche. In questo caso quindi, quando si parla di proteine 
associate alle membrane, si intendono tutte quelle proteine presenti nella frazione 
intermedia che conterrà sia proteine solubili, sia proteine poco idrofobiche, sia proteine 
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associate a proteine di membrana o alle membrane stesse. Prove di western-blot hanno 
validato il metodo.   
Il protocollo del Triton X-114 e‟ stato di seguito impiegato per l‟analisi proteomica 
differenziale di un problema di alto interesse biomedico: lo studio dei meccanismi 
molecolari dell‟omeostasi del ferro esplicata dai macrofagi.  
I macrofagi sono cellule del sistema reticoloendoteliale deputate allo svolgimento di funzioni 
altamente specializzate, quali l‟immunoregolazione, l‟attività antimicrobica, la risposta 
all‟infiammazione, attività antitumorale, la demolizione di cellule non più funzionali o 
danneggiate, il riciclo del ferro. Una caratteristica peculiare del metabolismo del ferro è la 
dinamica con cui questo metallo viene conservato e ri-distribuito all‟interno dell‟organismo 
(ogni giorno ben il 3-4% del ferro e‟ riciclato, a fronte di uno 0.4% assunto con la dieta e di 
uno 0.03% escreto). L‟omeostasi del ferro si presenta dunque come un meccanismo 
finemente regolato. Nonostante il ruolo fondamentale che ricoprono i macrofagi 
nell‟omeostasi del ferro, il riciclo del ferro da parte di queste cellule rimane a tutt‟oggi uno 
dei processi metabolici meno compresi. Le problematiche aperte sul metabolismo del ferro 
sono relative a: i trasportatori a livello di membrana di ferro ionico e di ferro eme; il 
meccanismo e i relativi trasportatori coinvolti, nella traslocazione del ferro dal fagolisosoma 
al citosol del macrofago; la via di riciclo del gruppo eme, se esistano trasportatori 
intracellulari del gruppo eme, e come venga poi rilasciato il ferro; il sistema di 
coordinamento intracellulare del riciclo del ferro.  
Il disegno sperimentale ha previsto la mappatura delle proteine espresse dalla linea 
cellulare C3H WT di macrofagi reticolo-endoteliali murini a seguito di trattamento, sia con 1) 
concentrazioni fisiologiche di ferro in forma ionica, per mimare la risposta del macrofago al 
ferro proveniente dalla dieta; mentre in un altro caso con 2) globuli rossi senescenti, per 
mimare l‟attività di riciclo dei gruppi eme da parte del macrofago. In ciascun esperimento, il 
corredo proteomico dei macrofagi trattati e‟ stato confrontato con il corredo dei macrofagi 
controllo. In questo modo e‟ stato possibile identificare quelle proteine che variano la loro 
espressione in risposta al trattamento e di conseguenza correlarle con i meccanismi 
molecolari coinvolti nel metabolismo del ferro. La intensa relazione tra 
riciclo/internalizzazione del ferro e trasportatori di membrana rende evidente l‟importanza 
del lavoro di messa a punto di un metodo di frazionamento per le proteine di membrane. 
 
Macrofagi stimolati con ferro ionico 
Nei macrofagi trattati con ferro in forma ionica, l‟analisi statistica ha permesso individuare 
19 proteine sovra espresse e 20 sotto espresse nella frazione citosolica. Nella frazione di 
membrana sono state individuate 24 proteine sovra espresse e 9 sotto espresse, mentre 
nelle proteine associate alle membrane sono state individuate 15 proteine sovra espresse e 
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3 proteine sotto espresse. Dopo l‟identificazione tramite MS e MS/MS, le proteine 
differenzialmente espresse sono state suddivise in classi funzionali che rispecchiano il ruolo 
biologico da esse esplicato. In presenza dello stimolo del ferro è stato osservato un 
incremento del metabolismo basale e un incremento delle proteine coinvolte nella risposta 
allo stress ossidativo. Entrambi sono probabilmente classificabili come meccanismi di 
difesa messo in atto dai macrofagi, per contrastare l‟ambiente ossidativo con la produzione 
di proteine coinvolte nella risposte redox. Sono attuati meccanismi di demolizione delle 
proteine danneggiate e di preservazione del loro corretto ripiegamento. Il trattamento con 
ferro, induce inoltre un rilevante incremento della proteina di accumulo del ferro, la ferritina. 
La ferritina è la principale proteina di deposito del ferro ed ha la capacità di accumularlo in 
una forma solubile, non tossica e facilmente utilizzabile. Per quanto concerne 
l‟assorbimento del ferro è interessante notare che i nostri risultati indicano chiaramente la 
presenza della gliceraldeide 3 fosfato deidrogenasi (GADPH) sulle membrane dei macrofagi 
e oltretutto sovraespressa nelle cellule trattate con il ferro. In condizioni normali la GADPH è 
un enzima appartenente alla glicolisi e si trova di conseguenza nel citoplasma. 
Recentemente è stato però dimostrato che in presenza di ferro i macrofagi traslocano la 
GADPH sulle membrane e che essa ha la capacità di interagire con la transferrina, formando 
un complesso che viene internalizzato negli endosomi. Sembra quindi che la GADPH possa 
funzionare come recettore per la transferrina in alternativa al Tfr1 e Tfr2, probabilmente 
grazie ad un meccanismo ancestrale di ricezione. Il citoscheletro sembra essere fortemente 
coinvolto sia nell‟assorbimento sia nel rilascio del ferro (risultano sottoespresse diverse 
forme dell‟actina e proteine coinvolte nella sua polimerizzazione). Una possibile spiegazione 
a questo fenomeno è che le proteine del citoscheletro potrebbero essere coinvolte nel 
trasporto interno delle proteine tramite i microtubuli. Infine risulta di particolare interesse la 
nuova sintesi della proteina Mif (fattore di inibizione della migrazione dei macrofagi), che ha 
la capacità di indurre una risposta all‟infiammazione. Il Mif è una citochina altamente 
conservata ed originariamente è stato descritto come un fattore espresso dai linfociti T che 
blocca la migrazione dei macrofagi. Il Mif potrebbe quindi essere l‟anello di congiunzione tra 
il ferro e l‟immunità per il controllo delle infezioni. 
 
Macrofagi trattati con globuli rossi senescenti  
I risultati ottenuti con macrofagi esposti a globuli rossi senescenti hanno mostrato 26 
proteine sovra espresse e 27 sotto espresse nella frazione citosolica mentre nella frazione 
di membrana sono state individuate 33 proteine sovra espresse e 28 sotto espresse. Dopo 
l‟identificazione tramite MS e MS/MS, le proteine differenzialmente espresse sono state 
suddivise in classi funzionali che rispecchiano il ruolo biologico da esse esplicato. In 
presenza dei globuli rossi senescenti, risultano regolate numerose proteine del 
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citoscheletro. In particolare risultano sovra espresse le proteine fondamentali per 
l‟eritrofagocitosi, che comprende un rimodellamento veloce ed efficace della forma della 
cellula che si appresta a inglobare il globulo rosso. Non a caso sono state trovate sovra 
espresse quattro diverse isoforme di beta e gamma actina, sia nella frazione citosolica sia 
nella frazione di membrana. E‟ stato infatti stimato che durante la fagocitosi le cellule 
incrementano il loro contenuto di actina del 40%. Inoltre esistono una miriade di proteine 
che legano l‟actina e che ne regolano spazialmente e temporalmente la crescita dei 
filamenti. Di tutte queste proteine noi abbiamo trovato regolate nell‟espressione, in seguito 
ad eritrofagocitosi, la gelsolina, CapG, la coronina-1, ARP3, e una chaperonina (CCT). Le 
proteine appena elencate sono fondamentali nell‟attività fagocitica e agiscono dalla 
polimerizzazione/depolimerizzazione dell‟actina sino alla formazione degli pseudopodi. 
Strettamente correlata alla fagocitosi è la richiesta di ATP. Si stima infatti che il 50%  
dell‟ATP prodotta da una cellula venga utilizzata nella riorganizzazione del citoscheletro, è 
quindi plausibile che durante il processo di eritrofagocitosi aumenti la richiesta di ATP e a 
supporto di questa tesi noi abbiamo osservato la sovra espressione dell‟ATP sintasi e della 
creatine-chinasi coinvolte rispettivamente nella sintesi e nella distribuzione dell‟ATP nel 
citoscheletro. I dati indicano inoltre la presenza di uno stress a livello del reticolo 
endoplasmatico (RE) in seguito ad eritrofagocitosi. Risulta infatti sottoespressa la proteina 
BiP, la cui funzione è quella di bloccare i recettori dello stress su RE, questa regolazione e la 
contemporanea sovra espressione della valosin containing protein sono chiari segnali che 
stanno ad indicare un‟ inizio di stress a livello dell‟RE. Inoltre, a supporto di questa ipotesi, 
abbiamo trovato sottoespressi una serie di enzimi metabolici e alcune proteine della 
traduzione: l‟attenuazione del metabolismo e l‟attenuazione del processo di traduzione 
sembrano essere la prima e immediata risposta della cellula all‟attivazione dei sensori di 
stress RE. Lo stress del reticolo endoplasmatico appare inoltre essere correlato ad una 
risposta infiammatoria. Infatti numerose proteine coinvolte nell‟infiammazione risultano 
essere regolate e di particolare importanza sono l‟α-fetoproteina, la cui sottoespressione 
induce la sintesi delle citochine, l‟E2N che è essenziale per la trasmissione dei segnali nella 
via di attivazione del fattore di trascrizione NF-kB ed infine l‟endoplasmina (nuovamente 
indotta dopo l‟eritrofagocitosi) che è considerata un chaperone fondamentale per i TLR e il 
principale induttore della sintesi delle citochine nei macrofagi. Questi dati sono di 
fondamentale importanza perché indicano che esiste un collegamento tra l‟eritrofagocitosi e 
l‟infiammazione e tale anello di congiunzione sembra essere lo stress a livello del reticolo 
endoplasmico. Inoltre non vi è traccia dei gruppi eme legati alle emoglobine dei globuli rossi 
fagocitati. Né vi è regolazione delle eme-ossigenasi, che dovrebbero digerire i gruppi eme, 
né delle ferritine. Qual è dunque il destino dei gruppi eme? Saranno necessarie ulteriori 
analisi per aggiungere un altro pezzo al puzzle ancora incompleto dell‟omeostasi del ferro. 
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Siamo in attesa di dati di RT-PCR e microarrays sul ferro ionico e sull’internalizzazione dei 
globuli rossi dai nostri colleghi della University of Utah. 
 
Concludendo, tutti gli studi di analisi proteomica comparativa, effettuati durante questi tre 
anni  di dottorato, confermano che l‟elettroforesi bidimensionale, accoppiata all‟analisi 
tramite spettrometria di massa, è una tecnica efficace per l‟analisi globale della variazione 
dell‟espressione proteica e per lo studio e la comprensione dei meccanismi molecolari che 
stanno alla base di importanti processi biologici. 
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PREFACE 
 
Proteomics is an emerging area of science that attempts to study proteins on a massively 
parallel scale. It is by essence a multidisciplinary science: physics, chemistry, bioinformatics 
and mathematics join biochemistry, biology and medicine to solve general life science 
questions. Scientists worldwide are applying proteomic technology to solve problems which 
cannot be resolved by traditional methods, particularly in the biochemical field. 
Methodologically, proteomics is based on highly efficient methods of separation and 
analysis of proteins in living systems, which need to be continuously improved in order to 
achieve and maintain high resolution standards. Proteomics is considered a key technology 
in many biomedical sectors such as molecular medicine, drug discovery, clinical diagnostics, 
as well as microorganisms and plant studies. Shared problem in proteomic analysis is the 
great complexity of the samples, thus the proteomic technology needs improvements and 
new contributes to overcome the actual limitations in the samples treatment and recovery, 
to shorten and ease the recovery protocols, to affirm reproducibility and to effectively 
remove contaminants, in order to reach the degree of automation and cross-laboratory 
reproducibility collectively expected by the scientific community. 
 
The objectives of this thesis were both the development of protocols for protein recovery in 
order to achieve higher resolution and reproducibility in 2-DE, and at the direct applications 
of the set methods to the understanding of two selected and interesting proteomic cases. 
Concerning microbiological proteomics, we studied the molecular mechanism of acid-
resistance in Ga. hansenii; and concerning the biomedical proteomics, the molecular basis 
of iron homeostasis in macrophages was studied. 
 
The thesis work was performed at the Biochemical Methodology and Proteomics laboratory 
of Department of Biotechnology of the University of Verona, in collaboration with other 
laboratories. Regarding the study on macrophages, we collaborated with Dr. Annalisa 
Castagna and Prof. Domenico Girelli, Unit of Internal Medicine B, Department of Clinical and 
Experimental Medicine of the University of Verona, with Dr. Ivana De Domenico, Division of 
Hematology, Department of Medicine, School of Medicine, University of Utah, and Prof. Jerry 
Kaplan, Department of Pathology, School of Medicine, University of Utah, and with Dr. Anna 
Maria Timperio and Prof. Lello Zolla, Department of Ambiental Science, University of “La 
Tuscia”, Viterbo. Regarding the study on Ga. hansenii we collaborated with Dr. Giacomo 
Zapparoli, Department of Biotechnology of the University of Verona and with Prof. Paolo 
Giudici, Department of Agricultural and Food Science, University of Modena and Reggio 
Emilia. 
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PROTEOME AND PROTEOMICS 
Proteomics is an emerging area of research in the postgenomic era that deals with the 
global analysis of gene expression via a combination of techniques for resolving, identifying, 
quantifying, and characterizing proteins (Banks et al., 2000). 
The terms proteomics and proteome were coined by Marc Wilkins and colleagues in the 
early 1990s, and have then been adopted by the research community at large. The 
proteome term refers to the full complement of proteins encoded by the genome of an 
organism (Wilkins et al., 1996, Wilkins et al., 1996 ). It can be seen as the end product of 
the genome: it is the set of expressed proteins at a given time under defined conditions.  
Biochemical studies of protein activity have historically focused on the analysis of single 
molecular species. The rapid discovery of new gene products, via large-scale genomic 
initiatives, has necessitated the development of alternative strategies to evaluate protein 
function. The challenge in recent years has been to develop high-throughput approaches to 
facilitate systematic protein analysis of biological samples, to map functional interactions 
between proteins on a global scale, and to place them in a biological context. 
To really understand biological processes, we need to understand how proteins work inside 
and around cells since they are the functioning units. Proteomic, the science that studies 
the proteome, includes not only the identification and quantification of proteins, but also the 
determination of their localization, modifications, interactions, activities, and, ultimately, 
their function. Cells express genes encoding proteins with unique, cell-specific functions in 
addition to proteins that carry out generic, yet essential functions. Many complex 
mechanisms involve deoxyribonucleic acid (DNA) conversion into protein. The central dogma 
describes the one-way mechanism by which protein is produced by DNA. This process begins 
by transcribing DNA into ribonucleic acid (RNA). The RNA molecule in complementary to the 
DNA template strand and, unlike DNA, has the ability to leave the nucleus. Once outside the 
nucleus, the process of translation converts RNA‟s nucleotide sequence into specific amino 
acid building blocks. The summation of these building blocks leads to the creation of a 
protein (Pierce et al., 2007). Then the protein is subjected to post-translational 
modifications (PTMs). While it is often conceptualized that one gene produces one protein, it 
is known that the expressed products of a single gene in reality represent a protein 
population that can contain large amounts of micro-heterogeneities (Fig. 1-A). Consider the 
example of a protein that has three potential modification states: glycosylation, 
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phosphorylation and ubiquitination. There are eight potential protein forms that could be 
presented if each modification only occurs at a single site and is not mutually exclusive (Fig. 
1-B). Each additional state (e.g. another phosphorylation, acetylation, protease cleavage, 
lipidation, acetylation, etc.) or modification site would add a large amount of additional 
diversity to the expression profile of that protein (64 potential forms for just six 
modifications). 
Approximately 200 different post-translational modifications have been reported, 
encompassing a wide variety of reversible and irreversible chemical reactions, which 
influence the diversity, affinity, function, cellular abundance and transport of proteins (Peng  
and Gygi, 2001). The proteome comprises all of these forms, which make its analysis 
incredibly complex, as any protein may be present in a cell, in any form, at any given time.  
As a consequence, every organism possesses one genome and multiple proteomes. 
Proteomes are constantly changing in response to environmental stimuli, chemicals and 
drug treatments, as well as growth and disease processes (Reynolds, 2002). Many of these 
changes hold considerable interest for researchers seeking to understand complicated 
pathologies, regulation of cell processes and response to stress. While proteomics initially 
encompassed just two-dimensional (2D) gel electrophoresis for protein separation and 
identification, now it refers to any procedure that characterizes large sets of proteins. The 
explosive growth of this field is driven by multiple forces: genomics and revelation of more 
and more new gene products; powerful protein technologies, (such as newly developed 
mass spectrometry approaches, global yeast two-hybrid techniques, and spin-offs from DNA 
arrays); and innovative computational tools and methods to process, analyze, and interpret 
prodigious amounts of data.  
 
  SESSION 1 
5 
 
 
 
 
 
 
 
 
  
Fig 1. Complexity of the proteome. A. One gene can produce multiple mature mRNAs via alternative splicing of 
pre-mRNA transcripts. Following translation, a myriad of post-translational modifications can produce further 
variations in the number and types of protein forms. B. An example of a protein that exists with three 
potential post-translational modifications is shown: glycosylation, phosphorylation and ubiquitination. Eight 
potential protein types can be formed. The presence of each modification is noted by a tick. Adapted from 
Peng and Gygi, 2001.  
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CHAPTER 1 
CLASSICAL PROTEOMICS  
 
1. SAMPLE PREPARATION AND PROTEIN EXTRACTION 
Extracting analytes from cells and biological tissues is often a serious challenge for 
analytical chemists. The challenge is even more difficult for proteins, due to their high 
degree of heterogeneity and to the difficulty of breaking their structural interactions and 
release them when they are bound in macromolecular assemblies. For this reason, cells and 
tissues should be treated as the sum of individual parts or fractions and cannot be 
considered as homogeneous substrates. Protein extracts can be used for a variety of 
purposes: identification and quantification, functional studies, proteomic analysis etc. 
(Canas et al., 2007). The results of any experiment are dependent on the condition of the 
starting material. Therefore, choosing the proper experimental model and preparing the 
sample carefully is crucial for obtaining significant and trustworthy results.  
Sample preparation is a matter of great importance, especially in comparative proteomics, 
where we are usually looking for minor differences between experimental and control 
samples. One of the main obstacles associated with analyzing such complex material as a 
biological sample is the dynamic range of protein abundance. In a single cell there could be 
only 10 copies of transcription factor at the bottom of this range, but at the other end we 
may expect up to 1,000,000 copies of a more abundant protein. To deal with this problem, 
it is advisable to remove the most abundant proteins, thus the complexity of the entire 
sample could be reduced. Several methods of samples fractionation and techniques of 
proteins enrichment could be used to achieve this goal (Bodzon-Kulakowska et al., 2007).  
Besides biological samples may contain contaminants that interfere with analysis by two 
dimensional electrophoresis (2-DE). Lysates or biological fluids are complex mixtures that 
contain a wide variety of non-protein substances in addition to the proteins to be analyzed. 
These substances often interfere with the resolution of the electrophoretic separation or the 
visualization of the result. Macromolecules (e.g., polysaccharides and DNA) can interfere 
with electrophoretic separation by clogging gel pores. Small ionic molecules can impair 
isoelectric focusing (IEF) separation by rendering the sample too conductive. Other 
substances (e.g., phenols and lipids) can bind to proteins, influencing their electrophoretic 
properties or solubility. In many cases, measures to remove interfering substances can 
result in significantly clearer 2D patterns with more visible spots and better resolution. It 
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should be borne in mind, however, that analysis of samples by 2-DE is usually most 
successful and informative when performed with minimally processed samples, so it is 
important that any steps taken to remove interfering substances is appropriate to the 
sample and performed only when necessary. Procedures for the removal of interfering 
substances therefore represent a compromise between removing non-protein contaminants, 
and minimizing interference with the integrity and relative abundances of the sample 
proteins (Berkelman, 2008). Depending on these remarks, demands on the extraction and 
preparation procedures are different.  
 
1.1 SOURCE OF SAMPLES 
Tissues, cell lines, primary cell cultures and body fluids (such as plasma or cerebrospinal 
fluid (CSF)) can be used as protein source. Different branches of proteomics are also 
devoted to plant, bacteria and virus proteins. Anyway, independently from the experimental 
model, sample preparation is a matter of great importance, especially in comparative 
proteomics. Thus, not only an appropriate experimental model, but also an optimized protein 
extraction protocol, have to be carefully considered to obtain reliable results.  
 
1.1.1 Eucaryotic source of sample: animal cells 
Recent advances in medical sciences would not be possible without animal research. 
Animal models for human diseases are indispensable in understanding the background and 
biology of a disease and in finding out the methods for its treatment. Mice and rats, for 
several reasons, are the models of choice. Well-characterized strains of animals are 
available. Physiological processes that occur in humans are often (but not always!) similar to 
those in rodents. Thus, studies on the physiopathology of various diseases at the proteome 
level are possible due to a relatively high similarity between the rats/mice and human 
proteins. Transgenic animals seem to be another great promise for obtaining appropriate 
and useful models. It has to be remembered that these models cannot be considered as a 
complete equivalent of human disorders, as they present only some of their aspects. We 
have to be aware that, apart from similarities, some systems could be different (for example, 
the rat steroid system is different from the human one). Aspects of gender, weight, feeding, 
etc., also need to be taken into consideration before establishing a model for a particular 
experiment. When a particular animal model has been established, usually the tissue 
connected with a particular disease is chosen for detailed analysis. It‟s obvious that every 
tissue has its own characteristics and has to be handled properly for protein extraction. 
During tissue preparation for proteomic analysis, it is important to diminish its 
heterogeneity, as much as it is possible. The sample should be pure and relevant. It seems 
to reflect the state of living organism, and sometimes, collected material could be cultured 
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for further experiments. On the contrary, simplification of the sample is one of the greatest 
advantages of cell culture serving as experimental model, especially in proteomics. This 
model allows for studying the behaviour of a single type of cell in the absence of the 
complexity of the entire tissue. This may help to reveal changes in low abundance proteins, 
which could be impossible in the whole tissue study. Body fluids are another important 
source providing vital information on the function of living organisms. Body fluids (such as 
blood, CSF, urine, and saliva) are relatively easily available; thus they are commonly used for 
clinical diagnosis (Hortin et al., 2006, Sowell et al., 2009).  
 
1.1.2 Procaryotic source of sample: bacteria 
Concerning bacterial samples preparation, problems can arise in disrupting cells, due to the 
presence of thick cell walls and polysaccharide capsule of certain bacterial groups (Cash, 
1998). Some bacteria could simply be lysed by the constituents of the lysis buffer (reducing 
agents and detergents), but others must be disrupted mechanically (e.g. by sonication). 
Sometimes, removal of the cell wall by enzymatic digestion is necessary. It has to be 
remembered that 2-DE analysis or another technique, used to separate and analyze 
bacterial proteins, will reflect the proteome of the bacteria at the time when proteins were 
solubilized. It means that all manipulations, such as centrifugation, may stress the bacteria 
and thus, influence the protein pattern. Another promise of bacterial proteomics, arises from 
the fact that the genomes of some bacteria, e.g. Escherichia coli, are now determined; so 
the complementary proteome analysis may bring some new interesting facts concerning 
cellular metabolism. The relatively small size of bacterial genomes makes it likely that we 
obtain a complete description of the free living organism from its genes to its 
complementary proteins and their functions, in the next few years. 
 
1.2 METHODS OF CELL DISRUPTION 
The first step in sample preparation for proteomic analysis is cell disruption. One of the 
simplest methods is homogenization that helps to break down the initial sample, to finer 
particles in the nano- to micro-meter scale, so that target molecules, such as proteins, can 
be released from the tissue for further processing. Ultrasonic homogenizers (also called 
disintegrators), are based on the piezoelectric effect. Alternatively, pressure homogenizers 
(such as French press) are an effective system for homogenization of eukaryotic, as well as 
microbial and plant cells in suspension. In addition, French press is often applied for the 
preparation of cell membranes for further experiments. Finally, osmotic lysis methods utilize 
osmotic pressure to destroy cell walls and membranes. Detergents are also efficient for cell 
disruption and extraction of nuclear and mitochondrial membranes. The most commonly 
applied detergents are Triton X-100, Tween 80, Nonidet P-40 (NP 40) and saponin.  
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1.3 PROTEIN SOLUBILIZATION 
Protein solubilization strongly affects the quality of final results and thus determines the 
success of the entire experiment. Once isolated, proteins are often insoluble in their native 
state. To avoid protein modifications, aggregation or precipitation (resulting in the 
occurrence of artefacts and subsequent protein loss), sample solubilization implicates the 
use of chaotropes, detergents, reducing agents and protease inhibitors. 
Usually, a neutral chaotropic agent, urea, is used at high concentrations ranging from 5 to 
9 M to effectively disrupt secondary protein structure. As indicated by Rabilloud (1997), 
addition of thiourea to the denaturing solution containing urea, allows for substantial 
improvement of protein solubility. Addition of thiourea to the sample buffer decreases 
solubilization of urea. Therefore, when combined with 2 M thiourea, urea concentration 
should not exceed 5–7 M (Herbert, 1999).  
Detergents and amphipathic molecules enable protein extraction and solubilization. It has 
already been reported the great solubilizing power of zwitterionic detergents (Chevallet et 
al., 1998, Perdew et al., 1983), in addition it has been proved that non-ionic detergents are 
also efficient (Luche et al., 2003, Taylor et al., 2003). Nowadays, sulfobetaine 3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) is most commonly applied 
in proteomic studies due to its high solubility and a relative lack of detergent-induced 
artefacts. As regarding solubilization of the integral or membrane-associated proteins it has 
to be improved by using specific detergents (e.g. Triton X-114 (Polati et al., 2009)). 
Reducing agents disrupt disulfide bonds between cysteine residues, thus, promote protein 
unfolding and enable analysis of single protein subunits. Conventionally, phosphines, e.g. 
tributhylphosphine (TBP) and triscarboxyethylphosphine (TCEP) are used as sulfhydryl 
reducing agents: they are apolar, therefore don‟t migrate out of the pH gradient while 
performing isoelectric focusing. Moreover phosphines do not interact with the alkylating 
substrates such as 4-vinylpyridine and acrylamide (Herbert et al., 1998). Thus, reduction 
and alkylation may be performed in a single step. 
Finally, if not inhibited during cell membrane disruption, endogenous proteases are 
responsible for uncontrolled enzymatic proteins degradation. Such proteolysis may produce 
artefacts and hence complicate further analysis (Olivieri et al., 2001). In general, addition of 
specific protease inhibitors, or cocktails of them with a broader activity spectrum, is 
recommended (Rai et al., 2005, Terry et al., 2004). 
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1.4 REMOVAL OF CONTAMINANTS 
Among most common contaminants, salts and lipids naturally occur in body fluids and 
tissues, and may interfere with electrophoretic separation of proteins (Yuana and Desiderio, 
2005). Most often, salt removal is being accomplished via (spin, micro) dialysis (Manabe et 
al., 1999, Lai et al., 2000), ultrafiltration (Jiang et al., 2004, Sickmann et al., 2000), gel 
filtration, and precipitation (Simpson, 2004). In addition, the use of centrifugal filter devices 
and the sample buffer added of CHAPS allows for efficient lipid and salt removal. 
Alternatively, precipitation in acetone or in trichloroacetic acid (TCA)/acetone removes lipids 
efficiently. Polysaccharides and nucleic acids are negatively charged polymers which 
interact with proteins and clog the pores of the polyacrylamide gels causing streaking visible 
on 2D gels. In order to exclude polysaccharides and nucleic acids from the sample, 
precipitation may be beneficial (e.g. by complexing them with carrier ampholytes). This 
phenomenon is particularly serious in Gram negative bacteria. In fact, the cell wall is made 
of high molecular weight polysaccharides that tend to form complexes with nucleic acids 
that streak in the acidic part of the 2D map. Moreover in order to remove DNA and RNA, 
digestion with protease free DNase and RNase is often applied (Kikkawa et al., 2006). 
Finally, buffers, salts and detergents (included in solubilizing solutions) often tend to 
interfere with further protein separation steps: they inhibit the in-gel digestion process and 
interfere with the mass spectrometry analysis. Thus they need to be removed at a proper 
time of analysis. Protein precipitation followed by resuspension in an adequate sample 
solution belongs to the most commonly applied procedures enabling removal of most of 
contaminants. Unfortunately, there is currently no method that would allow precipitating all 
proteins and, consequently, only precipitated proteins can be further resolubilized. Most 
commonly, precipitation with TCA, acetone, chloroform/methanol, ammonium sulphate or 
combinations of the above are being performed.  
 
1.5 PROTEIN DEPLETION AND ENRICHMENT METHODS 
The proteome and subproteomes of any living cell are highly dynamic and of unknown 
complexity, making the characterization of proteomes a formidable challenge. While the 
concentration range of proteins in a given sample may exceed 10 orders of magnitude 
(Anderson et al., 2002), currently available proteomic approaches are estimated to focus on 
the 30% most abundant proteins in an extract. Proteomic analyses are, hence, complicated 
and detection of least abundant proteins is hampered by those molecules present at higher 
concentration. Plasma, serum and CSF, are protein sources of great importance to 
biomedicine, diagnostics and therapeutics, containing up to 90% of highly abundant 
proteins such as albumin, immunoglobulins (IgG and IgA), antitrypsin, transferrin, 
transthyretin, α1-antitrypsin, hemopexin and haptoglobin. Removal of these proteins may 
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increase detection of other molecules present at lower concentration. Various strategies 
have been presented for the removal of high-abundant proteins (Sitnikov et al., 2006), most 
of which are based on affinity chromatography employing mimetic ligands (Kabir, 2002, 
Sato et al., 2002), proteins A and G (Funtoulakis et al., 2004), and antibodies. 
On the other side, enrichment methods allow for increasing the concentration of proteins of 
interest. This statement is really important in the proteomics study, because usually low-
abundance proteins carry valuable diagnostic information and are responsible for processes 
ongoing in cells. In order to increase the likelihood of detecting less abundant proteins, a 
variety of protein separation techniques are applied to reduce the complexity of a sample 
prior to proteome analysis (Funtoulakis et al., 2003, Yates et al., 2005). The fundamental 
idea of prefractionation is to isolate the sample into distinct fractions containing restricted 
numbers of molecules. Preparative liquid electrophoretic methods are common 
fractionation systems for proteome profiling. The latest technology platforms that have been 
developed for proteomics include the Rotofor, a multicompartment instrument capable of 
fractionating proteins according to their pI (Righetti et al., 2005). 
Alternatively, common methods of protein enrichment and purification rely on selective 
precipitation and immunoprecipitation. A novel approach for mining the “unseen proteome” 
is ProteoMinerTM technology (Bio-Rad), which exploits solid phase combinatorial peptide 
ligand libraries (Guerrier  et al., 2008, Righetti et al., 2008). ProteoMinerTM simultaneously 
reduces the concentration of high abundance proteins and enriches the concentration of 
trace proteins without depletion of any specific proteins, in a high throughput manner. Each 
bead binds a specific binding partner and a wide diversity of ligands is available (typically 
millions). The population of beads has such diversity that a binding partner should exist for 
most, if not all, proteins present in a sample. In this system the binding capacity for high 
abundance proteins is, in principle, equal to that for low abundance proteins. Thus, when a 
complex sample is incubated with the bead library, high abundance proteins saturate their 
binding partner and excess protein is washed away, whilst low abundance proteins are 
“concentrated” on their specific affinity ligand. In this way the abundance of trace proteins is 
increased relatively to the highly abundant proteins (see Fig. 2). Importantly, in this system, 
unlike the use of depletion methods, no fraction is discarded and proteins that may be 
complexed with high abundance species like albumin are not lost. 
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Fig 2. ProteoMinerTM technology: each bead has a different ligand, with affinity for specific proteins of the 
sample. Adapted from Guerrier et al., 2008. 
 
2. METHODOLOGIES AND TECHNOLOGIES IN CLASSICAL PROTEOME STUDY 
Once proteins are purified and ready to be separated, there is a plethora of proteomic 
techniques to investigate the biological problem the scientist is dealing with. The choice of a 
given proteomic approach should depend on the type of biological question asked, since 
each proteomic technology is characterized by specific applications, technical advantages 
and limitations. In general, proteomic approaches can be used for a) proteome profiling, b) 
comparative expression analysis of two or more protein samples, c) localization and 
identification of posttranslational modifications, and d) studying protein–protein 
interactions. A classical widely used proteome approach relies on 2-DE coupled to mass 
spectrometry analysis. 
 
2.1 TWO-DIMENSIONAL GEL ELECTROPHORESIS  
The traditional two-dimensional gel electrophoresis (2-DE) method was introduced in 1975 
by O‟Farrell (O‟Farrell, 1975) and represents now one of the most commonly applied 
techniques in proteomics. This method is based on orthogonal separation of proteins 
according to different physicochemical principles. Proteins in complex mixtures are 
electrophoretically separated, first according to their isoelectric point (pI) by isoelectric 
focusing (IEF) and, subsequently, according to their relative molecular mass (Mr) by sodium-
dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). Depending on the gel size 
and pH gradient, it is possible to resolve simultaneously more than 5000 protein spots 
(Goerg et al., 2000). 2-DE is used for large-scale protein separation since its invention for 
purification, identification as well as quantification of proteins (Fig. 3). Moreover, 2-DE 
provides information on changes in protein expression, as well as on different protein 
isoforms and post-translational modifications (Mukherji, 2005).  
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Fig 3. Overview of two-dimensional gel electrophoresis (2-DE) based strategy. 
 
2.1.1 2-DE Methodologies 
As mentioned in previously, the success of any protein separation and purification 
techniques depends on the protein solubilization method. A traditional sample preparation 
for 2-DE involves cell or tissue disruption and protein solubilization in presence of high 
concentrations of urea, reducing agents and detergents. A common 2-DE sample buffer 
contains 7 M urea, 2 M thiourea, 20 mM Tris, 3% CHAPS. The immobilized pH gradient strip 
(IPG strip) is then rehydrated with sample, and proteins are separated by IEF.  
During IEF, under the influence of an electric field, each protein migrates through the pH 
gradient until it reaches its pI. Until recently, a mixture of carrier ampholytes was commonly 
used to create the pH gradient for IEF. However, problems were occurring with these carrier 
ampholytes-created pH gradients, such as so-called “cathode drifting” and pH flattening 
near the anode (Righetti et al., 1973). In order to circumvent the ampholyte-linked technical 
difficulties, commercially available immobilized pH gradients (Bjellqvist et al., 1982) are now 
generally used. The pH gradient in IPG strips is created by acrylamido-buffers (containing 
weakly acidic or basic buffering groups) admixed to neutral acrylamide monomers and 
poured gradient-wise via a two-vessel gradient mixer. Covalent immobilization of the 
buffering groups inside the polyacrylamide gel prevents drifting of the pH gradient under the 
influence of an electric current, thus increasing the resolution as well as the reproducibility 
of 2-DE patterns. Moreover, by using IPG strips with a reduced slope of the pH gradient it is 
possible to significantly increase the resolution of protein separation. Another application of 
IPG strips is the creation of the so-called zoom-gels, where narrow pH gradients are used 
allowing for high-resolution separation of spots containing proteins with the same molecular 
mass but slightly different pI.  
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After IEF, the IPG strips (with focused proteins) is equilibrated in a SDS-containing solution in 
order to proceed with the second dimension, where proteins are separated according to 
their molecular mass by means of SDS-PAGE. Also the resolution of second dimension may 
be improved by changing the percentage of polyacrylamide and by using pore gradient gels 
(Fountoulakis et al., 1998). However, SDS-PAGE separation of high molecular mass proteins 
as well as very low molecular mass ones is still rather challenging. The applicability of 2-DE 
analysis generally remains limited to proteins with molecular size between approximately 10 
and 150-200 kDa. 
 
2.1.2 Protein Detection And Quantification  
Protein spots on 2-DE gels can be visualized by a variety of protein staining techniques, 
each characterized by specific technical aspects, sensitivity, linear range for quantitation, 
reproducibility and compatibility with mass spectrometric analysis (Table 1). In fact, the 
major challenge for protein visualization in 2-DE is the compatibility of sensitive protein 
staining methods with mass spectrometric analysis. Among the most commonly used 
protein staining methods, Coomassie Blue staining has a sensitivity of up to 30 ng/spot and 
compatibility with mass spectrometry, while silver staining has an higher sensitivity 
(1 ng/spot), but was originally incompatible with mass spectrometric analysis, due to the 
aldehyde fixation steps. Several fluorescent staining methods have been also developed, 
including Sypro staining and Cy-dyes. 
 
Table 1. Commonly used protein staining methods for 2-DE analysis. 
 
Sypro Ruby staining (Berggren et al., 2000) allows for a much higher sensitivity, a 
significantly wider dynamic range, less false-positive staining, and is compatible with mass 
spectrometric analysis. In addition, Sypro Ruby allows for the detection of lipoproteins, 
glycoproteins, metalloproteins, calcium-binding proteins, fibrillar proteins and low molecular 
mass proteins that are very difficult to stain by using other methods. The recently developed 
Staining 
Method 
Sensitivity Reversible 
MS 
compatibility 
Straightforward 
protocol 
Highly 
reproducible 
Linearity: 
order of 
magnitude 
Silver 1 ng - - - ±    1 
Coomassie 100 ng + + + +    2 
Coomassie 
R250 
50 ng + + + +    2 
Colloidal 
coomassie 
10 ng + + + +    2 
Sypro Ruby 1 ng + + + + > 3 
Cy-dyes 125 pg + + + +    4 
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Flamingo stain (Bio-Rad) proved to be even more sensitive than Sypro Ruby. Based on Cy-
dyes, two-dimensional difference in-gel electrophoresis (DIGE) technology has been 
developed. It permits the simultaneous separation of two samples on the same gel by the 
differential labelling with different cyanine dyes prior to the first dimension (Unlu et al., 
1997). Cyanine dyes carrying an N-hydroxysuccinimidyl ester reactive group covalently bind 
the ε-amino group of lysine residues in proteins. Staining with these dyes is more sensitive 
than silver staining, giving a linear response to protein concentrations of up to four orders of 
magnitude. In addition, no fixation or destaining steps are required during DIGE analysis, 
reducing protein loss from the gels. Hence, a major advantage of this technique is a 
significant reduction in inter-gel variability, facilitating spot identification and matching 
during image analysis, thus increasing the number of analyzable spots. 
 
2.1.3 Two-Dimensional Gel Image Analysis 
The possibility of detecting protein expression changes (associated with diseases and 
treatments or finding therapeutic molecular targets) has been, among many other 
applications, a major incentive to the development of dedicated software systems for 2-DE 
gel image analysis. In the early 1980s, the first packages started to be delivered to the 
public and some of them have survived the computational evolution of the last two decades. 
Among these were PDQuest and ImageMaster 2D Platinum (based on Melanie). Table 2 
gives a list of the major available packages. In general, besides basic visualisation 
properties, the major functions of software systems for 2-DE gel image analysis are (i) 
detection and quantification of protein spots on the gels, (ii) matching of  
 
Table 2. Major commercialised 2-DE image analysis software. 
Software Company Source website 
DeCyder GE Healthcare www.gehealthcare.com 
Delta2D Decodon www.decodon.com 
ImageMaster 2D Platinum GE Healthcare www.gehealthcare.com 
PDQuest Bio-Rad www.bio-rad.com 
Progenesis (formerly Phoretix) Nonlinear Dynamics www.nonlinear.com 
Proteomeweaver Definiens/Bio-Rad 
www.definiens.com/www.bio-
rad.com 
 
corresponding spots across the gels, and (iii) detection of significant protein expression 
changes. Any other additional feature, such as data management and database integration, 
may or may not be included. Moreover, detection algorithms included in the packages 
generally comprise filtering steps to automatically remove streak artefacts and noise spikes. 
Spot detection algorithms also produce quantitative information of the protein spots, such 
as the spot area and OD (maximum intensity value in the area). Matching of gel images is a 
critical process: it depends on the similarity of the spatial distribution of spots across all the 
gels, which may vary according to experimental gel running conditions and gel scanning. 
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Some tools propose the initialisation of a few corresponding spots representing the same 
proteins in different gels: a landmarking step. These landmarks will then be used to warp 
the gel images and correct possible distortions, and consequently improve the matching 
quality. Anyway, each tool has its own strengths and weaknesses that vary depending on the 
gel type and experimental conditions. In the software that deals with DIGE gels, only the spot 
detection function is adapted. Since the same proteins will be localised in the same x and y 
coordinates on the gels, the spot detection procedure is the same for the co-detected gels. 
The matching step is thus straightforward and subject to much less errors. Finally, it should 
be noted that, despite continuous optimization of algorithms used by these software, a time-
consuming visual verification remains necessary for all steps of software analyses of 2-DE 
patterns. 
 
2.1.4 Advantages And Limitations Of 2-DE Based Proteomics 
2-DE has the enormous advantage to display simultaneously thousand of proteins on a 
single 2D map, obtaining a picture of any complete proteome being studied. Furthermore, it 
permits to analyze polypeptides in their full-length form, thus allowing for characterization of 
single PTMs by detection with specific antibodies, as well as with specific staining (e.g. Pro-
Q® Diamond phosphoprotein stain). However, while the scientific community is digging more 
deeply in proteomes, also thanks to fractionation methodology, there are still 2-DE based 
studies which are “re-discovering similar proteomes in different samples”. This observation 
creates the impression of scratching the surface: it seems that many studies still reveal 
similar “housekeeping proteomes” as found in many cell and tissue types, or that the 
candidate biomarkers for a specific disease are often markers for a generic phenomenon 
underlying several diseases, such as inflammation (Petrak et al., 2008). Indeed many 
proteins are expressed at such low levels that they will escape detection, and other 
technical problems linked with 2-DE proteomic approach remain, such as co-migration of 
proteins and loss of insoluble ones (Bronstrup, 2004). Nevertheless, 2-DE remains a very 
useful method for displaying and quantification of a majority of proteins in almost any kind 
of biological samples, and its technologies are robust and increasingly reproducible. 
Moreover, the sensitivity and applicability of presently available technologies are improving 
continuously, and for many types of biological questions, specific proteomic approaches are 
currently available. 
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2.2 MASS SPECTROMETRY TECHNOLOGIES 
The invention of mass spectrometers made possible the analysis of proteins and peptides – 
molecules that have classically been studied individually or in small numbers – in a large-
scale and in a high-throughput mode (Wilkins et al., 1996). Remarkable progress has been 
achieved in the meantime: current mass spectrometric platforms can cover a dynamic range 
of up to 104 (Lescuyer et al., 2007), and extensive protein and peptide pre-fractionation and 
sophisticated data acquisition and processing are in place. Today's shotgun proteomic 
approaches reveal up to some 2000 protein identities and the number of true positive 
protein identifications within those long lists has enormously increased over the years. This 
important achievement can be attributed to (a) improved mass spectrometric 
instrumentation with better sensitivity and specificity, the latter based on superior mass 
accuracy and resolution (e.g. Orbitrap (Makarov, 2000)); and (b) more sophisticated 
software for peptide sequencing and protein identification. 
 
2.2.1 Protein Identification By Mass Spectrometry 
In a typical proteomic experiment, proteins of interest are digested with enzymes for 
identification by mass spectrometric analysis. Trypsin is the most commonly used protease 
in proteomic analysis and displays good activity with in-gel digestion, as well as with in-
solution digestion.  
Mass spectrometers consist of an ion source that converts analyte molecules into gas-phase 
ions, a mass analyzer that separates ionized analytes on the basis of their mass-to-charge 
(m/z) ratio, and a detector that records the number of ions at each m/z value. Regarding ion 
sources, matrix-assisted laser desorption/ionization (MALDI) (Karas et al., 1988) and 
electrospray ionization (ESI) (Fenn et al., 1989) are central in proteomics.  
MALDI is generally more salt-tolerant than ESI and it is typically coupled to time-of-flight 
(TOF) analyzers. For successful MALDI analysis, the key point is the proper choice of matrix 
and sample deposition method, to achieve the highest possible sensitivity and accuracy. The 
most popular matrices for proteomic applications include α-cyano-4-hydroxycinnamic acid 
(CHCA), sinapinic acid (SA) and 2,5-dihydrobenzoic acid (DHB). Particularly, MALDI mass 
spectrometry, thanks to its speed, sensitivity, accuracy, satisfactory tolerance to impurities 
and ease of automation, allows for protein identification by the set of measured proteolytic 
peptide masses. This process is known as peptide mass fingerprinting (PMF) and Mascot is 
among the most used algorithms in this identification approach (Perkins et al., 1999). 
Briefly, the experimental mass profile is matched against those generated in silico from the 
protein sequences in the database using the same enzyme cleavage sites. Unfortunately, 
the lack of sequence data makes identification by PMF ambiguous. The recent introduction 
of LC-MALDI technology offered a sophisticated and efficient mean of sample purification 
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and separation combining the advantages of capillary liquid chromatography (LC) with the 
sensitivity and accuracy of MALDI-MS; in fact in the newest instruments, peptides eluted 
from the column are directly spotted onto target plate by robot machines (Ro et al., 2006).  
ESI, instead, is often coupled to ion trap (IT) or quadrupole (Q) analyzers as this combination 
enables efficient peptide sequencing by induced fragmentation (MS/MS). In an ESI ion 
source the ionization process occurs under atmospheric pressure and the sample is 
introduced as liquid, therefore electrospray may be coupled directly to liquid 
chromatography systems. In particular, reversed-phase liquid chromatography coupled to 
tandem mass spectrometry (RP-LC-MS/MS) is a well established and commonly used 
procedure for identification of the in-gel digested proteins. Furthermore, newly introduced 
nano HPLC combined with ESI-MS/MS has emerged among the most widely used and the 
most powerful tools for proteomic research. Indeed, miniaturizing the HPLC separation 
column inner diameter improves electrospray sensitivity, because the concentration of 
equally abundant analytes in the LC mobile phase is proportional to the square of the 
column internal diameter. Moreover, because the sample must be loaded at flow rates of 
200 nL/min, the sample volume to be injected onto a conventional nano HPLC system is 
usually only 1-2 μL. This approach usually requires an additional salt removal step during 
peptides preparation. In fact, a disposable C18 RP extraction tip, to remove insoluble 
particles and salts, and to pre-concentrate peptides has been introduced (Rappsilber et al., 
2003). For similar reasons, commercially available capillary chromatography systems 
include trapping pre-columns, where the sample is purified, desalted and pre-concentrated 
prior to injection onto the capillary column. In proteomic applications, the positive ion mode 
is mostly used, in which ionization is based on protonation of the analyte molecules, 
therefore the sample is often acidified, e.g. with formic or trifluoroacetic (TFA) acids, to 
facilitate ion formation.  
Very recently, a new ionization technique was devised termed desorption electrospray 
ionization (DESI). Here the charged droplets of solvent are sprayed onto the analyzed object, 
so that molecules present on its surface are ionized (Takats et al., 2004). DESI can be 
applied to solids, liquids (including complex biological samples) and adsorbed gases. 
Importantly, DESI apparently does not require sophisticated sample pre-treatment and 
tissue sections could be directly analyzed. 
The mass analyzer is central to mass spectrometric technology, and in the proteomics 
context, its key parameters are: sensitivity, resolution, mass accuracy and ability to produce 
information-rich fragment mass spectra from peptide ions (tandem mass or MS/MS 
spectra). There are five basic types of mass analyzers currently used in proteomics 
(Aebersold et al., 2003): ion trap (IT), time-of-flight (TOF), quadrupole (Q), Fourier transform 
ion cyclotron resonance (FT-ICR), and the newly developed Orbitrap system (Makarov, 
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2000). Often, they work as stand-alone mass analyzer, but the current trend points towards 
hyphenated systems in order to combine the advantages of different analyzers in one mass 
spectrometer (Fig. 5). In reflector TOF instruments (Fig. 5a), the ions are  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 5. Mass spectrometers used in proteomic research. The left and right upper panels depict the two ionization 
technologies, electrospray ionization (ESI) and matrix-assisted laser desorption/ionization (MALDI). The different 
instrumental configurations (a–f) are shown with their typical ion source. Adapted from Aebersold and Mann, 
2003. 
 
accelerated to high kinetic energy and are separated along a flight tube as a result of their 
different velocities. The ions are turned around in a reflector, which compensates for slight 
differences in kinetic energy. The TOF-TOF instrument (Fig. 5b) incorporates a collision cell 
between two TOF sections. Ions of one m/z ratio are selected in the first TOF section, 
fragmented in the collision cell, and the masses of the fragments are separated in the 
second TOF section. Quadrupole mass spectrometers select ions by time-varying electric 
fields between four rods, which permit a stable trajectory only for ions of a particular desired 
m/z. In the triple quadrupole analyzer or linear ion trap (LTQ) (Fig. 5c), ions of a particular 
m/z are selected in a first section (Q1), fragmented in a collision cell (q2), and the 
fragments separated and scanned out in Q3. The Q-TOF instrument (Fig. 5d) combines the 
front part of a triple quadruple instrument with a reflector TOF section for measuring the 
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mass of the ions. The (three-dimensional) ion trap (IT) (Fig. 5e) captures the ions as in the 
case of the linear ion trap, fragments ions of a particular m/z, and then scans out the 
fragments to generate the tandem mass spectrum. The FT-ICR instrument (Fig. 5f) also traps 
the ions, but does so with the help of strong magnetic fields. In the Orbitrap technology (Fig. 
5g) ions orbit around a central spindle-like electrode and oscillate harmonically along its axis 
with a frequency characteristic of their m/z values. 
On the basis of this development, a new hybrid mass spectrometer became commercially 
available very recently: it consists of a LTQ coupled to an IT and the Orbitrap. It combines the 
robustness, sensitivity, and MS/MS capability of the LTQ with very high mass accuracy and 
high resolution capabilities of the Orbitrap. The IT-FT-ICR and IT-Orbitrap instruments are 
especially efficient when combined with fragmentation techniques such as electron capture 
dissociation (ECD) (Zubarev et al., 2000) or electron-transfer dissociation (ETD) (Syka et al., 
2004). 
Irrespectively to the type of ion source and mass analyzer, MS/MS provides access to 
sequence data, which allows to more confidently identify peptides. In an MS/MS 
experiment, daughter ions obtained from fragmentation of a precursor ion produce a unique 
signature which can be used for database searching. This process is described as peptide 
fragment fingerprinting (PFF) as opposed to PMF. Identification of proteins using MS/MS 
data is nowadays performed using three different approaches: (i) peptide sequence tag 
(Mann et al., 1994), (ii) cross-correlation method and (Eng et al., 1994), (iii) probability 
based matching (typical example is Mascot (Perkins et al., 1999)). All previously described 
approaches are based on the assumption that a proteomic or translated genomic databases 
is available to perform the search. De novo sequencing approach, instead, uses the MS/MS 
spectra as the only reference to directly deduce the peptide sequence using specifically 
developed string similarity search algorithms. They require spectra of higher quality with 
smaller fragment errors (such as those obtained with FT-ICR or Orbitrap instruments). 
Currently, PFF is the most common strategy for identifying proteins because of the greater 
robustness than PMF or de novo. 
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CHAPTER 2 
GEL-FREE PROTEOMICS  
 
1. MS-BASED PROTEOMICS 
MS-based proteomics gives the possibility to identify and quantify as many proteins as 
possible in a single experiment. Nowadays, LC-MS/MS systems have become one of the 
preferred methods to conduct large-scale characterization of proteomes. High-performance 
liquid chromatography (HPLC) is an important separation technique in proteomics. It can 
easily be coupled to mass spectrometry, which makes it a perfect tool for separation of 
proteins and peptides directly prior to mass analysis. Liquid chromatography may be used 
both in top–down and bottom–up proteomics approaches. In the first case, the protein 
sample is separated and then individual proteins (or simple mixtures) are identified directly 
by means of tandem mass spectrometry. In the bottom–up approach, the protein, or protein 
mixture is digested. Single- or multidimensional LC coupled to MS (MudPit) is then used for 
separation of peptide mixtures and identification of their compounds (Fig. 6). In particular, 
strong cation exchange (SCX) chromatography is usually adopted as a part of 2D systems, 
where sample components are first separated on an SCX column and then transferred to 
the RP column. Chromatographic separation also lowers sample complexity, which makes 
the analysis more sensitive for low-level components (Kislinger et al., 2005, Yates et al., 
2009). 
 
 
 
 
 
 
 
 
 
 
                   Fig 6. Overview of MudPit based strategy. Adapted from Motoyama and Yates, 2008. 
 
While still producing excellent results, “gel-based” quantitative proteomics is going to be 
superseded by “gel-free” MS-based quantitative proteomics approaches, where 
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quantification is performed using the mass spectrometric data. In both MALDI- and ESI-MS 
the relationship between the amount of protein present and the measured signal intensity is 
measured via different approaches. A first solution came with the technique of stable-
isotope dilution. This method is based on the fact that pairs of chemically identical 
molecules (in this case peptide pairs), but with different stable-isotope composition (2H 
instead of 1H, for example) can be differentiated in a mass spectrometer owing to their mass 
difference only. Thus the ratio of signal intensities for such peptide pairs should be a direct 
and accurate measure of the abundance ratio between the two peptides, or proteins, 
derived from two different biological conditions. To accomplish this purpose, three main 
approaches exist today which are: (i) metabolic stable-isotope labelling (for example by 
amino acids in cell culture, SILAC (Ong et al., 2002)), (ii) isotope tagging by chemical 
reaction and (iii) stable-isotope incorporation via enzyme reaction (Mirgorodskaya et al., 
2000). Regarding the second method, a wide variety of isotopically labelled chemicals has 
been reported (Panchaud et al., 2008). Isotope-coded affinity tagging (ICAT was the first 
approach described in 1999 by Gygi and co-workers ) (Gygi et al., 1999). Recently, Gygi and 
colleagues have described a new method called catch-and-release (CAR) (Gartner et al., 
2007). Several strategies have been reported that target amines isobaric tag for relative 
and absolute quantification (iTRAQ) (Ross et al., 2004). A clear advantage of all these 
chemical approaches is the multitude of available functional groups in proteins allowing 
designing almost any kind of quantitative tag. However, reactions have to be specific, 
proceed to completion and involve minimal sample handling. Side reactions are 
problematic, too, as they considerably increase the sample complexity. It has to be noted 
that, if such experiment is undertaken, one needs to be able to quantify thousands of 
labelled peptides using automatic tools capable of extracting the intensity for both peptides 
of a pair and report a protein ratio based on all identified and quantified peptides. Even 
more important, such tools should be able to process data from different instrument 
manufacturers and should also be able to accept result input from different search engines 
(Mascot, SEQUEST, etc.). Several open-source softwares have been developed by scientific 
laboratories performing large-scale quantitative proteomic experiments and in general each 
of them has been developed according to supported instruments or database search 
algorithms. 
 
2. SELDI 
As a conceptual modification of MALDI-TOF measurements, surface-enhanced laser 
desorption/ionization (SELDI) technique, that combines chromatographic separation and 
mass spectral measurement for proteomic profiling and biomarker discovery is marketed by 
Bio-Rad. The SELDI chips contain chromatographic coating of selected type (i.e. 
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hydrophobic, ion-exchange, metal-binding, etc.), on which sample components of a given 
type are captured. Unbound compounds are washed off, thus contaminants are removed 
and sample complexity is markedly reduced. After application of a proper energy-absorbing 
matrix, such as CHCA or SA, the proteins bound to the stationary phase are analyzed for MS 
profiling. The great advantage of SELDI lies in its ability to remove salts and other impurities 
prior to MS analysis, thanks to which crude samples can be analyzed, such as urine (Nguyen 
et al., 2005), cerebrospinal fluid (Ranganathan et al., 2005), serum (Fig. 6) (Ho et al., 
2006), etc. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 6. Analysis of serum proteins using ProteinChip arrays and SELDI-TOF/MS. A. Crude serum sample is placed 
(and processed) on a ProteinChip array which contains chemically (cationic, anionic, hydrophobic, hydrophilic, 
etc.) or biologically treated surfaces for specific interaction with proteins of interest. Proteins, thus, bind to 
chemical or biological "docking sites" on the ProteinChip surface. Non-binding proteins, salts, and other 
contaminants are washed away, eliminating sample "noise". B. Retained proteins are "eluted" from the 
ProteinChip array by Surface-Enhanced Laser Desorption/Ionization (SELDI). Ionized proteins are detected and 
their mass accurately determined by Time-of-Flight Mass Spectrometry (TOF/MS). Adapted from Abramovitz and 
Leyland-Jones, 2006. 
 
3. PROTEIN MICROARRAY 
Protein microarrays are valuable platforms for both classical and functional proteome 
analysis and can provide valuable information at the systems-level which is not possible 
using other techniques. In protein microarrays, antibodies or purified proteins are 
immobilized on glass slides, which are then used for screening cellular responses to a 
stimulus (e.g. challenge with plant pathogens) directed against the immobilized proteins and 
for screening protein-protein interactions (Duburcq et al., 2004, LaBaer et al., 2005) (Fig. 7). 
The application of protein microarray technologies in proteomics is now becoming more 
widespread and many approaches involving antibody and other protein have been used for 
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generating these microarrays. Protein microarrays can be integrated with new techniques 
such as surface plasmon resonance (SPR) and MS.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig 7. A. Analytical protein microarray. Different types of ligands, including antibodies, antigens, DNA or RNA 
aptamers, carbohydrates or small molecules, with high affinity and specificity, are spotted down onto a 
derivatized surface. These chips can be used for monitoring protein expression level, protein profiling and clinical 
diagnostics. Similar to the procedure in DNA microarray experiments, protein samples from two biological states 
to be compared are separately labelled with red or green fluorescent dyes, mixed, and incubated with the chips. 
Spots in red or green colour identify an excess of proteins from one state over the other. B. Functional protein 
microarray. Native proteins or peptides are individually purified or synthesized using high-throughput approaches 
and arrayed onto a suitable surface to form the functional protein microarrays. These chips are used to analyse 
protein activities, binding properties and post-translational modifications. With the proper detection method, 
functional protein microarrays can be used to identify the substrates of enzymes of interest. Consequently, this 
class of chips is particularly useful in drug and drug-target identification and in building biological networks. 
Adapted from Phizicky et al., 2003. 
 
4. CHEMICAL PROTEOMICS 
Most classical proteomic techniques do not allow direct assessment of post-translational 
regulation by factors such as protein–protein and/or protein–inhibitor interactions so they 
often fail to provide an understanding of global protein function (Gygi et al., 1999). In 
particular, many enzymatic proteins such as proteases are synthesized as precursor 
(zymogen) forms that must be post-translationally activated resulting in activity profiles that 
are often poorly correlated with overall abundance. In order to address this limitation in 
classical proteomic methods, the field of chemical proteomics has recently been established 
as a means to profile global patterns of enzyme activity through the use of synthetic small 
molecules known as activity-based probes (ABPs) (Cravatt and Sorensen, 2000, Greenbaum 
et al., 2002). These chemical reagents can be designed to target a distinct subset of 
enzymatic targets and facilitate identification as well as activity-based protein profiling 
(ABPP) of enzymes in complex proteomes. These methods have proven to be a powerful 
addition to the proteomics toolbox, however, as with the use of any kind of small molecule 
A B 
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tool there exists the possibility of off-target effects that are difficult to resolve. Generally, 
these issues can be addressed with detailed follow-up studies using classical genetics and 
biochemistry and by using multiple classes of probes that modify the same enzyme target. 
The central component of this method is the ABP which consists of three basic structural 
elements: a reactive group (or „warhead‟), a linker/specificity region and a tag region (Jeffery 
and Bogyo, 2003). The warhead group serves as the key functional element that directs 
covalent, activity-dependant modification of a target enzyme or enzyme family. The linker 
region serves as a scaffold for attachment of functional groups that direct the selectivity of 
the probe and the tag is used to visualize the resulting modified target enzymes. A number 
of different warheads, linkers and tags have been used and are the focus of several other 
extensive reviews (Adam et al., 2002; Jeffery and Bogyo, 2003, Berger et al., 2004, Speers 
and Cravatt, 2004). Two basic approaches have been taken in the design of ABPs: a 
directed approach aimed at designing probes to target a specific enzyme or class of 
enzymes and a non-directed approach aimed at characterizing enzyme families for which 
selective active-site reagents have not yet been identified. In both cases, the ABP provides a 
facile means to simplify a complex proteome into a „functional‟ proteome thus allowing a 
focused look at regulation of a small set of enzymatic targets (Phillips and Bogyo, 2005). 
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PROTEOMICS MEETS MICROBIOLOGY  
 
MICROBIAL PROTEOMICS  
With the completion of over 1000 prokaryotic and eukaryotic genome sequences and with 
hundreds of sequencing projects currently underway (Celestino et al., 2004), researchers 
are now facing the daunting task of assigning functions to the thousands of predicted gene 
products. While microarray technologies (Shalon et al., 1996) provide invaluable information 
concerning the levels of global mRNA expression, it is clear that in many cases mRNA 
transcripts do not directly correlate with protein expression (Anderson and Seilhamer, 1997; 
Gygi et al., 1999a). Therefore, the field of proteomics is challenged with the task of providing 
both quantitative and functional data to further complement genomics efforts. 
In particular the sequencing of the genomes of most economically important microbial cells, 
allow the application of proteomic technologies during various steps of process 
development, starting with the selection and optimization of the functions of the industrial 
strains, application of the knowledge of cell function in response to the changes of 
production parameters, validation of the downstream processing, and thorough 
characterization of the final product. 
Proteomic methods in food technology and biotechnology, as well as in quality control were 
at the beginning rather limited. However, this has changed rapidly and proteomics 
technology is now becoming more practical, and the terms “industrial process proteomics” 
(Incamps et al., 2005) and “industrial proteomics” (Josic et al., 2007) have been introduced. 
Nowadays proteomic technologies can be used in “classical” fermentation industry, for 
identification of targets for bioprocess improvement (Wang et al., 2003). In addition, 
proteomics is also used for quality control in industrial processes of other food products of 
animal origin (Pineiro et al., 2003). While classical proteomic techniques provide methods to 
determine the identity and abundance of proteins within a given proteome, an 
understanding of protein function can only be inferred from changes in expression. In the 
case of enzymes, activity is often tightly regulated by a series of post-translational controls 
and therefore may not be directly correlated with protein abundance. To address the need to 
profile global patterns of enzyme activity, a new set of proteomic techniques has been 
developed that make use of small molecule chemical probes that provide an indirect 
readout of enzyme activity (Phillips and Bogyo, 2005). 
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Yeast fermentation in food processing has been a tradition for thousands of years, and 
optimization of the fermentation process, purification, productivity, yield and purity, and 
characterization of the final process are crucial steps in integral process development. For 
these reasons, baker‟s yeast (Saccharomyces cerevisiae) was the first eukaryote to have its 
complete genome sequenced, and it is also the eukaryote with the deepest level 
investigations of its proteome. 
On the other hand, bacteria are widely used in biotechnology, for production of proteins and 
chemicals (Lee et al., 2003), and also for unusual applications like the recovery of ancient 
frescos (Antonioli et al., 2005). In both the above-mentioned cases, proteomic techniques 
are used to follow the production process, such as biosynthesis of recombinant proteins and 
digestion of hardened glue. Among the most important bacterial organisms, Escherichia coli 
was one of the first sequenced genomes due to its small genome size and prevalent use in 
laboratory. As a host organism for production of therapeutic proteins, E. coli has been for a 
long time a topic for intensive proteomic analyses (Lee et al., 2003, Zhang et al., 2007). 
Acetobacter and Lactobacillus strains are also important industrial microorganisms in wine 
and other food fermentations, for production of acetic and lactic acid and other 
bioconversions, and as a source of bactericidal agents. The physical and molecular 
responses to environmental stress of different species, important for processing of food and 
beverages, have already been described extensively (De Angelis et al., 2004). An 
increasingly important topic in microbial research is that concerning “biofilms”. Biofilms are 
medically important, accounting for over 80% of microbial infections in the body (Davies, 
2003). Proteomic analyses of biofilm forming microorganisms give important information 
about their behaviour during industrial processes, infection of the host organism, symbiosis, 
and their defence against antimicrobial agents. Furthermore, several recent large-scale 
screening efforts have been addressed to search for novel pharmacological tools to assess 
global protein function in pathogenic organisms such as Toxoplasma gondii (Carey et al., 
2004). 
Because of incomplete genome sequencing of some microbes of major industrial 
importance, analysis of their proteome during the production process is still not possible. 
Nevertheless, in the near future, proteomics will play, together with genomics and 
metabolomics, an important role in process development. Possibly, these technologies will 
be used to enhance productivity of microbial cells or to influence targeted properties of the 
final product. 
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CHAPTER 1 
A METHOD FOR THE PREPARATION OF TOTAL 
PROTEIN EXTRACT OF MICRORGANISM FOR 
PROTEOMIC ANALYSIS 
 
 
 
1. INTRODUCTION 
Two-dimensional electrophoresis (2-DE) has proven to be extremely effective to map most of 
the proteins expressed by a microrganism in a defined moment of its life. However often 
streaks and smears on the first or on the second dimension of the gel hamper the resolution 
of the maps. In particular, the proteome analysis of microrganisms that are equipped with 
inner and outer membranes and a cell wall compartment can be tricky. The cell wall is made 
of high molecular weight polysaccharides, that tend to form complexes with nucleic acids 
and to obstruct the pores of the IEF in immobilised pH gradients (IPG) gel, precluding the 
access of proteins to the gel matrix (Herbert et al., 2006). Moreover, during the IEF step, 
proteins could bind to polysaccharides and nucleic acids, forming complexes with poor 
focalization properties, that streak in the acidic part of the 2D map, or that shift the protein 
apparent isoelectric point (pI) towards the acidic part of the gradient (Berkelman, 2008, 
Rabilloud, 1996).  
We developed a protocol based on the use of the cationic detergent CTAB for the 
preparation of clean total protein extracts for 2-DE. CTAB, cetyltrimethylammonium bromide, 
is a strong ionic denaturing detergent. This surfactant has been used to facilitate the 
separation of proteins from nucleic acids in extractions of biological materials. The CTAB 
method capitalizes on the previous observations that nucleic acids can be selectively 
precipitated with CTAB (Ralph and Bellam, 1964). RNA and DNA are soluble in CTAB and 
0.7 M NaCl but precipitate when the salt is reduced below 0.4 M. However, many 
polysaccharides are insoluble over this salt range and are thus not solubilized (Murray and 
Thompson, 1984). The technique was first developed to isolate DNA from barley seedlings 
by Doyle and Doyle (1987) using the buffer system reported by Saghai-Maroof et al. (1984) 
and has been widely used to obtain high-quality nucleic acids from plants for various 
applications (Allen et al., 2006, Bekesiova et al., 1999, Chang et al., 1993, Flagel et al., 
2005, Jaakola et al., 2001, Kim and Hamada, 2005, Puchooa, 2004, Wang et al., 2005). 
CTAB-based methods have also been used to prepare samples from infected plants for PCR-
based detection of DNA viruses, bacteria and phytoplasmas (Francis et al., 2006, Hren et 
al., 2007, Hu et al., 1996, Li et al., 2006, Wyatt and Brown, 1996), but its application for 
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PCR-based detection of plant RNA viruses and viroids is less reported (Chang et al., 2007, 
Harjua et al., 2005, López et al., 2006, Mumford et al., 2000, Parmessur et al., 2002). 
CTAB-based methods have been previously reported for extraction of high-quality nucleic 
acids from plants, especially from plants with high levels of polyphenols and polysaccharides 
(Li et al., 2008). Thus we exploited the properties of CTAB to clean our 2-DE protein sample. 
In particular the method that we developed was applied for the preparation of total protein 
extracts of wine spoilage microrganisms (acetic acid bacteria and an acid adapted yeast). 
Such microrganisms are interesting for their particular physiology and for their relevance in 
industrial processes (Gullo et al., 2006, Gupta et al., 2001, Park et al., 2003); they are also 
often associated with detrimental organoleptic effects in wines (Silva et al., 2004). Their 
main characteristic is the ability to survive to acidic environments as wines. AABs endure 
high level of acetic acid, which has been reported acting as cytotoxic for the majority of the 
microbial species known (Steiner and Sauer, 2001). To date, studies on the proteome of 
AAB had to overcome the presence of cell wall polysaccharides, and of celluloses in 
cellulose producing strains (Bossi et al., 2007). Here, the treatment with CTAB proved to be 
effective in the removal of such interferents: the 2D gels obtained were very clean and 
highly resolved. Gluconoacetobacter hansenii AAB0248, a cellulose productive strain  (Gullo 
et al., 2006), was used to set up the protocol. Further, the CTAB protocol was tested with 
success on the following microrganisms: Acetobacter malorum AAB01, Gluconoacetobacter 
europeaus AAB017, Acetobacter pasteurianus AAB0246 and the yeast Brettanomyces 
bruxellensis DSM70001. 
 
2. MATERIALS AND METHODS 
2.1 Cell culture 
AAB strains of Acetobacter malorum AAB01, Acetobacter pasteurianus AAB0246, 
Gluconoacetobacter europaeus AAB017, Gluconoacetobacter hansenii AAB0248 and the 
yeast Brettanomyces bruxellensis DSM70001 were cultivated respectively in GYP for AAB 
and in YM for the yeast and incubated at 28 °C without agitation. The growth was estimated 
as CFU ml−1 by plate count on GYP or YM agar, after the incubation of the plates aerobically 
for seven days at 28 °C. 
 
2.2 Lysis protocol 
Cells were precipitated by centrifugation at 3900 × g for 20 min, and washed one time with 
physiological solution (0.9% NaCl). Cell lysis was in 6 ml of 0.9% NaCl and sonicated for 10 
cycles (15 s sonication and 30 s standing each time). Protein were precipitated in 
acetone : methanol (8:1 v/v) for 2 h at −20 °C, followed by centrifugation at 18,300 × g for 
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10 min. The protein content was measured with Bradford assay (Sigma, MA, USA), 
calibration curve y (Abs 595 nm) = 0.0879 × (protein_g). 
 
2.3 CTAB protein protocol 
Pellet obtained from cell lysates has been treated with CTAB as follows (Table 1 for a visual 
summary): the pellet of acetone : methanol (8:1 v/v) re-suspended in 100 µl of 1 M Tris, 
4 M NaCl, 2% (w/v) CTAB, double distilled (DDI) water, protease inhibitors MiniComplete 
(Roche) and incubated for 1 h at 37 °C. Then, upon addition of 900 µl of DDI water, CTAB 
was let precipitated by centrifuging 5 min at 1000 × g. The supernatant was then 
precipitated 2 h on ice in acetone : methanol 8:1 (v/v) and centrifuged for 10 min at 
18,300 × g, washed twice with 70% ethanol to get rid of CTAB residues. Proteins were then 
re-suspended in 7 M urea, 2 M thiourea, 3% CHAPS, 40 mM Tris, centrifuged 30 min at 
21,200 × g, the pellet discharged and the supernatant collected, quantified and run onto 
2D gels, in quadruplicate. 
 
Table 1. The CTAB protocol. 
 
2.4 Other re-solubilisation protocol 
Pellet obtained from cell lysates has been treated according to the following methods: (1) re-
suspended in the usual buffer used for the 2D electrophoresis (Bossi et al., 2007); (2) 
treated with 1% ampholines pH 3–10 (Galante et al., 1976, Righetti et al., 1978); (3) 
treated with phenol : chloroform : isoamylic alcohol (25:24:1 v/v) as described for the 
removal of nucleic acid (Yolles and Freeman, 1967); (4) treated with acidic extraction, as 
described in (Herbert et al., 2006). The proteins collected are re-suspended in the usual 
buffer used for the 2D electrophoresis (7 M urea, 2 M thiourea, 3% CHAPS, 40 mM Tris) and 
run as explained below. 
 
Step #  Description  Practical details and recipes  Time and conditions 
 
Step 1.  
 
Pellet re-suspension and 
incubation 
 
Add 100 µl of 1 M Tris, 4 M NaCl, 2% (w/v) 
CTAB, DDI water, protease inhibitors 
MiniComplete (Roche) to pellets and vortex  
 
  Let incubate  1 h at 37 °C 
Step 2.  
Precipitation of CTAB, collection 
of supernatant 
Add 900 µl of DDI water and centrifugation 
(1000 × g)  
5 min 
Step 3.  Protein recovery Supernatant of Step 2. is precipitated with 
acetone:methanol 8:1 (v/v)  
2 h on ice 
  Pellet recovery by centrifugation 18,300 × g  10 min 
Step 4.  
Washing steps to eliminate 
traces of CTAB from pellet Wash twice with 70% ethanol  – 
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2.5 2-DE electrophoresis 
Gels were run in quadruplicate. Conditions are as indicated in (Bossi et al., 2007). Proteins 
were mixed with solubilisation buffer (2 M thiourea, 7 M urea, 3% CHAPS, 40 mM Tris) to 
obtain a final volume of 450 µl and a final quantity of 66 µg of proteins. Each sample was 
reduced and alkylated with 5 mM tributylphosphine and 10 mM acrylamide. The mixture 
was then applied to the dry gel strip (IPG 70mm, pH 3–10 linear gradient, and pH 4–7) for 
reswelling. Focusing was performed at 300 V for 2 h, 400 V for 1 h, 1000 V for 6 h, 2000 V 
for 2 h, 3500 V for 5 h, 10,000 V until the complete focalization (25,000 Vh). The current 
was limited to 50 µA per strip, and the temperature was kept at 20°C for all IEF steps. For 
SDS-PAGE, the IPG strips were incubated in equilibration buffer (6 M urea, 2% SDS, 
20% glycerol, 0.375 M Tris–HCl pH 8.8) for 26 min and then transferred for the second 
dimension onto 10–20% gradient acrylamide gels. The gels were run (10 mA per gel) until 
the bromophenol blue front had reached the bottom of the gel (20 mA per gel). The 2-DE 
gels were stained in Sypro Ruby: the proteins were first fixed in a solution of 7% acetic acid 
and 10% methanol for 1 h, then incubated in Sypro Ruby overnight and finally destained in 
7% acetic acid and 10% methanol for 2 h. Sypro Ruby stained 2-DE gels were digitized using 
VersaDoc (BioRad) and bioinformatic analysis was performed with PDQuest 7.3.0 (BioRad). 
 
2.6 Control of the quality of proteins trapped within CTAB fraction 
CTAB fractions were re-suspended in 100 µl of 1 M Tris, 4 M NaCl, proteins content 
recovered by precipitation for 2 h on ice in acetone : methanol 8:1 (v/v) and centrifuged for 
10 min at 18,300 × g, washed twice with 70% ethanol to get rid of CTAB residues. Quantity 
of proteins was determined with Bradford assay, then 50 µg of proteins run onto 2-DE. 
 
2.7 Detection of nucleic acids 
Nucleic acid detection on the various fractions (control, CTAB treated, CTAB trapped) was 
performed with gel electrophoresis on 2% agarose. Sample A (control) was 15 µl of bacterial 
lysate added of 3 µl loading buffer 6× (0.25% bromophenol blue, 0.25% xylene cyan, 
40% w/v saccharose). Sample B was CTAB trapped components, resolubilised in 200 µl 
4 M NaCl. An aliquot added of loading buffer. Sample C: protein fraction recovered after 
CTAB treatment, precipitated with acetone : methanol 8:1, resolubilised in MilliQ water. An 
aliquot added of 15 µl added of loading buffer. Samples have been loaded onto a 2% 
agarose gel in TAE (40 mM Tris–acetate, 1 mM EDTA) added of 0.5 µg/ml ethidium bromide 
and run at 95 V constant for 30 min. Fluorescence has been used to detect bands. 
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2.8 Detection of polysaccharides 
It has been performed with gel electrophoresis of the fractions obtained at the end of the 
CTAB treatment and coupled to a polysaccharides specific staining method based on 
periodic acid Schiff (PAS) (Konat et al., 1984). Glycols treated with periodic acid are oxidised 
to aldehydes, Schiff reagent forms an adduct with such groups and pararosaniline stains of 
bright red the glycols. Control sample, 20 µl of bacterial lysate was added to 5 µl loading 
buffer 4× (0.5% bromophenol blue, 40% glycerol). Protein fraction recovered after CTAB 
treatment, precipitated with acetone : methanol 8:1, resolubilised in MilliQ water. An aliquot 
added of 5 µl loading buffer 4×. Aliquots of 25 µl of samples have been loaded and run onto 
12% T polyacrylamide gels in three steps: 5 mA 1 h, 10 mA 1 h and 20 mA to the 
completion. At the end of the run, gel have been fixed with 50% methanol 30 min, washed 
twice with 3% acetic acid 20 min and kept in 1% periodic acid, 3% acetic acid 20 min. 
Washed twice with 3% acetic acid and incubated 15 min in the dark with Schiff reagent. 
Staining developed in a 5 min washing in 0.5% (w/v) sodium bisulphite and destained in 
3% acetic acid. 
 
3. RESULTS AND DISCUSSION 
CTAB, has a cationic nature that has been described to interact strongly with nucleic acids, 
for such a reason it has been used since many years in genetic and molecular biology, for 
the recovery of nucleic acids (Murray and Thompson, 1980). In solution, CTAB forms 
complexes with nucleic acids also below its critical micellar concentration (CMC) and with 
polysaccharides (Mel‟nikov et al., 1995). CTAB stays in solution when the concentration of 
NaCl is higher than 0.7 M, while when the concentration of NaCl drops below 0.7 M, it forms 
insoluble aggregates, which trap all the molecules bound earlier in the soluble form (Murray 
and Thompson, 1980, Mel‟nikov et al., 1995, Möller et al., 1992). Here the treatment with 
CTAB was tested to eliminate nucleic acids and polysaccharide contaminants in the sample 
preparation prior to 2-DE. Treated and control samples were run onto 2-DE. Fig. 1 shows the 
2D map of the total protein population of G. hansenii AAB248 obtained upon CTAB 
treatment and compared with the map of the protein extract precipitated just with 
acetone : methanol (8:1, v/v).  
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Fig 1. Comparison between the proteomic map of G. hansenii AAB0248 control (A) and after CTAB treatment (B). 
 
The maps resulted more sharply resolved upon CTAB treatment. To proof the nature of the 
components removed by CTAB, the CTAB trapped fraction was resolubilised, added of 
ethidium bromide and run on agarose (2%) gel electrophoresis together with control (non-
treated) and with CTAB treated samples (Table 1, step 4): as shown in Figure 2, no nucleic 
acids were detected in CTAB treated samples, while the CTAB trapped fraction was rich in 
nucleic acids.  
 
Fig 2. Assay on agarose gel of the nucleic acids content in non treated samples, CTAB treated sample and CTAB 
trapped fraction. (A) Control sample that shows the presence of nucleic acid. (B) CTAB trapped fraction: the 
nucleic acid content is clear. (C) CTAB treated sample shows no residual presence of nucleic acids. 
 
In another experiment, the CTAB trapped fraction was resolubilised, increasing again the 
ionic strength and run on gel electrophoresis (12% acrylamide gels). Parallel lanes were 
used to run the CTAB treated fraction (Table 1, step 4) and a control (non treated) sample. 
The staining with Schiff reagent (Konat et al., 1984), specific for polysaccharides, evidenced 
that control, non treated sample, resulted in a smear and material deposited at the top of 
the lane was visible (Fig. 3, lane A), while the CTAB treated sample resulted in the 
separation in bands, possibly of glycoforms (Fig. 3, lane B).  
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Fig 3. Electrophoresis followed by detection of polysaccharides with PAS staining. (A) Control sample and (B) 
CTAB treated sample.  
 
These experiments accounted for the role of CTAB in removing nucleic acid and 
polysaccharides. Digitalised images of 2D maps of CTAB treated samples were qualitatively 
compared with maps obtained with four other protocols described in the literature (use of 
usual buffer used for the 2D electrophoresis (Bossi et al., 2007); ampholines (Galante et al., 
1976, Righetti et al., 1978); phenol : chloroform : isoamylic alcohol (25:24:1 v/v) (Yolles and 
Freeman, 1964) and treated with acidic extraction). Table 2 compares the results by 
indicating the number of protein spots counted with the PDQuest Software (BioRad) on each 
set of maps. The highest number of spots resulted from the CTAB protocol: 507 were 
counted on Minigels (7 cm length), thus allowing to detect a hundred protein more, respect 
the other protocols tested. The treatment with CTAB proved to be superior also in terms of 
resolution: the spots on the 2D map (e.g. Fig. 1B) appeared highly focused with no streaks 
and smears. 
 
Table 2. Comparison of the 2D maps upon different treatments for the removal of nucleic acid and 
polysaccharides. Sample was total protein extract of G. hansenii AAB0248. Gels for a single treatment were run 
in quadruplicate, a same quantity of protein extract was loaded on each gel to allow comparison. 
 
 
 
 
 
 
 
 
The number of spots counted after CTAB treatment and the resolution of CTAB treated 
maps, accounted for an efficient removal of contaminants by CTAB. The loss in proteins, 
Treatment  Spot counted 
CTAB  507 ± 12 
No treatment  357 ± 8 
Ampholines 1%  392 ± 11 
Phenol:chloroform:isoamilic acid  188 ± 13 
Acidic extraction  381 ± 4 
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possibly segregated into the CTAB fraction, was evaluated by mapping the proteins trapped 
in the CTAB (Fig. 4). The quantity of proteins recovered after CTAB treatment was 1 mg, 
while the quantity of proteins trapped into CTAB was 50 µg, thus the loss in proteins was 
considered negligible.  
 
Fig 4. CTAB trapped proteins were re-solubilised and analysed in 2-DE. The map shows the relevant presence of 
a sole central spot. 
 
Fig. 4 indicates the evident presence of a single central spot, surrounded by the faint 
presences of other proteins. According to literature evidences, it could be hypothesised that 
nucleic acid and polysaccharides have higher affinity for the detergent and compete 
effectively with the acidic proteins in the binding of CTAB (Husale et al., 2008), thus 
corroborating the results that only a minimal part of proteins are sequestered with this 
treatment. CTAB was also applied to treat the total protein extracts of some acetic acid 
bacteria. The 2D maps are reported in Figure 5.  
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Fig 5. 2D maps of A. malorum control (A) and CTAB treated (B); G. europaeus control (C) and CTAB treated (D); A. 
pasteurianus control (E) and CTAB treated (F). 
 
 
 
Fig 6. 2D maps of the yeast B. bruxellensis control (A) and CTAB treated (B). 
 
  SESSION 2, Chapter 1 
46 
 
The CTAB treatment resulted always in highly resolved maps. Eventually, a yeast adapted to 
acidic environment (Silva et al., 2004), B. bruxellensis, was treated with CTAB and mapped 
(Fig. 6), showing again the advantage of CTAB in terms of sharpness of resolution. According 
to Yamaguchi et al. (2008), CTAB was the most effective agent for the solubilisation of highly 
hydrophobic proteins (e.g. myelin proteins) and integral membrane proteins, thus a possible 
limitation of our method could lie in the loss, by entrapment in the CTAB fraction, of the 
more hydrophobic proteins. Nevertheless, we propose the CTAB protocol for the analysis of 
cytosol and total protein extracts, where the vast majority of proteins are hydrophilic, thus it 
could be expected that in the present case the loss in hydrophobic proteins will be limited or 
negligible. It should be noted that the identification of hydrophobic proteins is rare in 2-DE 
proteomics maps because of low abundance, poor solubility, and inherent hydrophobicity 
(Pedersen et al., 2003). Membrane proteins still remain elusive in proteomic studies and 
specific protocols of extraction are necessary to investigate cell surface proteins of bacteria 
and yeasts by 2-DE (Zoubi-Hasona et al., 2004). It could be evaluated the opportunity to 
employ the CTAB both for the removal of contaminants and for the selective entrapment of 
the hydrophobic proteins, to promote the 2D mapping of membranes.  
 
4. CONCLUSIONS 
In conclusions, the cationic detergent CTAB was here used to complex and remove 
polysaccharides and nucleic acids from a total protein extract, playing on its salt solubility, 
prior to proteome analysis. The proteome analysis showed a significant improvement in the 
2D map upon CTAB treatment. The comparison with other methods showed CTAB treatment 
gave superior results. Despite we were primarily interested in mapping the proteome of the 
acidic adapted bacteria G. hansenii AAB0248, the CTAB protocol was of benefit in general of 
wine spoilage bacterial and yeast 2D maps. This protocol could provide a general solution 
for microbial proteomic analysis where it could significantly alleviate the problems of 
contamination by nucleic acid and polysaccharides. 
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CHAPTER 2 
AN APPLICATION OF CTAB-METHOD: 
PROTEOMIC ANALYSIS OF MOLECULAR BASIS 
OF ACID-RESISTANCE IN Ga. hansenii  
 
 
1. INTRODUCTION 
The microorganisms oxidizing ethanol to acetic acid are commonly called acetic acid 
bacteria (AAB). Even though AAB have been extensively studied, researchers are still 
unravelling the mechanisms of their unique metabolism. In recent years, there have been 
major advances in understanding AAB taxonomy, molecular biology, and physiology, and in 
methods for their isolation and identification, but the knowledge obtained remains 
somewhat scattered (Rapsor and Goranovic, 2008).. 
AAB are polymorphous, cells are gram negative, ellipsoidal to rod shaped, straight or slightly 
curved, 0.6 to 0.8 μm long, and occurring singly, in pairs, or in chains. There are non-motile 
and motile forms with polar or peritrichous flagella. They are mesophilic obligate aerobes 
and some produce pigments, some valuable cellulose. Cellulose produced by Ga. xylinus, for 
example, has excellent properties such as transparency, tensile strength, fiber-binding 
ability, adaptability to the living body, biodegradability and high purity (Takai and Erata, 
1998) so that it has a number of potential uses, including the manufacture of wound 
dressings for patients with burns, chronic skin ulcers, or other extensive loss of tissue 
(Alvarez et al., 2004; Czaja et al., 2006; Fontana et al., 1990).  
Physiologically, AAB oxidize a broad range of substrates such as sugars, sugar alcohols, and 
ethanol, with the production of acetic acid as the major end product. During acetic acid 
production, ethanol is almost quantitatively oxidized to acetic acid. The ability of AAB to 
oxidize several substrates has long been known and is still attracting attention. Based on 
this characteristic, several useful oxidation products are produced industrially, and such 
processes are called oxidative conversions. The principal biotransformation involving AAB is 
the production of L-sorbose from D-sorbitol, a fundamental intermediate for the synthesis of 
L-ascobic acid (vitamin C) (Gonzales, 2006, Hancock and Viola, 2002, Kim et al., 1999, 
Kubicek and Karaffa, 2006, Stefanova et al., 1987).  
This special primary metabolism at low pH differentiates them from all other bacteria. In fact 
AAB exhibit resistance to low pH (as low as 2.0 to 2.2 (Du Toit and Pretorius,2002)) and high 
acetic acid concentrations (Rapsor and Goranovic, 2008). For instance in industrial settings, 
Acetobacter aceti can grow at acetate concentrations of up to about 60 g/liter (Park et al, 
1991) and accumulate final concentrations exceeding 140 g/liter in semicontinuous 
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processes (Ebner et al., 1996). As one of the most prominent low-molecular-weight products 
of microbial metabolism, acetate is well known for its cytotoxicity that includes retardation of 
growth and product formation at concentrations below 5 g/liter. These toxic effects are 
related to the weak lipophilic nature of the undissociated acid that enables the molecule to 
cross the cytoplasmic membrane. This diffusion is generally thought to dissipate ion 
gradients, increase the internal acetate concentration, and/or disrupt membrane processes, 
thereby poisoning the cell. While most microorganisms are sensitive to higher 
concentrations of acetate, a few are known to be relatively resistant. The molecular 
mechanism of resistance in AAB, however, remains essentially unknown (Steiner and Sauer, 
2001). 
Here we investigate the changes in global protein expression levels during long-term 
adaptation of Ga. hansenii to low pH, as a first step to the characterization of the molecular 
mechanisms underlying acetate resistance. For this purpose, Ga. hansenii AAB0248 wild-
type was exposed to mild acetate concentrations (50 mM) in serial batch and subsequently 
analyzed by two-dimensional protein electrophoresis (2-DE). Detection and sequences of 
proteins that are induced exclusively in response to acetate adaptation are described. 
 
2. MATERIALS AND METHODS 
2.1 Strain  
In this study the strain AAB0248 belonging to Ga. hansenii was used. This strain was 
isolated from balsamic vinegar (De Vero and Giudici, 2008). 
 
2.2 Culture conditions  
Cells of Ga. hansenii were grown in two different mediums: for control cultures, the bacteria 
were cultivated in batch culture in 1 liter flasks at a working volume of 200 ml at 28 °C in 
GYP medium for AAB at pH 5.8 (2.0 g yeast extract, 3.0 g peptone, 5.0 g glucose). For 
acetate adaptation experiments, the cultures were grown in GYP medium added with 50 mM 
acetic acid to reach pH 4 and 3% ethanol. The growth was estimated as CFU ml−1 by plate 
count on GYP agar, after the incubation of the plates aerobically for seven days at 28 °C. 
 
2.3 Growth kinetics  
The growth kinetic of the Ga. hansenii AAB0248 strain was estimated through OD 
measurements that were used to follow cell growth at a wavelength of 595 nm. The OD 
measurements were performed with Microplate Reader model 680 (BIORAD). 
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2.4 Protein sample preparation for 2-DE electrophoresis 
Cells were harvested by centrifugation for 20 min at 6,000 × g and 4°C. The pellets were 
resuspended in 0,9% NaCl aliquoted in microcentrifuge tubes, and centrifuged again for 
10 min at 10,000 × g and 4°C, the washing was repeated three times. Protein samples for 
2-DE were prepared according to the protocol of Polati et al. (2009). Briefly cells were lysed 
in 1 ml of 1 M Tris, 4 M NaCl, 2% (w/v) CTAB, double distilled (DDI) water, protease 
inhibitors MiniComplete (Roche), sonicated for 10 cycles (15 s sonication and 30 s standing 
each time) and incubated for 1 h at 37 °C. Then, upon addition of DDI water, CTAB was let 
precipitated by centrifuging 5 min at 1000 × g. The supernatant was then precipitated 2 h 
on ice in acetone : methanol 8:1 (v/v) and centrifuged for 10 min at 18,300 × g, washed 
twice with 70% ethanol to get rid of CTAB residues. Proteins were then re-suspended in 
7 M urea, 2 M thiourea, 3% CHAPS, 40 mM Tris, centrifuged 30 min at 21,200 × g, the 
pellet discharged and the supernatant collected and quantified with Bradford assay (Sigma, 
MA, USA), calibration curve y(Abs 595 nm) =0.0879× (protein mg). 
 
2.5 2-DE electrophoresis 
Proteins samples (800 μg) were mixed with solubilization buffer (2 M thiourea, 7 M urea, 
3% CHAPS, 20 mM Tris) to obtain a final volume of 450 μl. Each sample was reduced and 
alkylated with 5 mM tributylphosphine and 10 mM acrylamide. The mixture was then 
applied in gel for reswelling with a dry IPG 170 mm, pH 3-10 linear gradient. Focusing was 
performed at 300 V for 2 h, 400 V  for 1 h, 1000 V for 6 h, 2000 V for 2 h, 3500 V for 5 h, 
10000 V until the complete focalization (65000 Vh). The current was limited to 50 μA per 
strip, and the temperature was kept at 20°C for all IEF steps. For SDS-PAGE, the IPG strips 
were incubated in equilibration buffer (6 M urea, 2% SDS, 20% glycerol, 0.375 M Tris-HCl 
pH 8.8) for 26 minutes and then transferred for the second dimension onto 10%-
20% gradient acrylamide gels. The gels were run overnight (10 mA per gel) until the 
bromophenol blue front had reached the bottom of the gel (20 mA per gel). The 2-DE gels 
were stained in Sypro Ruby: the proteins were first fixed in a solution of 7% acetic acid and 
10% methanol for 1 h, then incubated in Sypro Ruby overnight and finally destainined in 
7% acetic acid and 10% methanol for 2 h. Sypro Ruby stained 2-DE gels were digitized using 
Versadoc (BIORAD) and bioinformatic analysis was performed with PDQuest 7.3.0 (BIORAD). 
 
2.6 Protein Pattern Differential Analysis  
Gels were scanned using a Bio-Rad VersaDoc 1000 imaging system. 2D gel analysis was 
performed by PDQuest software (Bio-Rad), version 7.3. Each gel was analysed for spot 
detection, background subtraction and protein spot OD intensity quantification (spot 
quantity definition). The gel image showing the higher number of spots and the best protein 
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pattern was chosen as a reference template, and spots in a standard gel were then 
matched across all gels. Spot quantity values were normalised in each gel dividing the raw 
quantity of each spot by the total quantity of all the spots included in the standard gel. Gels 
were divided into two separated groups (acetic acid and glucose-grown cells) and, for each 
protein spot, the average spot quantity value and its variance coefficient in each group were 
determined. Data were log transformed and quantitative and a Student‟s t-test were 
performed in order to compare the two groups and identify sets of proteins that showed a 
statistically significant difference with a confidence level of 0.05 and a minimum two fold of 
variation.  
 
2.6 In-Gel Digestion  
Spots showing a statistically significant differential expression were carefully manually cut 
out from 2D Sypro Ruby stained gels and subjected to in-gel trypsin digestion according to 
Shevchenko et al. (2001) with minor modifications. The gel pieces were swollen in a 
digestion buffer containing 50 mM NH4HCO3 and 12.5 ng/µL of porcine trypsin (Promega, 
Madison, WI, US) in an ice bath. After 30 min the supernatant was removed and discarded, 
20 µL of 50 mM NH4HCO3 were added to the gel pieces and digestion allowed to proceed at 
37 °C overnight. The supernatant containing tryptic peptides was dried by vacuum 
centrifugation. Prior to mass spectrometric analysis, the peptide mixtures were redissolved 
in 10 µL of 5% formic acid.  
 
2.7 Peptide sequencing by nano HPLC-ESI-MS/MS  
Peptide mixtures were separated by using a nanoflow-HPLC system (1200 series Agilent 
Technologies, CA). A sample volume of 10 µL was loaded by the auto-sampler onto a 2 cm 
fused silica pre-column (75 µm I.D.; 375 µm O.D.) at a flow rate of 2 µL/min. Sequential 
elution of peptides was accomplished by using a flow rate of 200 nl/min and a linear 
gradient from Solution A (2% acetonitrile; 0.1% formic acid) to 50% of Solution B 
(98% acetonitrile; 0.1% formic acid) in 40 minutes over the pre-column in-line with a 
homemade 15 cm resolving column (75 µm I.D.; 375 µm O.D.; Zorbax 300-SB C18, Agilent 
Technologies, CA). Peptides were eluted directly into a ion Trap (model Esquire 6000, 
Bruker-Daltonik, Germany). Capillary voltage was 1.5-2 kV and a dry gas flow rate of 
10 L/min was used with a temperature of 230 °C. The scan range used was from 300 to 
1800 m/z. Protein identification was performed by searching in the National Center for 
Biotechnology Information non-redundant database (NCBInr) using the Mascot program 
(http://www.matrixscience.com). The following parameters were adopted for database 
searches: complete propionamide formation on cysteines and partial oxidation of 
methionines, peptide Mass Tolerance ± 1.2 Da, Fragment Mass Tolerance ± 0.9 Da, missed 
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cleavages 2. For positive identification, the score of the result of [-10 x Log(P)] had to be 
over the significance threshold level (p < 0.05). 
 
2.8 Protein Categorization  
Gene ontology (GO) lists were downloaded using web tools for the functional analysis of 
groups of genes in high-throughput experiments along with the use of information on Gene 
Ontology terms. Each protein was classified with respect to its biological process and 
molecular function using GO annotation. When no GO annotation was available, proteins 
were annotated manually based on literature searches and closely related homologues. 
 
3. RESULTS AND DISCUSSION 
3.1 Growth kinetics 
Ga. hansenii AAB0248 can grow indistinctly in both culture media used. The adaptation 
phase to the environmental conditions is almost the same and last approximately 20-
24 hours both in the pH 4 medium and in the pH 5.8 medium (Fig. 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1. Growth kinetics of Ga. hansenii AAB0248 in pH 4 medium and in pH 5.8 medium. 
 
The two growth curves are almost overlapped and this suggest a good adaptation of Ga. 
hansenii AAB0248 to both growth conditions applied. Besides we calculated the maximum 
growth rates (µmax) (Fig. 2) both in the pH 4 medium (µmax= 0,0037 h-1) and in the pH 5.8 
medium (µmax= 0,0027 h-1). The acidophilic nature of Ga. hansenii AAB0248 emerges from 
the comparison of the two µmax obtained. 
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Fig 2. Maximum growth rates (µmax) of Ga. hansenii AAB0248 in pH 4 medium and in pH 5.8 medium. 
 
3.2 Ga. hansenii AAB0248 2-DE Protein Pattern Analysis 
To analyze the effect of the acetic acid on the growth of Ga. hansenii, the proteome profiles 
of cells. grown in medium supplemented with acetic acid (pH 4) or normal GYP (pH 5.8), 
were evaluated by 2D-PAGE. Protein spots showing a statistically significant differential 
expression in pH 4-grown cells were analyzed at 5 days by means of 2-DE in the pH range of 
3 to 10. Figure 3 shows all the 2D maps obtained for acetic acid (pH 4) medium and control 
(pH 5.8) medium grown cells. 
 
 
Fig 3. Ga. hansenii AAB0248 2D maps of pH 4 and pH 5.8 grown cells. The proteins (about 800µg) were first 
separated in a linear pH gradient of 3-10, then followed by separation in an SDS-PAGE (10-20%) and Sypro Ruby 
fluorescent staining. 
 
By PDQuest analysis we detected protein spots and measured differential protein 
expression by analyzing the 4 replica of 2D maps obtained for each group. The average 
number of spots detected was 552 ± 11 and 578 ± 7 for 2D maps of pH 4 and pH 5.8 
grown cells respectively. A total of 79 different spots (matched across all the replica 2D 
maps) were found to be differentially expressed in cells grown in medium supplemented 
with acetic acid: in particular 34 spots were found up-regulated and 45 down-regulated. 
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Figure 4 shows the typical high resolution 2-DE protein pattern (master map) obtained from 
Ga. hansenii AAB0248. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 4. The standard map is represented with all 79 spots (marked by blue squares) found to be differentially 
expressed in Ga. hansenii AAB0248 grown in presence of acetic acid. 
 
 
We identified 86 single polipeptidic chains that belong to proteins involved in whole cellular 
processes. In table 1, the successfully identified proteins corresponding to up- or down 
regulated spots are shown, together with the gene names, the spot number, the 
identification parameters and the indication of their gene ontology (GO) annotation 
(biological process and molecular function). Since the complete genome of Ga. hansenii has 
not been sequenced yet, the identification were obtained by using protein sequences of 
Gluconacetobacter europaeus, Gluconobacter oxydans, Magnetospirillum 
magnetotacticum, Gluconacetobacter diazotrophicus, Blastopirellula marina, Deinococcus 
geothermalis, Zymomonas mobilis, Gloeobacter violaceus, Sinorhizobium meliloti and 
Escherichia coli. Most of the spots were identified as proteins involved in sugar metabolism 
(28%) and translation/transcription (22%). But were also identified proteins involved in lipid 
metabolism (14%), cell redox homeostasis (8%), proteins turnover (7%), nucleic acid 
metabolism (7%), membrane transport (4%) and aminoacid metabolism (3%). Figure 5 
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shows a pie chart with the distribution of the identified proteins catalogued according to the 
biological process in which they are involved.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 5. Distribution of the identified proteins according to the biological function. Assignments were made on the 
basis of information provided by gene ontology (GO) lists downloaded using FatiGO from Babelomics 
(http://fatigo.bioinfo.cipf.es/). The absolute number of proteins to which the distribution is referred is: 3 
(aminoacid metabolism), 24 (sugar metabolism), 19 (transcription/translation), 5 (proteins turnover), 4 
(membrane transport), 7 (cell redox homeostasis), 6 (nucleotide/nucleic acid metabolism), 12 (lipid 
metabolism), 6 (others cellular and metabolic proceses).  
 
Our data suggest that acetic acid have a global effect on protein expression and alter the 
expression of a relatively high number of proteins belonging to important cellular and 
metabolic pathways.  
Sugar metabolism 
Bacteria are able to live in environmental conditions that change frequently and, most often, 
rapidly. For doing so, they have evolved a series of adaptive mechanisms through which they 
constantly monitor their surroundings and adjust their physiology accordingly. In particular, 
they possess an array of regulatory devices that facilitate the conversion of available 
nutrients into components of central metabolic pathways and, thereby, the production of 
precursors of new cell material as well as energy for substrate uptake, biosynthesis, and 
growth (Cozzone, 1998). One of these pathways is the tricarboxylic acid cycle, or Krebs 
cycle, which plays two essential roles. First, it is responsible for the total oxidation to CO2, of 
acetyl coenzyme A, which is derived mainly from the pyruvate produced by glycolysis. 
Second, it provides intermediates that are required for the biosynthesis of amino acids, and 
therefore of cellular macromolecules, as well as heme biosynthesis. Bacteria must 
continuously replenish the pools of these intermediates in order to maintain them at 
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sufficient levels for active metabolism (Cozzone, 1998). Surprisingly the cells of Ga. hansenii 
grown in presence of acetic acid, down-regulates the enzymes belonging to Krebs cycle  and 
in particular we found a negative variation of isocitrate dehydrogenase (SSPs 6502, 7502, 
7504, 7505, 7509, respectively down regulated of 2.44, 2.38, 2.50, 4.76, 3.70 folds), 
citrate synthase (SSP 7701, ↓2.27 folds, SSP 7703, ↓2.78 folds and SSP 7706, ↓3.03 
folds), aconitate hydratase (SSP 5809, ↓3.45 folds and SSP 5810, ↓2.50 folds) and 2-
oxoglutarate dehydrogenase (SSP 6704, ↓2.94 folds). The down regulation of the enzymes 
of Krebs cycle and of pyruvate dehydrogenase (SSP 2501, ↓4.54 folds) correspond to a 
simultaneous up regulation of glycolytic enzymes such as D-3-phosphoglycerate 
dehydrogenase (SSP 5607, ↑2.59 folds), enolase (SSP 1604, ↑2.49 folds) and pyruvate 
phosphate dikinase (SSP 2902, ↑2.10 folds). The result of this regulation is an excess of 
pyruvate that could be transformed in acetate from aldehyde dehydrogenase, that we found 
up regulated at pH 4.0 (SSP 5805, ↑5.77 folds and SSP 4804, ↑2.32 folds). Perhaps the 
acetate produced by fermentation of pyruvate may be utilized from bacteria during cellulose 
synthesis. In fact Ga. hansenii AAB0248 was selected not only for his resistance to acetic 
acid but also for his capacity of cellulose production: we found up regulated in cells grown in 
presence of acetic acid the enzyme dTDP-6-deoxy-3,4-keto-hexulose isomerase (SSP 4205, 
↑2.16 folds) that is fundamental in cellulose synthesis (Ross et al., 1991). Bacterial 
cellulose appears to fulfil a structural role in the sense that it may confer mechanical, 
chemical, or biological protection within the natural habitat or facilitate cell adhesion 
processes necessary for symbiotic or infectious interactions. Presumably, the purpose of 
this extracellular material is to provide a firm surface matrix in which the embedded cells 
may benefit from close contact with the atmosphere. In addition cellulose pellicles provided 
protection from competitors which used the same substrate and were also observed to 
protect cells from the killing effects of UV light. Thus, cellulose pellicles may have multiple 
functions in the growth and survival of the organisms in nature (Ross et al., 1991) and may 
be implicated also in the resistance of Ga. hansenii AAB0248 to high acetic acid 
concentrations.  
Lipid metabolism 
As a consequence of the fermentation of pyruvate to acetate, there is a low production of 
acetyl-CoA and simultaneously there is the down regulation of the majority of the enzymes 
belonging to lipid metabolism. In fact we found a negative variation of 3-oxoacyl-(acyl carrier 
protein) synthase II (SSP 8202, ↓2.22 folds), acetyl-CoA carboxylase carboxyl transferase 
(SSP 8410, ↓2.13 folds), acetyl-CoA hydrolase (SSPs 6701, 6702, 6705, 5705, respectively 
down regulated of 2.17, 3.57, 3.70, 2.50 folds), dihydrolipoamide acetyltransferase (SSP 
1506, ↓5.0 folds) and lipoyl synthase (SSP 8504, ↓2.70 folds). When acetate is the sole 
source of carbon and energy, it must first be activated to acetyl coenzyme A (acetyl CoA) to 
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become usable for replenishing intermediates of the tricarboxylic acid cycle via the 
glyoxylate bypass. This activation is also required when acetate is used for oxidation, for lipid 
synthesis, or for amino acid synthesis (Clark and Cronan, 1996). Nevertheless our data 
show that Ga. hansenii AAB0248 employed the acetate for cellulose synthesis instead of 
lipid synthesis. 
Membrane transport 
Our data indicate that membrane functions, possibly including acetate transport and 
respiration, are involved in the acetate resistance mechanism of Ga. hansenii. Because the 
substrate, ethanol, and the product, acetic acid, of acetic acid fermentation are both toxic to 
the cell, acetic acid bacteria synthesize ATP by oxidative fermentation under extremely 
unfavourable conditions. It is conceivable that acetic acid bacteria have developed the 
GinI/GinR system to control the GmpA (an outer membrane protein) expression via GinA. In 
particular we found two outer membrane proteins (SSP 5307, ↑2.16 and SSP 6406,  ↑2.12 
folds) up-regulated in cells grown in presence of acetic acid. The OmpA (outer membrane 
proteins) family proteins play a structural role in the maintenance of gram-negative bacterial 
membrane integrity by embedding their N-terminal transmembrane strands into the outer 
membrane and providing their C-terminal domains in the periplasmic space as a physical 
linkage between the outer membrane and the peptidoglycan layer  (Iida et al., 2008). It is 
possible that Ga. hansenii could reduce acetic acid production from ethanol, because the 
outer membrane containing OmpA prevents the passage of ethanol into the periplasm, 
where alcohol dehydrogenase and aldehyde dehydrogenase, both of which are anchored to 
the inner membrane and are required for ethanol oxidation into acetic acid, are present. 
Stress response 
It is noteworthy  that acetic acid in its undissociated form is capable of diffusing into the cell, 
thus reducing the intracellular pH and this, in turn, may elicit the expression of several 
stress proteins including alkyl hydroperoxide reductase (SSP 1201, ↑2.53 and SSP 5105, 
↑7.70 ) and radical SAM family Fe-S protein (SSP 8706, ↑2.13). In particular iron-sulfur 
(Fe/S) cluster-containing proteins perform central tasks in electron transport, catalysis, and 
the regulation of environmental responses. The complex bacterial biosynthetic systems that 
assist in the assembly of Fe/S clusters and their transfer into apo-proteins fall into three 
classes: the house-keeping ISC system, which is widely distributed across taxa; the NIF 
machinery dedicated to the assembly of the Fe/S clusters of nitrogenase from nitrogen-
fixing bacteria; and the SUF machinery, which is required under oxidative stress and iron-
limiting conditions (Gelling et al., 2007). Besides our data indicate that Ga. hansenii 
AAB0248 synthesises a complete battery of molecular chaperones and proteins involved in 
translation and transcription to contrast the stress conditions. For example the main 
function of chaperone protein dnaK (SSP 1806, ↑2.57 folds) and GroEL (SSP 5705, ↓2.50 
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folds) appears to be prevention of accumulation of unfolded protein intermediates during 
stress (Di Cagno et al., 2009). The increase in the expression of EF-Tu (SSP 0403, ↑3.71 
and SSP 1605, ↑2.87) might also be related to its behavior as a chaperone (Caldas T et al., 
2000). Also ribosomal proteins, used in ribosome assembly or stability, were involved in 
sensing stress (Di Cagno R et al., 2007). For instance ribosomal protein S2 is required for 
the recruitment of ribosomal protein S1 to the 30S ribosomal subunit during translation 
initiation, the appropriate interaction of S1 with S2 being required for translation of bulk 
mRNA in prokaryotes (El-Fahmawi and Owttrim, 2007). Our data indicate that there are 
three isoforms of S2 that are differentially regulated from Ga. hansenii: SSP 0401 and SSP 
0403 are up regulates respectively of 3.98 and 3.71 folds and SSP 3401 that is down 
regulated of 7.14 folds. This is a unique observation as relatively little is known regarding 
the expression or regulation of S2 function in any other system. The different expression of 
the isoforms of S2 might be related to the combination of 2 post-translational modifications, 
phosphorylation and polyphosphate addition, that may synergistically reduce or induce the 
level of functional S2 and translation initiation. 
The ribosomal protein S19 (SSP 0001, ↑3.35 folds) acts indirectly by altering the 
cytoplasmic translation. In E. coli, at the structural level, S19 has been involved in the 
binding of initiation factors on the ribosome and is the major protein cross-linked to the 
central part of an amino acid-tRNA bound in the ribosomal A site. Moreover S19 forms a 
complex with S13 that strongly binds the 16S RNA. Thus, S19 could play a role in initiation 
of translation and decoding (Dequard-Chablat and Sellem, 1994). 
Finally ribosomal protein L7/L12, that we found down regulated (SSP 1005, ↓2.08 and SSP 
5002, ↓2.33) is one of a few bacterial ribosomal proteins of which accumulated evidence 
points to its functional roles in protein synthesis, whereas other ribosomal proteins appear 
to play structural roles in folding and modulating the conformations of the ribosomal RNAs, 
which catalyze peptide bond formation and decoding. Recent in vitro studies have 
demonstrated that L7/L12 interact with the G protein factors EF-Tu, EF-G, RF3, and IF2 
(Nechifor et al., 2007). The simultaneous down regulation of L7/L12 and of the translation 
initiator factor IF-2 (SSP 7903, ↓6.67) might slow down the translation process. 
Cells division 
Bacteria normally divide at the midpoint of the long axis of the cell (midcell). How the 
division machinery selects this site over other sites in the cell is not well understood. 
Surprisingly we found the new induction of cell division topological factor MinE (SSP 8004, 
↑20.30 folds) in Ga. hansenii grown in presence of acetic acid. MinE is a small protein (88 
aa) with at least two function. The protein not only suppresses MinC/D mediated division 
inhibition, but also appears capable of distinguishing midcell from the cell poles. Over 
expression of MinE causes suppression of MinC/D action at all potential division sites in the 
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cell and, therefore, loss of topological specificity (de Boer et al., 1989).  Studies on E. coli 
demonstrated that MinE in present in young cells and is necessary in the selection of the 
proper division site and may be invoveld in maintaining or establishing polarity in the cells 
(Raskin and de Boer, 1997). In the light of this considerations, our results indicates that  Ga. 
hansenii, in this environment, has a renewed metabolic force. 
 
4. CONCLUSIONS 
In conclusion, this study represented the first contribution to understand the mechanism 
involved in acetic acid resistance of Ga. hansenii. The data obtained indicate that the 2D-
PAGE based protocol is a sensitive and accurate method to identify protein pattern changes 
and can provide fascinating contributions to the understanding of complex mechanism, 
such as resistance of a bacterium to a cyto-toxic molecule.  Summarizing, the response to 
acetic acid seems to involve cellulose synthesis and simultaneously the suppression of 
Krebs cycle and lipid metabolism. Our data shows that also the process of translation is 
slow down. Besides, cells grown in presence of acetic acid demonstrate a good adaptation 
to the acidic environment through the new induction of MinE. 
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Tab. 1 Identification of the differentially expressed proteins in acetic acid-grown cells of  Ga. hansenii AAB0248 strain. 
Protein name 
Gene 
name 
Spot 
no. 
SwissPr
otTrEM
BL acc. 
# 
NCBI 
acc. # 
Mr. (Da)  
theor. 
pI 
theor. 
No. of 
peptides 
identified 
Mascot 
score  
Sequenc
e 
Coverag
e  (%) 
microrganism 
Molecular 
function              
GO term 
Fold of 
variatio
n at pH 
4.0 
d)
 
Amino acid metabolism 
acetolactate synthase 3 regulatory subunit ilvH 8111 A9GZJ1 gi|162145865 /18452 /6.75 2 66 11  
acetolactate 
synthase activity 
Down 2.38 
ketol-acid reductoisomerase ilvC 6406 B2R335 gi|162145866 /36465 /5.69 3 131 8 
 ketol-acid 
reductoisomeras
e activity 
Up 2.12 
Serine hydroxymethyltransferase glyA 7609 A9HRP5 gi|162148783 /46976 /6.29 8 401 15 
 glycine 
hydroxymethyltra
nsferase activity 
Up 4.44 
Sugar metabolism 
2-oxoglutarate dehydrogenase E2 component sucB 6704 A9HFG9 gi|162147212 /49848 /8.72 2 82 2  
transferase 
activity 
Down 2.94 
aconitate hydratase acnA 5809 A9HEZ2 gi|162147150 /97168 /6.30 13 681 16  
4 iron, 4 sulfur 
cluster binding 
Down 3.45 
aconitate hydratase acnA 5810 A9HEZ2 gi|162147150 /97168 /6.30 9 537 12  
4 iron, 4 sulfur 
cluster binding Down 2.5 
adenylosuccinate lyase 
GbCGDNIH
1_1658 
5706 Q0BRJ6 gi|114328322 /49363 /5.96 2 97 5 
 adenylosuccinat
e lyase activity 
Down 2.94 
adenylosuccinate lyase purB 7603 A9HJE7 gi|162147738 /49363 /5.96 4 180 10  
adenylosuccinat
e lyase activity 
Up 2.68 
adenylosuccinate synthetase purA 5607 A9HLQ1 gi|162148039 /46329 /5.80 5 214 12 
 adenylosuccinat
e synthase 
activity 
Up 2.59 
aldehyde dehydrogenase aldH  5805 O30329 gi|2598224 /84053 /6.86 13 589 18 
Gluconacetobacter 
europaeus 
oxidoreductase 
activity 
Up 5.77 
aldehyde dehydrogenase aldH 4804 O30329 gi|2598224  /84053 /6.86 15 635 19 
Gluconacetobacter 
europaeus 
oxidoreductase 
activity 
Up 2.32 
citrate synthase GDI1830 7701 A9HII7  gi|162147614 /47427 /6.32 6 211 17  
citrate (Si)-
synthase activity 
Down 2.27 
citrate synthase GDI1830 7703 A9HII7 gi|162147614 /47427 /6.32 4 153 11  
itrate (Si)-
synthase activity 
Down 2.78 
citrate synthase GDI1830 7706 A9HII7 gi|162147614 /47427 /6.32 5 176 13  
itrate (Si)-
synthase activity 
Down 3.03 
D-3-phosphoglycerate dehydrogenase serA 5607 A9HIU7 gi|162147658 /45320 /6.43 4 169 8  catalytic activity Up 2.59 
enolase protein eno 1604 B2QW92 gi|162147711 /44781 /4.70 4 185 12 
 phosphopyruvate 
hydratase 
activity 
Up 2.49 
fructose 1,6-bisphosphatase II glpX 2501 A9HCQ2 gi|162146849 /40891 /8.46 2 106 6 
 fructose-1,6-
bisphosphatase 
activity 
Down 4.54 
Isocitrate dehydrogenase GDI1991 0309 A9HJQ1 gi|162147775 /36255 /5.93 2 65 3 
 isocitrate 
dehydrogenase 
(NAD+) activity 
Up 5.85 
isocitrate dehydrogenase GDI1991 6502 A9HJQ1 gi|162147775 /36255 /5.93 8 328 14 
 isocitrate 
dehydrogenase 
(NAD+) activity 
Down 2.44 
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isocitrate dehydrogenase GDI1991 7502 A9HJQ1 gi|162147775  /36255 /5.93 6 319 15 
 isocitrate 
dehydrogenase 
(NAD+) activity 
Down 2.38 
isocitrate dehydrogenase GDI1991 7504 A9HJQ1 gi|162147775 /36255 /5.93 2 66 6 
 isocitrate 
dehydrogenase 
(NAD+) activity 
Down 2.5 
isocitrate dehydrogenase GDI1991 7505 A9HJQ1 gi|162147775  /36255 /5.93 8 318 14 
 socitrate 
dehydrogenase 
(NAD+) activity 
Down 4.76 
isocitrate dehydrogenase GDI1991 7509 A9HJQ1 gi|162147775 /36255 /5.93 5 183 10 
 isocitrate 
dehydrogenase 
(NAD+) activity 
Down 3.70 
isocitrate dehydrogenase GDI1991 8505 A9HJQ1 gi|162147775 /36255 /5.93 5 249 10 
 isocitrate 
dehydrogenase 
(NAD+) activity 
Up 2.62 
putative NAD-dependent aldehyde dehydrogenase GOX1122 7710 Q5FRV6 gi|58039582 /50498 /5.69 5 275 12 
Gluconobacter 
oxydans 621H 
oxidoreductase 
activity 
Up 2.51 
putative pyruvate dehydrogenase E1 component 
subunit beta 
pdhB 2501 A9HHP7 gi|162147505 /36882 /5.00 2 115 5 
 
catalytic activity Down 4.54 
pyruvate phosphate dikinase podA 2902 A9HEP2 gi|162147113 /96121 /5.22 3 139 3  kinase activity Up 2.10 
Transcription/Translation 
DNA-directed RNA polymerase subunit alpha rpoA 1506 B2QY59 gi|162149150 /37384 /4.89 3 115 10 
 DNA-directed 
RNA polymerase 
activity 
Down 5 
electron transfer flavoprotein subunit beta etfB 6308 A9HEE6 gi|162147074 /26296 /6.45 3 124 15  
electron carrier 
activity 
Up 4.51 
elongation factor Tu tufB 0403 B2QY33 gi|162149176 /42982 /5.33 3 121 9  motor activity Up 3.71 
elongation factor Tu tufB 1605 B2QY33 gi|162149176 /42982 /5.33 12 506 33 
 translation 
elongation factor 
activity 
Up 2.87 
prolyl-tRNA synthetase proS 5706 A9HRR5 gi|162148795 /53065 /5.07 3 122 6 
 
ATP binding Down 2.94 
Ribosomal protein L4 rplD 0207 B2QY36 gi|162149173 /21758 /10.03 4 178 12 
 structural 
constituent of 
ribosome 
Up 5.61 
Ribosomal protein L7/L12 rplL 1005 B2QY27 gi|162149181 /12910 /4.90 5 245 33 
 structural 
constituent of 
ribosome 
Down 2.08 
Ribosomal protein L7/L12 rplL 5002 B2QY27 gi|162149181 /12910 /4.90 1 69 14 
 structural 
constituent of 
ribosome 
Down 2.33 
Ribosomal protein L10 rplJ 9302 A9H3S7 gi|162149182 /19224 /10.40 1 57 7 
 
Protein binding Up 3.25 
Ribosomal protein L33 amb3569 0011 Q2W1A2 gi|23012441 /6390 /10.12 3 97 40 
Magnetospirillum 
magnetotacticum 
MS-1 
structural 
constituent of 
ribosome 
Up 2.03 
Ribosomal protein S2 Gdia_3347 0401 B2R098 gi|209545460 /28117 /6.09 6 281 31 
 structural 
constituent of 
ribosome 
Up 3.98 
Ribosomal protein S2 Gdia_3347 0403 B2R098 gi|209545460 /28117 /6.09 5 197 18 
 structural 
constituent of 
ribosome 
Up 3.71 
Ribosomal protein S2 Gdia_3347 3401 B2R098 gi|209545460 /28117 /6.09 11 508 47  
structural 
constituent of 
Down 7.14 
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ribosome 
Ribosomal protein S19 rpsS 0001 B2QY39 gi|162149170 /10253 /10.54 3 118 35 
Gluconacetobacter 
diazotrophicus PAl 5 
structural 
constituent of 
ribosome 
Up 3.35 
translation-associated GTPase GDI0937 1605 A9HC06 gi|162146759 /39269 /4.93 7 438 21  GTP binding Up 2.87 
transcription elongation factor NusA nusA 0801 A9HF12 gi|162147158 /58182 /4.64 8 306 15  
transcription 
factor activity 
Down 2.08 
transcription elongation factor NusA nusA 0802 A9HF12 gi|162147158 /58182 /4.64 6 222 12  
transcription 
factor activity 
Up 7.33 
translation initiation factor IF-2 GDI1365 7903 B2QZ86 gi|162147160 /97805 /7.24 13 616 13 
 translation 
initiation factor 
activity 
Down 6.67 
tRNA pseudouridine synthase B 
DSM3645_
06384 
7202 A4A2R8 gi|87312284 /30557 /5.30 2 72 2 
Blastopirellula marina 
DSM 3645 
RNA binding Down 2.78 
Protein turnover 
ATP-dependent Clp protease proteolytic subunit clpP 0306 A9HCR1 gi|162146853 /24688 /5.44 2 69 9  
endopeptidase 
Clp activity 
Down 2.04 
chaperone protein dnaK dnaK 1806 A9HEA3 gi|162147057 /67139 /4.89 6 278 12  ATP binding Up 2.57 
chaperonin GroEL groL 5705 B2QWL8 gi|162147833 /57881 /5.43 3 99 8  protein binding Down 2.5 
cold shock-like protein cspE cspE 9301 A9HIW8 gi|162147665 /23316 /9.51 4 228 15  DNA binding Down 7.14 
lipoprotein signal peptidase Dgeo_2580 1006 Q1J3C0 gi|94972048 /18159 /10.21 1 63 6 
Deinococcus 
geothermalis DSM 
11300 
aspartic-type 
endopeptidase 
activity 
Down 2.04 
Membrane transport 
electron transfer flavoprotein beta-subunit etfB 7304 Q5NMF6 gi|56552376 /27257 /5.53 1 103 6 
Zymomonas mobilis 
subsp. mobilis ZM4 
electron carrier 
activity 
Up 3.42 
FeS assembly protein SufC sufC 5301 A9HRY6 gi|162148829 /25885 /5.90 9 472 42  ATP binding Down 2.13 
Outer membrane protein GDI0041 5307 A9GZP4 gi|162145880 /40378 /7.18 3 120 8  protein binding Up 2.16 
Outer membrane protein GDI0041 6406 A9GZP4 gi|162145880 /40378 /7.18 2 111 6  
cell outer 
membrane 
Up 2.12 
Cell redox homeostasis 
Alkyl hydroperoxide reductase subunit C GOX1332 1201 Q5FRB2  gi|58039776 /20535 /4.98 6 391 36 
Gluconobacter 
oxydans 621H 
oxidoreductase 
activity 
Up 2.53 
Alkyl hydroperoxide reductase subunit C GOX1332 5105 Q5FRB2 gi|58039776  /20535 /4.98 2 88 14 
Gluconobacter 
oxydans 621H 
oxidoreductase 
activity 
Up 7.70 
putative glyoxalase GDI0871 2003 A9HBG9 
 
gi|162146693
  
/14115 /4.80 2 87 13 
 
oxidoreductase 
activity 
Down 3.57 
putative oxidoreductase GDI2680 7402 A9HPR5 gi|162148460 /28942 /6.32 2 126 7  
oxidoreductase 
activity 
Down 8.33 
putative oxidoreductase GDI0555 7702 A9H878 gi|162146380 /34036 /6.19 1 66 4 
 oxidoreductase 
activity 
Down 4.76 
radical SAM family Fe-S protein GDI0718 7903 A9HA97 gi|162146542 /54411 /6.94 8 224 16  catalytic activity Down 6.67 
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radical SAM family Fe-S protein GDI0718 8706 A9HA97 gi|162146542 /54411 /6.94 10 373 24  catalytic activity Up 2.13 
Nucleotide/nucleic acid metabolism 
Adenylate kinase adk 4201 B2QY56 gi|162149153 /23784 /6.62 2 94 10  
adenylate kinase 
activity Down 4.54 
histidine triad (HIT) protein Gdia_1625 6105 B2R2Y2 gi|209543789 /13345 /6.12 1 84 12  catalytic activity Up 7.55 
inosine-5'-monophosphate dehydrogenase guaB 8702 A9HID1 gi|162147595 /53289 /6.23 4 135 11 
 IMP 
dehydrogenase 
activity 
Down 2.78 
phosphoribosylaminoimidazole-
succinocarboxamide synthase 
purC 0303 B2QWC4 gi|162147740 /28945 /5.67 1 58 6 
 phosphoribosyla
minoimidazolesu
ccinocarboxamid
e synthase 
activity 
Up 2.91 
phosphoribosylformylglycinamidine synthase II purL 1806 A9HJG3 gi|162147744 /77655 /4.89 6 279 8 
 phosphoribosylfo
rmylglycinamidin
e synthase 
activity 
Up 2.57 
sulfate adenylyltransferase subunit 2 cysD 8407 A9H0V9 gi|162149006 /30554 /6.35 3 100 13 
 sulfate 
adenylyltransfera
se (ATP) activity 
Down 2.17 
Lipid metabolism 
3-oxoacyl-(acyl carrier protein) synthase III fabH 8202 Q7NF35  gi|37523261 /34675 /5.81 1 55 3 
Gloeobacter 
violaceus PCC 7421 
3-oxoacyl-[acyl-
carrier-protein] 
synthase activity 
Down 2.22 
Acetyl-CoA carboxylase carboxyl transferase accD 8409 A9HE81 gi|162147048 /33855 /8.93 4 166 9  
transferase 
activity 
Up 2.01 
Acetyl-CoA carboxylase carboxyl transferase accD 8410 A9HE81 gi|162147048 /33855 /8.93 7 293 14 
 transferase 
activity 
Down 2.13 
Acetyl-CoA hydrolase GDI1836 6701 A9HIK2 gi|162147620 /54894 /6.04 2 128 5  hydrolase activity Down 2.17 
Acetyl-CoA hydrolase GDI1836 6702 A9HIK2 gi|162147620 /54894 /6.04 3 186 11 
 
hydrolase activity Down 3.57 
Acetyl-CoA hydrolase GDI1836 6705 A9HIK2 gi|162147620 /54894 /6.04 3 200 11  hydrolase activity Down 3.70 
Acetyl-CoA hydrolase GDI1836 5705 A9HIK2 gi|162147620 /54894 6.04 2 132 5  transferase 
activity 
Down 2.5 
dihydrolipoamide acetyltransferase acoC 1506 A5YJ12 gi|148530006 /36174 /4.94 3 115 8  hydrolase activity Down 5 
enoyl-[acyl-carrier-protein] reductase fabI 6402 A9H0U5 gi|162149001 /37070 /6.80 3 126 8  
oxidoreductase 
activity 
Up 2.17 
FAD dependent oxidoreductase Gdia_3531 9701 A9HMF9 gi|209545640 /58994 /9.21 4 124 5  
oxidoreductase 
activity 
Down 4.35 
glycerol-3-phosphate dehydrogenase glpD 8701 Q9PB78 gi|15838857 /57273 /7.79 2 120 3 
 glycerol-3-
phosphate 
dehydrogenase 
activity 
Down 3.85 
lipoyl synthase lipA 8504 A9HJB7 gi|162147727 /36459 /7.15 5 189 14  
lipoate synthase 
activity 
Down 2.70 
Others (cellular and metabolic processes) 
hypothetical protein GDI0701 GDI0701 6103 A9H9B9 gi|162146525 /22418 /6.33 1 86 5  
unknown 
function 
Down 2.44 
hypothetical protein SMc01723 SMc01723 2104 Q92SF7 gi|15964195 /18704 /4.84 1 91 7 
Sinorhizobium 
meliloti 1021 
phosphatase 
activity 
Up 5.47 
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putative carboxymuconolactone decarboxylase 
protein 
GDI1413 8007 A9HFF9 gi|162147208  /11695 /5.33 2 118 12 
 
peroxidase 
activity 
Down 2.04 
putative cell division topological specificity factor minE 8004 A9HLY4 gi|162148068 /10393 /6.73 2 71 11  protein binding Up 20.30 
putative dTDP-6-deoxy-3,4-keto-hexulose 
isomerase 
wbtA 4205 Q6QNC8 gi|45644919 /15663 /5.26 1 64 6 Escherichia coli 
isomerase 
activity 
Up 2.16 
putative flagellar motor switch protein fliN fliN 0101 A9HHD1 gi|162147463 /12701 /4.59 1 73 9  motor activity Up 4.92 
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PROTEOMICS MEETS IRON 
 
 
IRON PROTEOMICS 
A large number of cellular enzymes depend on iron for their biological function and, 
consequently, this metal is essential for basic physiological processes. Iron can shuttle 
between two thermodynamically stable oxidation states, Fe3+ or ferric iron and Fe2+ or 
ferrous iron. This makes it ideally suited to the catalysis of biochemical reactions, but it also 
means that it is able to catalyze reactions leading to the production of toxic oxygen radicals, 
particularly when it is present in excess. Besides hydrated ferric ions are relatively strong 
acids; protons in water coordinated to ferric ions have a pKa ≈ 3. The conjugate bases of 
hydrated ferric ions form rapidly multinuclear species, accounting for the low solubility of 
aqueous ferric ions (10-18 M) and for rust formation (Theil and Goss, 2009). 
The chemical properties of iron makes it a fundamental element for life, complexing active 
sites of many crucial enzymes, while free iron leads to the formation of damaging free 
radicals via the Fenton series of reactions. As a result, individual cells and whole organisms 
must tightly regulate their iron influx and efflux to keep iron levels within the optimal 
physiological optimal range, enough to sustain metabolic functions, while preventing its 
accumulation in potentially toxic excesses (Anderson and Vulpe, 2009). Thus the organisms 
have evolved complex biochemical mechanisms for maintaining a balance between iron as 
an essential element and iron as a cytotoxic agent (Bleackley et al., 2009). 
Mechanisms to regulate iron homeostasis are most likely billions of years older than those 
for oxygen homeostasis. It could be hypothesised that contemporary microbes regulate iron 
in the absence of oxygen by modelling ancient organisms that lived before atmospheric 
oxygen appeared (Boyd et al., 2009). Moreover, proteins that manage iron and oxidants 
such as the mini-ferritins in contemporary bacteria, also called Dps (DNA protection during 
stress) proteins, are expressed in anaerobic archea (Wiedenheft et al., 2005). Mini-ferritins 
are 12 subunit protein cages from archea and bacteria that contrast with maxi-ferritins, the 
24 subunit cages from bacteria, animals and plants, which use iron and dioxygen as 
substrates, by consuming iron and hydrogen peroxide as substrates to make the mineral 
inside protein nanocages. Such peroxide-consuming ferritins may be progenitors of modern 
ferritins and may have contributed to the transition from anaerobic to aerobic life with iron 
and oxygen. Iron and oxygen homeostasis, in animals, integrate DNA/mRNA controls; 
regulation of these two processes intersect along many pathways. Iron homeostasis occurs 
within cells and between cells to confer balance throughout tissues and the organism. Each 
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cell or tissue type will have a different iron set point for homeostasis that reflects the 
specific role of each cell type. For example, animal red blood cells need much more iron 
than epithelial cells because of the synthesis of haemoglobin (Wrighting and Andrews, 
2008). Similarly, in plants, leaves contain much more iron than flowers because of the 
synthesis of ferredoxins important in photosynthesis (Kim and Guerinot, 2007). 
Major steps in understanding iron metabolism were made over the last decade (Templeton, 
2002). Peculiar is the discovery of iron role in regulating genes that involves its own 
metabolism and its trafficking at a post-transcriptional level (Cairo and Pietrangelo, 2000, 
Eisenstein, 2000, Theil and Eisenstein, 2000). Such role becames textbook examples of 
such a mode of regulation. A perhaps reawakened interest in the metal saw classical 
molecular biological approaches such as differential display and subtraction cloning used to 
address more global effects of iron (Barisani, 2000, Ye and Connor, 2000). Recently, 
microarray technology has dominated such efforts (Liu et al., 2005) and proteomics could 
provide new knowledge for understanding the iron metabolism or homeostasis.  
In single-cell organisms without recognizable organelles, i.e., most bacteria and archea, iron 
will be distributed relatively uniformly throughout the cytoplasm either in protein cofactors or 
in ferritins. The regulation of bacterial iron homeostasis is often controlled by the iron-
sensing ferric uptake repressor (Fur). The Bacillus subtilis Fur protein acts as an iron-
dependent repressor for siderophore biosynthesis and iron transport proteins. Through the 
use of proteomic techniques Gaballa et al. (2008) demonstrated that Fur also coordinates 
an iron-sparing response that acts to repress the expression of iron-rich proteins when iron 
is limiting. 
The iron distribution in single-cell organisms with internal compartments, such as 
photosynthetic plastids in Chlamdymonas or mitochondria in Saccharomyces and 
Chlamdymonas, is uneven with much higher iron concentrations in the organelles. In 
plastids, for example, high concentrations of iron are needed for the electron transfer by iron 
sulfur ferredoxins for photosynthesis and, in mitochondria, for the electron transfer by heme 
proteins of mitochondrial oxidative metabolism. A study on Saccharomyces cerevisiae 
analyzed metabolic changes under iron deficiency via proteomic methods. The YGH2 yeast 
strain expressing H-ferritin, the YGH2-KG (E62K and H65G) mutant strain, and the YGT 
control strain were used. Comparative proteomic analysis showed that the synthesis of 34 
proteins was at least stimulated in YGH2, whereas the other 37 proteins were repressed. 
The increased proteins included major heat-shock proteins and proteins related to 
endoplasmic reticulum-associated degradation (ERAD). On the other hand, the proteins 
involved in folate metabolism, purine and methionine biosynthesis, and translation were 
reduced. This suggests that intracellular iron depletion induces imperfect translation of 
proteins. This study is the first to present a molecular model for iron deficiency and may 
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provide valuable information on the regulatory network of iron metabolism (Seo et al., 
2008).  
Finally the distribution of iron among tissues or cells in multicellular organisms is not 
uniform. When the specialized role of a tissue requires large amounts of iron, the cellular 
iron concentration can be an order of magnitude higher than in a more average tissue or 
cell. Extracellular iron transport molecules can recognize cell or tissue iron need, which is 
often communicated by the total number of surface receptors that bind extracellular iron 
complexed to protein or chelator transporters. 
The most iron-rich parts of plants are the leaves, seeds and roots. For instance the 
proteome data analysis provided an integrated view of the adaptive metabolism change of 
tomato roots to iron deficiency, especially a clear configuration of the carbohydrate 
metabolism network. Most of the altered proteins in iron-deficiency roots of tomato are 
associated closely with iron uptake and delivery, sulfur metabolism, alleviating redox 
damage, root phenotypical change, signal reception, transduction, etc. (Li et al., 2008). 
In animals, tissues with specialized functions in iron or oxygen homeostasis have the 
highest iron concentrations. The most iron-rich part of animals is the blood, followed by 
spleen, liver, and kidney. Changes in gene expression maintain iron homeostasis during iron 
deficiency or iron excess. For instance the iron-low diet affected the epithelial cell proteome 
and inhibited the development of chronic intestinal inflammation, suggesting a critical role 
for nutritional factors in the pathogenesis of inflammatory bowel disease (Werner et al., 
2009).  The hormone that coordinates whole body responses to changes in iron is hepcidin 
propeptide (Wrighting and Andrews, 2008, Ganz, 2008, Nemeth, 2008, De Domenico, 2008 
), secreted by the liver. A proteomic study of Kartikasari et al. (2008) demonstrated for the 
first time that secretion of bioactive hepcidin-25 by liver cells correlates with its gene 
transcription and points towards synergism between iron and inflammation signaling 
pathways. The uncovered synergistic interaction between iron and inflammation pathways in 
hepcidin regulation holds potential implications especially in the management of iron 
disorder conditions. Two pathological conditions with altered iron homeostasis, the anemia 
of chronic disease and hereditary hemochromatosis, can be traced to abnormal hepcidin 
metabolism. The anemia of chronic disease is caused by increased hepcidin and reflects an 
innate immune response thought to protect the host by diminishing both transferrin bound 
iron and pathogen iron acquisition. This response has the side effect of causing a mild 
anemia in the host, an anemia due to a change in the iron distribution within the body. The 
result is that the red cells are iron-deficient but macrophages have excess iron. Hereditary 
hemochromatosis (HH) is associated with a decrease in serum hepcidin that leads to 
continued efflux of absorbed iron by enterocytes (gut epithelial cells) mediated by the efflux 
protein ferroportin on the basolateral (serum) surface of the intestine and a defect in 
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sensing body iron accurately. In particular hereditary hemochromatosis type I is an 
autosomal-recessive iron overload disease associated with a mutation in HFE gene. Petrak 
et al. (2007) undertook a proteomic study comparing protein expression in the liver of HFE 
deficient mice with control animals. They found 11 proteins that were differentially 
expressed in the HFE-deficient liver using two-dimensional electrophoresis and mass 
spectrometry identification. Of particular interest were urinary proteins 1, 2 and 6, 
glutathione-S-transferase P1, selenium binding protein 2, sarcosine dehydrogenase and 
thioredoxin-like protein 2. This data suggest possible involvement of lipocalins, TNF-alpha 
signaling and PPAR-alpha regulatory pathway in the pathogenesis of hereditary 
hemochromatosis and suggest future targeted research addressing the roles of the 
identified candidate genes in the molecular mechanism of hereditary hemochromatosis. 
All this studies mapping iron metabolism-specific protein expression pattern offers new 
directions to put the pieces of iron homeostasis puzzle together, nevertheless iron remains 
still somewhat enigmatic. 
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CHAPTER 1 
HIGH RESOLUTION PREPARATION OF 
MONOCYTE-DERIVED MACROPHAGES 
(MDM) PROTEIN FRACTIONS FOR CLINICAL 
PROTEOMICS 
 
1. INTRODUCTION 
Macrophages are involved in a number of key physiological processes and complex 
responses such as inflammatory, immunological, infectious diseases and iron homeostasis. 
Iron homeostasis is mainly controlled by the liver-produced hepcidin peptide (Nemeth et al., 
2004). This small hormone synchronizes systemic iron fluxes by binding to the iron export 
channel ferroportin located on the surface of macrophages, hepatocytes and intestinal 
enterocytes to cause its internalization and proteolysis (Andrews, 2008). Ferroportin, the 
only known cellular iron exporter, is highly expressed on cells involved in iron export, 
including the duodenal mucosa, macrophages and cells of the placenta. In macrophages, 
ferroportin is required for the efficient recycling of iron from ingested erythrocytes (De 
Domenico  et al., 2008). In vivo, tissue macrophages are derived from circulating monocytes 
recruited in the tissues by constitutive or inflammatory signals (Hansson, 1999, Dale et al., 
2008). Primary cultures of monocyte-derived macrophages (MDMs) constitute a good model 
for studying the biological activities of macrophages, and are excellent candidates for a 
proteomic approach; in fact they can be easily obtained and cultured within 12 days. During 
this period they acquire many of the characteristics of in vivo activated tissue macrophages, 
such as CD14 (LPS receptor)-expression (Schlegel et al., 1999), and the secretion of 
proteases involved in remodelling the extracellular matrix (Lepidi et al., 2001). Proteomic 
analysis is the most powerful method to elucidate the proteic effectors of cellular processes 
(O'Farrel, 1975, Van den Bergh and Arckens, 2005, Yang and Huang, 2007). Two 
dimensional electrophoresis allows to map protein populations, to identify and underpin 
proteins whose expression levels correlate with particular responses or with pathological 
states (Hanash, 2003), generating information to designate protein markers specific for the 
disease. Sometime, the analysis of total cell proteome poses practical challenges, due to its 
complexity (a thousand of proteins expressed in a cell), to the great dynamic range of 
protein expression and to the different protein properties (pI, molecular mass, 
hydrophobicity, post-translational modifications). Suitable strategies to decrease such high 
complexity are aimed at analysing subsets of the proteome, e.g. by narrowing the pH range 
used for the first dimension (Westbrook et al., 2001), or by the sub-fractionation of proteins 
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into more homogeneous classes (Righetti et al., 2001). The analysis of single cellular 
compartments, fractionating the proteins into common localisation categories, e.g. secreted 
components, membrane, nuclear, organelle's proteins and cytosol, has given important 
practical advantages and results offer a better insight into the protein expression of each 
cell fraction considered (Yates et al., 2005, Komatsu, 2007, Fischer et al., 2006, Song et 
al., 2006, Guimarães de Araújo and Huber, 2007). Sometimes the isolation of proteome 
sub-sets has been achieved with selective tagging methods for proteins, as in the case of 
surface proteins, membrane-associated components (Sabarth et al., 2002). Alternatively, 
sequential extraction methods are used to collect proteins with physico-chemical properties 
in-common (Cordwell, 2008). Aimed at understanding the molecular mechanisms occurring 
during the physiological responses of macrophages to different 
stimuli/environment/pathological conditions, the proteome of such cells has been 
submapped in secretome, cytosol and membrane proteomes (Dupont et al., 2004, 
Slomianny et al., 2006). Further optimisation of the protein extraction method would results 
in higher resolution of the 2D maps, with benefit in terms of comparative proteome studies, 
thus permitting to expand significantly our knowledge on macrophages and on their role in 
iron dealing. MDMs are a good model for macrophages proteomic studies, being easy to 
recruit, grow and mimicking well tissues differentiated ones. Here we report on the effective 
fractionation of cytosol and membrane proteins of MDMs, by the adaptation of a protocol 
that uses the neutral detergent Triton X-114, whose peculiarity is the temperature-
dependent solubility. 
The treatment proved to be very effective for fractionating proteins on the basis of their 
hydropathicity (Santoni et al., 2000). Membrane, cytosol and secretome proteins have been 
run on 2D gels. Mini gels allowed to count over 500 protein spots, with very sharply focused 
spots. MS/MS on sampled spots was used for deciphering the maps, indicating good 
correlation between the fraction analysed and the protein spot identified in the fraction. In 
preliminary experiments we also assessed the obtained fraction by SELDI-TOF-MS for 
hepcidin content, and we could detect a peptide with the same mass as hepcidin only in the 
cytosolic fraction, as expected. 
 
2. MATERIALS AND METHODS 
2.1 Monocyte Derived Macrophages Coltures 
Peripheral blood mononuclear cells were isolated from healthy human blood donors 
attending to the Transfusion Service, University Hospital of Verona. 
Primary cultures of human MDMs were prepared as described by Pinet et al. (2003) with 
minor changes. Monocytes were left to differentiate in a RPMI medium, containing 2 mM 
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streptomycin, 2 mM Gln, and 10% FCS. Monocytes purity was tested by flow cytometer, 
according to Pinet et al. (2003) quality criteria. 
 
2.2 Cell lysis 
After the differentiation, cells were lysed as suggest by Slomianny et al. (2006) with some 
modifications. Lysis solution was 10 mM HEPES, 10 mM KCl, protease inhibitor (Mini-
Complete Roche). Cell were washed 4–5 times with 10 ml DPBS at room temperature. The 
washes were collected and pooled for secretome analysis. Three ml of cold lysis buffer were 
added and incubate 10 min. Cells were scraped from the surface and centrifuged 25 min at 
16000 × g. Cytoplasm was recovered as supernatant, membranes as pellet. 
 
2.3 Extraction of secreted proteins 
The culture media were pooled and the proteins precipitated for 1 h at 0 °C by adding 
15% TCA. The protein pellets were collected by centrifuging at 13000 × g for 10 minutes at 
4 °C and washed two times with 1 ml of cold acetone. The pellets were then resuspended in 
buffer containing 2 M thiourea, 7 M urea, 3% CHAPS, 20 mM Tris, and protein concentration 
was determined by Bradford assay using BSA as standard. 
 
2.4 Extraction of intracellular (cytosol) proteins 
The supernatant was precipitated overnight at -20 °C with acetone : methanol (8:1 vol/vol), 
then centrifuged 20 minutes at 18300 × g; the pellet was recovered, let dry and re-
suspended in 7 M urea, 2 M thiourea, 3% CHAPS, 20 mM Tris, 1% ampholytes and 
centrifuged 40 minutes at 18300 × g to precipitate DNA contaminants (dark pellet on the 
bottom of the eppendorf). 
 
2.5 Extraction of membrane proteins 
The extraction buffer is prepared with 2% Triton X-114 in TBS (150 mM NaCl, 10 mM Tris-
HCl pH 7.6). The extraction is conducted on ice. The membrane pellet is re-suspended in 
100 μl MilliQ water and added of 500 μl extraction buffer, then 1) homogenised with a small 
syringe, 2) let stand in ice for 1 min, 3) vortex for 1 min, 4) let stand in ice for 1 min. The 
four steps are repeated five times and then the sample is kept on ice for 10 min, vortexed, 
and finally put 1 hour at 37 °C. The sample is then centrifuged for 5 minutes at 16000 × g 
at room temperature. The lower phase contains Triton X-114 with the membrane proteins, 
the upper phase contains the aqueous phase and proteins. The two phases are collected 
and each one is precipitated overnight at -20 °C with acetone : methanol (8:1 vol/vol), then 
centrifuged 20 minutes at 18300 × g. Each pellet was recovered, let dry and re-suspended 
in 7 M urea, 2 M thiourea, 3% CHAPS, 20 mM Tris. 
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2.6 Extraction of membrane-associated proteins 
The upper phase, expected to be enriched in hydrophilic proteins, collected during the 
extraction of membrane proteins, was precipitated overnight with cold acetone : methanol 
(8:1 vol/vol) at -20 °C. The protein pellets were recovered by centrifugation at 18300 × g for 
20 minutes at 4 °C. The pellets were then resuspended in buffer containing 2 M thiourea, 
7 M urea, 3% CHAPS, 20 mM Tris, and protein concentration was determined by Bradford 
assay. 
 
2.7 Control of fraction purity by western immunoblotting 
Protein fractions were separated by SDS-PAGE and immunodetected with antibody specific 
for a cytosolic protein (PGK I) and a membrane bound protein (MMP 9) by Western blot to 
verify the efficiency of separation protocol. Protein extracts were diluited 1:1 with Laemmli's 
sample buffer (62.5 mM Tris-HCl, pH 6.8, 25% glycerol, 2% SDS, 0.01% bromophenol blue, 
5% β-mercaptoethanol), boiled for 3 minutes and separated by SDS-PAGE on 12% T 
acrylamide gels in Tris/glycine/SDS buffer. Proteins were then electroblotted onto PVDF 
membranes (Biorad) at 60 V for 2 h at 4 °C. Non specific sites were blocked by incubating 
with 3% non-fat dried milk and 0.05% Tween-20 (Sigma-Aldrich) in Tris-buffered saline (TBS-
T) for 1 h at 37 °C. Membranes were incubated overnight at room temperature with the 
primary antibody for PGK-I (Sigma-Aldrich) diluited 1:500, in 3% non-fat dried milk and 
0.05% Tween-20 (Sigma-Aldrich) in TBS and with the primary antibody for MMP 9 (Sigma-
Aldrich) diluted 1:1000 in 3% non-fat dried milk and 0.05% Tween-20 (Sigma-Aldrich) in 
TBS. Membranes were washed four times for 15 min with TBS-T and then were incubated 
for 1 h at room temperature with the appropriate horseradish peroxidase-conjugated 
secondary antibody: ECL anti-goat IgG horseradish peroxidase-linked (Sigma-Aldrich) at 
1:20000 diluition for PGK I and ECL anti-rabbit IgG horseradish peroxidase-linked (Sigma-
Aldrich) at 1:5000 diluition for MMP-9. Membranes were washed three times for 15 min 
with TBS-T and once for 15 min with TBS. Finally the immunocomplexes were detected by 
chemiluminescence (ECL, GE Healthcare,) on X-ray XOmat AR (Kodak, Rochester, NY, USA) 
films. The Western-blot image was obtained by scanning films using Quantity One software 
Version 4.4 (Biorad). 
 
2.8 2-DE electrophoresis 
Proteins samples (100 μg for intracellular proteins, 100 μg for membrane proteins, 100 μg 
for membrane-associated proteins and 100 μg for secreted proteins) were mixed with 
solubilization buffer (2 M thiourea, 7 M urea, 3% CHAPS, 20 mM Tris) to obtain a final 
volume of 150 μl. Each sample was reduced and alkylated with 5 mM tributylphosphine and 
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10 mM acrylamide. The mixture was then applied to the dry gel strip (IPG 70 mm, pH 3–10 
non linear gradient) for reswelling. Focusing was performed at 300 V for 2 h, 400 V for 1 h, 
1000 V for 6 h, 2000 V for 2 h, 3500 V for 5 h, 5000 V until the complete focalization 
(25000 V x h). The current was limited to 50 μA per strip, and the temperature was kept at 
20 °C for all IEF steps. For SDS-PAGE, the IPG strips were incubated in equilibration buffer 
(6 M urea, 2% SDS, 20% glycerol, 0.375 M Tris-HCl pH 8.8) for 26 min and then transferred 
to the second dimension onto 10%–20% T gradient acrylamide gels. The gels were run 5 mA 
per gel for 1 h, 10 mA per gel for 1 h and 20 mA per gel until the bromophenol blue front 
had reached the bottom of the gel. The 2-DE gels were stained in Sypro Ruby: the proteins 
were first fixed in a solution of 7% acetic acid and 10% methanol for 1 h, then incubated in 
Sypro Ruby overnight and finally destained in 7% acetic acid and 10% methanol for 2 h. 
Sypro Ruby stained 2-DE gels were digitized using VersaDoc (BioRad, Hercules, CA) and 
bioinformatic analysis was performed with PDQuest 7.3.0 (BioRad). 
 
2.9 Mass spectrometry analysis 
In-Gel-Digestion 
Protein spots were carefully cut out from Sypro Ruby stained gels and subjected to in-gel 
trypsin digestion according to Shevchenko et al. (2006) and colleagues with minor 
modifications. The gel pieces were swollen in a digestion buffer containing 50 mM NH4HCO3 
and 12.5 ng/μl of trypsin (modified porcine trypsin, sequencing grade, Promega, Madison, 
WI) in an ice bath. After 30 min, the supernatant was removed and discarded, 20 μl of 
50 mM NH4HCO3 was added to the gel pieces, and digestion was allowed to proceed at 
37 °C overnight. The supernatant containing tryptic peptides was dried by vacuum 
centrifugation. Prior to mass spectrometric analysis, the peptide mixtures were redissolved 
in 10 μL of 5% formic acid.  
Protein Identification by nano-HPLC-MS/MS 
Peptide mixtures were separated using a nanoflow-HPLC system (Ultimate; Switchos; 
Famos; LC Packings, Amsterdam, The Netherlands). A sample volume of 10 μl was loaded 
by the autosampler onto a homemade 2 cm fused silica precolumn (75 μm i.d.; 375 μm 
o.d.; Reprosil C18-AQ, 3 μm (Ammerbuch-Entringen, DE)) at a flow rate of 2 μl/min. 
Sequential elution of peptides was accomplished using a flow rate of 200 nl/min and a 
linear gradient from solution A (2% acetonitrile and 0.1% formic acid) to 50% of solution B 
(98% acetonitrile and 0.1% formic acid) in 40 min over the precolumn in-line with a 
homemade 10–15 cm resolving column (75 μm i.d.; 375 μm o.d.; Reprosil C18-AQ, 3 μm 
(Ammerbuch-Entringen, Germany)). Peptides were eluted directly into a High Capacity ion 
Trap (model HCTplus, Bruker-Daltonik, Germany). Capillary voltage was 1.5–2 kV and a dry 
gas flow rate of 10 l/min was used with a temperature of 230 °C. The scan range used was 
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from 300 to 1800 m/z. Protein identification was performed by searching in the National 
Center for Biotechnology Information non-redundant database (NCBInr) using the Mascot 
program http://www.matrixscience.com. The following parameters were adopted for 
database searches: complete carbamidomethylation of cysteines and partial oxidation of 
methionines, peptide mass tolerance ± 1.2 Da, fragment mass tolerance ± 0.9 Da, missed 
cleavages 2. For positive identification, the score of the result of (-10 Log(P)) had to be over 
the significancethreshold level (P < 0.05). Even though high MASCOT scores are obtained 
with values greater than 60, when proteins were identified with only one peptide, a 
combination of automated database search and manual interpretation of peptide 
fragmentation spectra was used to validate protein assignments. In this manual verification, 
the mass error, the presence of fragment ion series, and the expected prevalence of C-
terminus containing (Y-type ions) in the high mass range were all taken into account. 
Moreover, replicate measurements have confirmed the identity of these protein hits. 
 
2.10 Method for SELDI-TOF analysis 
Hepcidin-25 measurements in the MDM fractions were performed by SELDI-TOF-MS, using a 
Ciphergen Protein Biosystem IIc mass spectrometer (model PBSIIc, Ciphergen Biosystems, 
Freemont, CA) and IMAC 30 ProteinChip arrays (Bio-Rad Laboratories, Hercules, CA), 
according to the manufacturer's instructions with some modifications. A similar protocol was 
used for semi-quantitative detection of urinary hepcidin (Bozzini et al., 2008). Finally, 1 μl of 
a saturated solution of sinapinic acid in 0.5% (vol/vol) trifluoroacetic acid and 50% (vol/vol) 
acetonitrile, used as energy-absorbing matrix (EAM), was applied to each spot surface, 
allowed to air-dry, and reapplied. Mass-to-charge (m/z) spectra were generated using the 
PBSIIc TOF mass spectrometer at laser intensity 180, detector sensitivity 9; high mass limit 
50 kDa; and optimization interval 1500 to 10000 Da. Synthetic 25-hepcidin (Peptides 
International, Louisville, KY) was used for external mass calibration and, spiked into the 
cytosolic fraction sample, for peak confirmation. Peak annotation was performed with 
ProteinChip Software after baseline subtraction. 
 
3. RESULTS AND DISCUSSION 
Primary cultures of human MDMs were prepared by differentiation of monocytes from blood 
donors according to literature (Pinet et al., 2003). Optical microscope analysis showed a 
good differentiation of MDMs in 12 days. The purity of the cultures was evaluated as in Pinet 
et al. (2003); the flow cytometry analysis permitted to assess the purity of the cultures by 
testing positivity of macrophages to CD14 and CD45 (Fig. 1).  
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               Fig 1. Analysis of macrophages purity by with flow cytometry: positivity control to CD14 and CD45. 
 
Iron metabolism and macrophages are closely linked; these specialized cells are devoted to 
iron storage and recycling, expressing crucial proteic effectors on the cell membrane such 
as ferroportin (the only known iron-exporting-channel) and other soluble iron-related proteins 
(Iron Regulatory Proteins -IRPs, Ferritin, etc.) (Pinet et al., 2003). While most of the genes 
and RNAs involved in iron homeostasis have been described, still little is known on the 
proteins deputed to such function. To unravel protein candidates of clinical interest, 
proteome analysis appears as the reference technology for such investigations. Due to the 
complexity of an entire cell lysate from a proteomic point of view, and willing to gain a wide 
range of information, we decided to fractionate the sample prior to 2D electrophoresis. 
Protein extraction from MDMs was obtained using a lysis and fractionation protocol which 
distinguished proteins on the basis of their hydropathicity. This method partially derives from 
what achieved in (Slomianny et al., 2006, Santoni et al., 2000) but was optimized for MDM 
cell and allowed the sub-fractionation of the total proteome of MDMs into intracellular 
proteome, membrane proteome, membrane associated proteome and secretome. In Figure 
2, 2D maps of the 4 fractions are compared with the total lysate normally obtained with a 
single step sample preparation, clearly showing the increase in resolution and amount of 
information obtainable.  
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Fig 2. 2D-Maps representing total protein extract from macrophages and protein fractions derived from the 
proposed protocol. 2D mini gels of a total protein extract from macrophages cells and the 4 fractions obtained by 
applying the extraction protocol with Triton X-114 (cytosolic fraction, membrane fraction, membrane associated 
fraction and secretome fractions, from the top to the bottom). All the 2D-PAGE are run on a 3–10 non linear IPG 
strip and an equal amount of total protein content was loaded on each gel. For each 2D map the spots count, as 
obtained with PDQuest software, is indicated. 
 
For each fraction the number of protein spots detected is also reported. Being most 
interested in the membrane fraction, we extracted membrane proteins of macrophages 
using the neutral detergent Triton X-114. The fractionation protocol exploits the temperature 
dependent solubility of Triton X-114. Fractionation steps include mixing Triton X-114 with 
cell lysates at 0 °C, where it is freely soluble and where it forms complexes associating 
hydrophobic proteins, followed by a step-wise change in temperature, reaching Triton X-114 
cloud point (23 °C), that induce the detergent precipitation, causing the trapping of the 
protein complexes in an insoluble phase. The treatment proved to be simple and very 
effective for fractionating membrane and cytosol proteins, permitting to obtain high 
resolution 2D gels. A fraction of "membrane associated" proteins was also recovered. The 
use of neutral detergent Triton X-114 for MDM membrane protein extraction was already 
demonstrated to give better results in comparison to solvent extraction (Slomianny et al., 
2006), even if it was used only in conjunction with liquid chromatography separations. Here 
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we employed Triton X-114 and analysed extracted proteins by 2D electrophoresis and MS. 
Upon lysis of human MDMs, the intracellular fraction was recovered by precipitation of the 
supernatant. The pellet of the lysis, containing the membranes was treated with the neutral 
detergent Triton X-114 for protein extraction. The protocol was adjusted for MDMs: the re-
iteration in sequence of the mixing steps with the detergent and incubation steps 
ameliorated the protein-detergent complexation. Fractions were run on 2D-PAGE (Minigel of 
8 cm length) and maps were analysed, after staining with Sypro Ruby, by PDQuest software. 
After images digitalization it was possible to highlight the presence of an elevated number of 
spots in all the maps representative of the fractions (i.e. 527 ± 12, 232 ± 8, 408 ± 11 in the 
intracellular, membrane and membrane associated fraction, respectively). These spots 
number accounts for a good quality and high resolution protein profiles. The quality of the 
fractions recovered (intracellular and membrane) was assessed by SDS-PAGE 
electrophoresis followed by MS-MS or Western blotting. Intracellular fraction was assayed 
for the presence of the cytosolic enzyme phosphoglycerate kinase (PGK I), a protein typical 
of the glycolytic pathway and for the absence of membrane protein contamination, (Fig. 3, 
panels A-B), by incubating the same Polyvinylidene Fluoride (PVDF) membrane with an 
antibody against the matrix metallopeptidase 9 (MMP 9).  
 
 
 
Fig 3. Western blot analysis for PGK-1 presence in the obtained fractions. Western blot analyses for the cytosolic 
enzyme phosphoglycerate kinase (PGK I), typical of the glycolysis, panel A, and for the membrane bound protein 
Metalloproteinase 9 (MMP9), panel B. The three fractions were run together on the same SDS-PAGE loading an 
equal amount of total protein. The same PVDF membrane was used. Film image with the relative protein bands 
only in the lane corresponding to the cytosolic compartment and to the membrane fraction are reported. Western 
blot images were captured by GS710 densitometer (Bio-Rad) and analyzed by QuantityOne software. 
 
The three main fraction were run on the same SDS-PAGE and equal amount of total protein 
were loaded in each lane. Only the lane referring to the cytosolic fraction showed a distinct 
band when developed with the anti-PGK 1 antibody, being clear the presence of the enzyme 
only in there and thus indicating no major contamination between fractions. In addition, only 
the lane referring to the membrane fraction showed a distinct band when developed with 
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the anti MMP 9 antibody, indicating no contamination of the cytosolic fraction by membrane 
proteins. Figure 3 shows some comparisons between selected zones of the total extract and 
the corresponding zone on 2D gels of fractions, highlighting the different resolution 
achieved when proteins where fractionated prior to the 2D run. In analogy with membrane 
proteome literature (Churchward et al., 2005), the recovery of integral and membrane 
associated proteins was successfully obtained with the use of detergents, because their 
lipophilic character mimics the native lipid membrane environment. A quantitative 
evaluation of the 2D maps was performed by comparing the results of spots image analysis 
of the membrane fraction with those of the total extract. It was evident that, in the selected 
zones (Fig. 4), the increase in spot density resulted 2.1 fold, thus indicating the substantial 
improvement in density gained with the fractionation. The membrane fraction was also 
subjected to qualitative studies. MS analysis of a sample of 21 spots from the membrane 
fraction gave the identifications shown in Table 1 (the cut spots are indicated with circles in 
the map in Fig. 5). Among these proteins, 10 are integral membrane proteins and the 
remaining proteins are all associated to the plasma membrane or to membrane proteins, 
being 90% the total recovery percentage. These results support the Triton X-114 extraction 
method for MDMs membrane protein studies. Figure 3D reports the number of protein 
counted in each fraction and the count of the map of the total extract. The number of 
proteins doubles in case of fractionation, also indicating the great advantage of the chosen 
protocol. The fractionation of the samples enabled to increase the amount of information 
achievable on the protein effectors in macrophages. All the four compartments analysed can 
be further studied and evaluated in terms of specific enzymes or antigens. Being interested 
in iron metabolism we also evaluated the fractions in term of hepcidin content (Fig. 6).  
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Fig 4. Comparison between total extract 2D map and fractions 2D maps. 2D gels of total extract and fractions 
with enlargements of specific zones and a diagram reassuming the numerical data obtained. A) total extract 
versus membrane fraction. B) total extract versus cytosolic fraction. C) total extract versus membrane associated 
fraction. D) Pie chart representing the Spots counts relative to the total extract (left panel) and the summary of 
the 4 fractions obtained with the proposed protocol. 
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Fig 5. 2D map of the membrane fraction used for spot excision and ID. 2D gel of the membrane fraction showing 
the cut spots as red circles numbered from 1 to 21. 
 
Hepcidin is the master regulator of iron homeostasis and acts by tuning iron influx into 
plasma from tissues dedicated to iron storage or transport. In particular macrophages 
recycle iron from senescent entherocytes. Our interest was to monitor hepcidin presence in 
the fraction in order to study its behavior in cultured macrophages. In preliminary 
experiments, a peptide matching the mass of hepcidin was detectable only in the cytosol but 
not in the other compartments (Fig. 6).  
 
 
Fig 6. SELDI analysis of the fractions. SELDI-TOF spectra representing the four fractions analysed on IMAC 30 
chip arrays. The peak of a peptide matching the mass of hepcidin 25 is shown when present. A spectrum 
containing the hepc 25 synthetic standard spiked into the cytosolic fraction is also shown. 
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Notwithstanding recent progress, much work remains to be done in defining the role of 
hepcidin in both healthy and diseased states. However, to date, few investigative tools are 
available (Ganz et al., 2008, Swinkels et al., 2008, Murphy et al., 2007, Murao et al., 2007). 
By means of SELDI-TOF-MS technology, we and others were successful to detect hepcidin 
and its isoforms in urine and serum (Nemeth et al., 2004, Kemna et al., 2008, Bozzini et al., 
2008). Our preliminary results appear to confirm the presence of hepcidin in macrophages 
also as protein, extending the data reported by Theurl and colleagues about hepcidin mRNA 
in monocyte/macrophages (Theurl et al., 2008). The presence of a peptide of the same 
mass as hepcidin in the cytosolic fraction is in agreement with the known cycle of hepcidin 
from liver to cells, by means of binding to ferroportin and internalization (Nemeth et al., 
2004, Andrews, 2008, De Domenico et al., 2007). We are going to validate this approach 
investigating other MDMs under different conditions. Further experiments are needed for a 
better understanding of the peptide behavior regarding its binding to membrane proteins. 
The mutual interaction of hepcidin with ferroportin is essential for the understanding of iron 
homeostasis in the cells (De Domenico et al., 2008) and the study of MDMs from patients 
and/or animal models of ferroportin disease (Pietrangelo, 2004) could give new insights into 
this field. 
 
4. CONCLUSION 
The purpose of this work was to find a feasible method for the study of cytosolic, integral 
membrane, membrane associated and secreted proteins in comparative proteomics 
experiments of clinically relevant samples. This technique, based on Triton X-114, allowed 
us to obtain high resolution 2D maps for all the fractions. The fractionation and extraction 
method gave as an improvement in spots number detectable and amount of information 
achievable. In particular the results obtained mapping membrane proteins are remarkable: 
the maps show high quality spots and no streaks. In fact membrane proteins, due to their 
hydrophobicity, usually focus poorly using the conventional isoelectrofocusing (IEF) 
procedure, often leading to horizontal streaks. Mapping separately the protein population of 
macrophages, in healthy and disease conditions, would allow a deeper understanding of 
Hereditary Hemochromatosis and iron related disorders. 
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SSP 
 
Mw, kDa 
theor. 
pI predict. 
No. of 
peptides 
identified 
Mascot 
Score 
NCBI Accession 
Number 
Protein ID 
 
5      51372 8.88 11 592 gi|872121 
isocitrate dehydrogenase (NADP+) 
[Homo sapiens] 
 
38780 
 
7.57 
 
21 
 
1301 
 
gi|18645167 
 
Annexin A2 
[Homo sapiens] 
 
21  
 
38639 
 
 
6.32 
 
 
3 
 
 
162 
 
 
gi|190200 
 
Porin 
[Homo sapiens] 
 
42128 
 
5.22 
 
4 
 
198 
 
gi|28336 
 
mutant beta-actin (beta'-actin)  
[Homo sapiens] 
 
 
17 
 
 
18537 
 
 
5.21 
 
 
 
2 
 
 
70 
 
 
 
gi|5453559 
 
ATP synthase, H+ transporting, 
mitochondrial F0 complex 
[Homo sapiens] 
  
58411 
 
 
7.58 
 
 
17 
 
 
1101 
 
 
gi|35505 
 
 
pyruvate kinase 
[Homo sapiens] 
 
 
13  
 
59828 
 
 
9.16 
 
 
 
2 
 
 
113 
 
 
gi|4757810 
ATP synthase, H+ transporting, 
mitochondrial F1 complex 
 [Homo sapiens] 
1 53738 5.03 36 1940 gi|340219 
Vimentin 
[Homo sapiens] 
14 42080 5.37 6 317 gi|62897625 
beta actin variant 
[Homo sapiens] 
15 12905 5.77 3 70 gi|34616 
beta-2 microglobulin  
[Homo sapiens] 
12 59785 9.07 20 1136 gi|127798841 
ATP synthase, H+ transporting, 
mitochondrial F1 complex, alpha 
subunit 1 
 [Homo sapiens] 
10 29843 5.57 9 485 gi|4505773 
prohibitin  
[Homo sapiens] 
3 50810 5.02 25 651 gi|37492 
alpha-tubulin 
 [Homo sapiens] 
18 30737 8.63 7 420 gi|238427 
Porin 31HM [human, skeletal 
muscle membrane] [Homo 
sapiens] 
11 30337 6.99 3 178 gi|4758788 
NADH dehydrogenase 
(ubiquinone) Fe-S protein 3, 
30kDa (NADH-coenzyme Q 
reductase) 
[Homo sapiens] 
20 49851 7.70 20 710 gi|704416 
elongation factor Tu 
[Homo sapiens] 
16 42052 5.29 5 131 gi|4501885 
beta actin 
[Homo sapiens] 
7 42080 5.37 8 398 gi|62897625 
beta actin variant 
[Homo sapiens] 
2 48083 4.95 17 1052 gi|89574029 mitochondrial ATP synthase, H+ 
Table 1. Membrane fraction identified proteins. 
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transporting F1 complex beta 
subunit 
[Homo sapiens] 
8 53559 5.93 4 189 gi|32709 
IFP53 
[Homo sapiens] 
6 42080 5.37 8 371 gi|62897625 
beta actin variant 
[Homo sapiens] 
4 53297 5.94 6 241 gi|46593007 
ubiquinol-cytochrome c reductase 
core protein I 
[Homo sapiens] 
19 53809 6.03 19 1278 gi|40889610 
Chain A, Crystal Structure Of 
Human Tryptophanyl-Trna 
Synthetase 
[Homo sapiens] 
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CHAPTER 2 
PROTEOMIC RESPONSE TO IONIC-IRON IN 
MURINE MACROPHAGES 
 
 
1. INTRODUCTION  
Iron is a trace element essential for life, as it is required for erythropoietic function, oxidative 
metabolism and cellular immune responses (Munoz et al., 2009). A distinctive feature of 
iron metabolism is the degree to which body iron is conserved and hence recycled. The body 
of a normal adult human contains typically 3 to 4 g of iron. Most of the iron is distributed 
within red blood cells (RBC) hemoglobin (65%; 2300 mg). Approximately 10% is present in 
muscle fibers (in myoglobin) and other tissues (in enzymes and cytochromes) (350 mg). The 
remaining body iron is stored in the liver (200 mg), macrophages of the reticuloendothelial 
system (RES; 500 mg), and bone marrow (150 mg). Only about 0.03% (or ~1-2 mg) is lost 
per day (Munoz et al., 2009). To replace the basal losses and remain in iron balance, a 
roughly equivalent amount of iron should be absorbed from the diet (1-2 mg absorbed from 
the ~15-20 mg of iron introduced with the diet). Thus, the daily exchange of iron between 
body and environment is relatively small and contrasts sharply with the comparatively large 
exchange of this metal between internal organs (Knutson and Wessling-Resnick, 2003). For 
example, each day the bone marrow utilizes approximately 24 mg of iron to produce over 
200 billion new erythrocytes. To meet the demand for heme production necessary for 
erythropoiesis, iron must be recycled from senescent red cells; this process is carried out by 
macrophages of the RES.  
Highly sophisticated strategies should be in place to acquire and regulate iron, also as 
consequence of the lack in the body of effective iron excretory routes (Siah et al., 2006). 
Particular attention should be given to the role of macrophages at the interface between 
iron and immunity, both in producing highly toxic hydroxyl radicals through iron-mediated 
oxydation, and by being at the same time the major site for iron storage.  
Under inflammatory conditions, iron uptake and/or release in macrophages is modulated by 
cytokines, radicals produced by macrophages themselves and acute phase proteins from 
the liver (Theurl et al., 2005). An increase in iron retention within macrophages is observed 
during inflammation. At the same time iron modulates macrophage effector pathways by 
regulating cytokine activities, the induction of anti-microbial effector pathways of 
macrophages and indirectly via regulating lymphocyte proliferation and activities which then 
affect macrophage differentiation and activation. Since iron is an essential compound for 
microbial growth and proliferation the control over iron homeostasis is a central battlefield 
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deciding about the fate of an infection. Thus, it is not surprising that proteins (e.g. 
phagolysosomal proteins) associated with resistance towards infections with intracellular 
pathogens also have been discovered to act as iron transporters (Porto et al., 1994, Roy 
and Andrews, 2001, Meyer et al., 2002, Weiss, 2002b).  
Despite the importance of iron physiology, iron recycling by macrophages has remained one 
of the least well-understood area of iron metabolism (Aisen, 1990). Information on genes 
involved in iron metabolism (Vidal et al., 1993, Feder et al., 1996, Fleming et al., 1997, 
Gunshin et al., 1997, Abboud and Haile, 2000, Kristiansen et al., 2001) and mostly –if not 
exclusively- expressed in the RES, and the identification of the serum peptide Hepcidin and 
of its role in iron metabolism offered a key contribute towards a better understanding of iron 
physiology (Nicolas, 2001), but still the dynamic character of such process is to be clarified. 
It is known that iron acquisition pathways by macrophages proceed through two alternative 
ways: either via phagocytosis or via endocytosis. Plus, a distinguo should be made between 
free iron form and heme iron acquisition. Dietary iron (non-heme) is prevalently absorbed in 
the non-bioavailable oxydised form (Fe3+). Ferrous ions are first reduced to Fe2+ by a 
ferrireductase (McKie et al., 2000) and then transported across metal transmembrane ion 
channels. Transporters are Nramp1 which is expressed exclusively in monocyte and 
macrophages and Nramp2, ubiquitous, this latter better known as divalent metal ion 
transporter 1 (DMT-1) (Fleming et al., 1997, Gunshin et al., 1997). Nramp1 localizes to 
lysosomes and late endosomes and is rapidly recruited to membranes of maturing 
phagosomes (Gruenheid et al., 1997, Searle et al., 1998, Govoni et al., 1999). DMT-1 
localizes to recycling endosomes (Tabuchi et al., 2000). Interestingly, macrophage DMT-1 
mRNA levels lack of iron responsiveness, as indicated from studies of cultured fibroblasts 
and erythroleukemic cells (Wardrop and Richardson, 1999) and consistently by results on 
macrophage cell lines (RAW264.7 and J774) where the levels of DMT-1 transcripts did not 
change in parallel with changes in transferrin receptor mRNA (Wardrop and Richardson, 
2000). 
The major pathway by which macrophages acquire heme-iron is erythrophagocytosis. 
Senescent erythrocytes are taken up via phagocytosis and are then degraded within the 
phagolysosome (Maines, 1997). Alternative iron acquisition pathways seems to be 
occasionally activated, as in case of bacterial infections; in the case, iron seems to be 
sequestered via a siderophore-like uptake pathway, mediated by the protein lipocalin-2, as a 
innate immune response, but the role of this pathway still need deeper investigations 
(Theurl et al., 2005). Another particular case of iron acquisition happens when erythrocytes 
are destroyed intravascularly (Garby and Noyes, 1959), the released hemoglobin is 
complexed by haptoglobin and goes mainly to liver clearance (Deiss, 1999). However, 
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studies have identified a hemoglobin scavenger receptor, CD163, expressed exclusively on 
monocytes and macrophages (Kristiansen et al., 2001).  
Once iron enters cells it is either stored within ferritin or utilized upon incorporation into iron 
containing enzymes. An estimate of 10–20% percent remain in the labile iron pool which is 
important for macrophage effector functions and the regulation of cellular iron homeostasis 
(Oppenheimer, 2001). Iron homeostasis is maintained mainly at the 
postranscriptional/translational level by interaction of cytoplasmic proteins, so called iron 
regulatory proteins (IRP)-1 and 2, with RNA stem loop structures, iron responsive elements 
(IRE) (Muckenthaler et al., 2008 ). 
Iron export is effected by Ferroportin (also called Ireg1 or SLC11A3), a transmembrane iron 
exporter, implicated in the basolateral transfer of ferrous iron to the circulation (Pietrangelo, 
2002). After being transported by ferroportin ferrous iron undergoes oxidation which is 
maintained by the membrane bound ferrioxidase hephaestin, and ferric iron release from 
cells can than be transferred for incorporations to transferrin (Vulpe et al., 1999). 
Besides the above mentioned molecular effectors, a comprehensive understanding of iron 
homeostasis, would offer a preferential point of view for gaining information on the proteins 
involved in cellular iron handling and on their interplay in iron tuning. Macrophages are 
identified as ideal candidates for such investigation, through a holistic approach that would 
help to unravel the complex responses associated to iron levels. The study proposed takes 
advantage of the proteomic approach, one of the most powerful method to elucidate the 
proteic effectors of cellular processes (O‟Farrel, 1975, Clarke et al., 2008, Zichi et al., 
2008). A comparative proteomic analysis was carried out on cultured murine macrophages 
challenged with iron (ferric ammonium citrate) at a near physiological concentration 
(10 µM).  
We report the mapping of iron-stimulated protein expression versus un-stimulated in its 
entire complexity. The comparison of the two proteomes helped in defining stimulus-
expressed or stimulus-suppressed proteins, identifying molecular candidates involved in the 
physiological handling of elemental iron and therefore suggesting potential implication for 
immunity and control of infections. 
 
2. MATERIALS AND METHODS 
2.1. Cell culture and protein extraction  
Mouse Bone Marrow macrophages isolated from C3H WT mice were maintained in culture 
for 7 days. Macrophages were incubated with ferric ammonium citrate (FAC) (10 nM Fe) for 
24 h in serum-free media. Intracellular, membrane, membrane associated fractions were 
obtained as described by Polati et al. (2009) and analysed on 2-DE. 
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2.2. 2-DE and statistical analysis 
Proteins samples (800 μg for intracellular proteins, 600 μg for membrane proteins, 300 μg 
for membrane-associated proteins) were mixed with solubilization buffer (2 M thiourea, 7 M 
urea, 3% CHAPS, 20 mM Tris) to obtain a final volume of 450 μl. Each sample was reduced 
and alkylated with 5 mM tributylphosphine and 10 mM acrylamide (Hamdan et al., 2001). 
The mixture was then applied in gel for reswelling with a dry IPG 170 mm, pH 3-10 non 
linear gradient. Focusing was performed at 300 V for 2 h, 400 V  for 1 h, 1000 V for 6 h, 
2000 V for 2 h, 3500 V for 5 h, 10000 V until the complete focalization (65000 Vh). The 
current was limited to 50 μA per strip, and the temperature was kept at 20 °C for all IEF 
steps. For SDS-PAGE, the IPG strips were incubated in equilibration buffer (6 M urea, 
2% SDS, 20% glycerol, 0.375 M Tris-HCl pH 8.8) for 26 min and then transferred for the 
second dimension onto 10%-20% gradient acrylamide gels. The gels were run overnight 
(10 mA per gel) until the bromophenol blue front had reached the bottom of the gel (20 mA 
per gel). The 2-DE gels were stained in Sypro Ruby: the proteins were first fixed in a solution 
of 7% acetic acid and 10% methanol for 1 h, then incubated in Sypro Ruby overnight and 
finally destainined in 7% acetic acid and 10% methanol for 2 h. Sypro Ruby stained 2-DE 
gels were digitized using Versadoc (BioRad) and bioinformatic analysis was performed with 
PDQuest 7.3.0 (BioRad). Experimental results were compared by one-way analysis of 
variance (ANOVA) and the data were expressed as means 6 SE. Group means were 
considered to be significantly different at p,0.05, as determined by the technique of 
protective least-significant difference (LSD) when ANOVA indicated an overall significant 
treatment effect, p,0.05. 
 
2.3. Mass Spectrometry Analysis 
In-Gel-Digestion                                                                                                                                  
Protein spots were carefully cut out from Sypro Ruby stained gels and subjected to in-gel 
trypsin digestion according to Shevchenko and colleagues with minor modifications 
(Shevchenko et al., 1996). The gel pieces were swollen in a digestion buffer containing 
50 mM NH4HCO3 and 12.5 ng/µL of trypsin (modified porcine trypsin, sequencing grade, 
Promega, Madison, WI) in an ice bath. After 30 minutes, the supernatant was removed and 
discarded, 20 µL of 50 mM NH4HCO3 was added to the gel pieces, and digestion was 
allowed to proceed at 37 °C overnight. The supernatant containing tryptic peptides was 
dried by vacuum centrifugation. Prior to mass spectrometric analysis, the peptide mixtures 
were redissolved in 10 µL of 5% formic acid. 
Protein Identification by nano-HPLC-MS/MS 
Peptide mixtures were separated using a nanoflow-HPLC system (Ultimate; Switchos; 
Famos; LC Packings, Amsterdam, The Netherlands). A sample volume of 10 µL was loaded 
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by the autosampler onto a homemade 2 cm fused silica precolumn (75 µm i.d.; 375 µm 
o.d.; Reprosil C18-AQ, 3 µm (Ammerbuch-Entringen, DE)) at a flow rate of 2 µL/min. 
Sequential elution of peptides was accomplished using a flow rate of 200 nL/min and a 
linear gradient from solution A (2% acetonitrile and 0.1% formic acid) to 50% of solution B 
(98% acetonitrile and 0.1% formic acid) in 40 minutes over the precolumn in-line with a 
homemade 10–15 cm resolving column (75 µm i.d.; 375 µm o.d.; Reprosil C18-AQ, 3 µm 
(Ammerbuch-Entringen, Germany)). Peptides were eluted directly into a High Capacity ion 
Trap (model HCTplus, Bruker-Daltonik, Germany). Capillary voltage was 1.5–2 kV and a dry 
gas flow rate of 10 L/min was used with a temperature of 230 °C. The scan range used was 
from 300 to 1800 m/z. Protein identification was performed by searching in the National 
Center for Biotechnology Information non redundant database (NCBInr) using the Mascot 
program (http://www.matrixscience.com). The following parameters were adopted for 
database searches: complete carbamidomethylation of cysteines and partial oxidation of 
methionines, peptide mass tolerance 1.2 Da, fragment mass tolerance 0.9 Da, missed 
cleavages 2. For positive identification, the score of the result of (−10 Log(P)) had to be over 
the significance threshold level (P < 0.05). Even though high MASCOT scores are obtained 
with values greater than 60, when proteins were identified with only one peptide, a 
combination of automated database search and manual interpretation of peptide 
fragmentation spectra was used to validate protein assignments. In this manual verification, 
the mass error, the presence of fragment ion series, and the expected prevalence of C-
terminus containing (Y-type ions) in the high mass range were all taken into account. 
Moreover, replicate measurements have confirmed the identity of these protein hits. 
 
2.4. Western Blotting 
Control of different expression by western immunoblotting 
Protein fractions were separated by 2-DE (Polati et al., 2009) and immunodetected with 
antibody specific for a cytosolic protein (ferritin - FTH) and a membrane bound protein 
(Glyceraldehyde 3 phosphate dehydrogenase - GAPDH) by Western blot to confirm their 
different expression. After the separation by bidimensional electrophoresis, proteins were 
electroblotted onto PVDF membranes (Biorad) at 60 V for 2 h at 4 °C. Non specific sites 
were blocked by incubating with 3% non-fat dried milk and 0.05% Tween-20 (Sigma-Aldrich) 
in Tris-buffered saline (TBS-T) for 1 h at 37 °C rocking. Membranes were incubated 
overnight at room temperature with the primary antibody for GAPDH (Sigma-Aldrich) diluited 
1:1000 in 3% non-fat dried milk and 0.05% Tween-20 (Sigma-Aldrich) in TBS and with the 
primary antibody for FTH (Santa Cruz) diluited 1:500 in 3% non-fat dried milk and 0.05% 
Tween-20 (Sigma-Aldrich) in TBS . Membranes were washed four times for 15 min with TBS-
T and then were incubated for 1 h at room temperature with the appropriate horseradish 
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peroxidase-conjugated secondary antibody: ECL anti-rabbit IgG horseradish peroxidase-
linked (Sigma-Aldrich) at 1:5000 diluition for both GAPDH and FTH. Membranes were 
washed three times for 15 min with TBS-T and one time for 15 minutes with TBS. Finally the 
immunocomplexes were detected by chemiluminescence (ECL, Amersham Biosciences) on 
X-ray X-Omat AR (Kodak, Rochester, NY, USA) films. The image of the western-blot were 
obtained by scanning films using Quantity One software Version 4.4 (Biorad). 
 
3. RESULTS 
3.1. Proteic pattern before and after iron stimulus: 2-DE 
Proteins extracted from 10x106 cells were fractionated with a method set up for obtaining 
high resolution 2D maps from monocytes/macrophages  (Polati et al., 2009). Three discrete 
fractions, indicated as intracellular proteins, membrane proteins and membrane associated 
proteins were recovered, quantified and analysed by 2-DE (5 replica gels for each fraction).  
 
3.1.1. Intracellular proteome 
2-DE gels of the intracellular fraction of cells treated with Fe and control cells (i.e. non-
treated) were run each in five replicas. The images of the gels, analysed by the software 
PDQuest 7.3.0 (BioRad), were used to develop a master map (Fig. 1) on which were counted 
a number of 913 protein spots representative of all the proteins of the two experimental 
groups analyzed. The comparative analysis highlighted the spots differentially expressed 
with statistical significance (minimum ratio accepted >1.5 fold) on the master map. The 
comparison of the cytosol fraction of treated cells versus control cells evidenced 19 proteins 
over-expressed and 20 proteins under-expressed. 
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Fig 1. A. Replica maps of intracellular proteome of macrophages treated with iron (+Fe) and not treated (-Fe). B. 
Master map of intracellular proteome of macrophages. Blue squares highlight proteins differentially expressed in 
macrophages. C. Protein GO categorization. Distribution of the identified proteins according to the biological 
function. Assignments were made on the basis of information provided by gene ontology (GO) lists downloaded 
using the tool FatiGO30 from Babelomics (http://fatigo.bioinfo.cipf.es/). The absolute number of proteins to 
which the distribution is referred is 15 proteins (2 up and 13 down) (cytoskeleton organization), 1 (1up) (nitrogen 
metabolism), 5 (3 up and 2 down) (protein folding and turnover),4 (3 up and 1 down) (carbohydrate metabolism), 
4 (1 up and 3 down) (cell redox homeostasis), 7 (7 up) (iron homeostasis). 
 
 
 
 
B 
C 
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3.1.2. Membrane proteome 
Similarly to 3.1.1., the master map of membrane proteins was elaborated (Fig. 2). A total of 
813 spots were counted, of which 24 were over-expressed and 9 were under-expressed 
upon Fe treatment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
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Fig 2. A. Replica maps of membrane proteome of macrophages treated with iron (+Fe) and not treated (-Fe). B. 
Master map of membrane proteome of macrophages. Blue squares highlight proteins differentially expressed in 
macrophages. C. Protein GO categorization. Distribution of the identified proteins according to the biological 
function. Assignments were made on the basis of information provided by gene ontology (GO) lists downloaded 
using the tool FatiGO30 from Babelomics (http://fatigo.bioinfo.cipf.es/). The absolute number of proteins to 
which the distribution is referred is 6 proteins (6 up) (chromatin and cytoskeleton organization), 6 (6 up) (iron 
homeostasis), 3 (3 up) (cell proliferation and differentiation), 2 (1 up and 1 down) (nitrogen metabolism), 2 (1 up 
and 1 down) (carbon metabolism), 3 (2 up and 1 down) (miscellaneous), 3 (3 up) (ion transport). 
 
 
3.1.3. Membrane associated proteome 
Finally, 2-DE gels of the membrane-associated fraction of mouse macrophages  treated with 
Fe and control were performed as well in five replica. The master map, shown in  Figure 3, 
showed a total of 316 spots. Regarding this fraction, the spots that resulted differentially 
expressed upon the Fe treatment were respectively 15 (over-expressed) and 3  (under-
expressed). 
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Fig 3. A. Replica maps of membrane-associtated proteome of macrophages treated with iron (+Fe) and not 
treated (-Fe). B. Master map of membrane-associated proteome of macrophages. Blue squares highlight proteins 
differentially expressed in macrophages. C. Protein GO categorization. Distribution of the identified proteins 
according to the biological function. Assignments were made on the basis of information provided by gene 
ontology (GO) lists downloaded using the tool FatiGO30 from Babelomics (http://fatigo.bioinfo.cipf.es/). The 
absolute number of proteins to which the distribution is referred is 6 proteins (5 up and 1 down) (actin 
cytoskeleton organization), 2 (2 up) (iron homeostasis), 4 (3 up and 1 down) (miscellaneous), 3 (3 up) (protein 
flding and turnover), 2 (1 up and 1 down) (cell redox homeostasis). 
 
3.2. Identification of iron-regulated proteins 
Proteins that resulted significantly varied on the 2D-maps were identified by nano-HPLC/MS-
MS and the complete lists are reported in Table 1 (intracellular proteins), Table 2 
(membrane proteins) and Table 3 (membrane associated proteins).  
B 
C 
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4. DISCUSSION 
In this study, we were able to improve the understanding of the molecular effects produced 
by an iron challenge on macrophage cells by analyzing the differential protein expression in 
control and in macrophages treated with near-physiological concentrations of iron (10 ng/L 
FAC). The choice of this concentration was based on the aim to mimic the conditions of 
physiological milieu in presence of iron while avoiding toxic or extreme responses. Cytosol, 
membranes and membrane-associated proteins were analysed independently with 
comparative proteomics. The analysis of homogeneous sub-fractions of the proteome, 
allowed to achieve the optimisation in the 2D separation and favoured a better insights of 
the protein population induced by iron exposure. 
The analysis of data in Table 1, 2 and 3, indicate that only few proteins in the different 
fractions are completely switched on/off (regulated >10 folds, i.e. ratio of normalized optical 
densities of treated samples vs. controls). In particular we found a protein (SSP 8603) over-
expressed of 15.59 folds in the intracellular fraction of macrophages cultured with Fe; a 
protein (SSP 7006) newly induced in the membrane fraction of macrophages cultured with 
Fe and finally, in the membrane-associated fraction, we found a protein (SSP 3104) over-
expressed of 22.08 folds in Fe-growth macrophages, while SSP7602 is completely switched 
off. All the other proteins differentially expressed, were regulated with quantitative ratios 
 10 fold. These results seem in line with the quasi-physiological condition of the treatment, 
in fact only a small number of proteins were strongly induced or repressed. The 
localization/function of the regulated proteins is shown in panels C of Fig. 1-3 where the 
different categories are present with the respective % indicating the regulation of functions 
upon iron stimulus. 
Basal metabolism supports stress conditions 
An overall enhancement of the metabolic rate was observed in presence of the Fe stimulus, 
as accounted by the up-regulation of several cytosolic enzymes: PGK1 (↑ 15.59 fold), 
Arginase (↑ 3.03 fold), Phosphopyruvate hydratase activity of LOC433182 hypotetical 
protein (↑ 1.74 fold). Fe induces also an increment in the levels of proteins related to 
oxidative stress, e.g. Peroxiredoxin 1, which is involved in the redox regulation of the cells, 
eliminating peroxides generated from metabolism. In parallel, protein folding and turnover 
result altered due to the presence of iron, as indicated by the increment of HSP proteins 
Hspd1 (↑ 1.75 fold) and Hspb1 (↑ 2.35 fold), the proteasome up-regulation (↑ 2.59 fold) and 
of components for RNA transcription (e.g. p100 co-activator, ↑ 3.96 fold). Changes in the 
expression of cystatin B (↑ 1.51 fold), and Peptidylproyl-isomerase (↑ 1.70 fold) and of 
proteasome components (subunit alpha, type 6, ↑ 1.66 fold) were also found onto the 
membrane. Thus, the basal metabolic enhancement upon Fe stimulus seems to trigger a 
wider cellular defence mechanism, put in place by macrophages at both cytosolic and 
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membrane levels to contrast the oxidative environment, and which constists of redox-related 
responses, folding preservation mechanisms and misfolding clean-up mechanisms, all 
simultaneously activated in response to iron. Besides, the metabolic rate enhancement 
invokes increase in the available energy, thus ATP synthase components, known for their 
proton transport activity, are significantly increased in their expression levels at the 
mithocondrial membrane. 
Iron homeostasis and iron uptake  
As expected, Fe induces the over-expression of storage proteins specific for iron, the 
ferritins, mainly localized within the cytosol. Ferritin takes up iron in a soluble, non-toxic, 
readily available form, in agreement with what reported on its induction by iron (Truty et al., 
2001). Western blot analysis of 2-DE with ferritin antibody confirmed  ferritin over-
expression in presence of iron stimulus (Fig. 4).  
 
 
 
 
 
 
Fig 4. Bidimensional western blot of Ferritin. A Ferritin isoforms expressed in macrophages after treatment with 
FAC. B Ferritin isoforms physiologically expressed in macrophages. 
 
Iron storage involves the uptake of iron (II) at the outer shell of ferritin, its oxidation by 
molecular oxygen at the dinuclear ferroxidase centers, and the movement of iron (III) into 
the cavity for deposition as ferrihydrite. The protein is formed by oligomers of 24 peptide 
chains, made of two types of subunits: L (light) chain and H (heavy) chain, that form a 
roughly spherical shell with a remarkable diameter of 12 nm and contains into the central 
cavity up to 4500 iron atoms deposited as insoluble mineral (Theil, 1990).   
As to what concerns routes for the uptake of iron, it is interesting to note that our results 
clearly indicate glyceraldehyde-3-phosphate dehydrogenase (GADPH) among membrane 
proteins, and up-regulated in presence of iron (↑ 2.36). GADPH role is normally associated 
with the glycolysis and localizes within the cytoplasm. However, the presence of GADPH on 
cell surfaces of human and murine macrophage and the link of its expression with the 
availability of iron in the medium was recently reported (Raje et al., 2007). These authors 
demonstrated that GADPH is able to interact with transferrin and that the GADPH-transferrin 
complex is subsequently internalized into the early endosomes, leading to the hypothesis of 
GADPH acting as receptor for transferrin, in alternative to the well known receptors Trf 1 and 
Trf 2. Our experiments completely confirmed GAPDH localization, as 2D gels indicate its 
expression on macrophage membranes, and GADPH modulated expression upon Fe 
A B 
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stimulus. Western immunoblot analysis of GADPH (Fig. 5) confirmed the data obtained with 
the comparative analysis indicating the diverse role of that protein: in presence of iron 
stimulus GADPH was prevalently localised on the membrane where it presumably acts as 
receptor for transferrin, whereas in non stimulated condition it is localised in the cytosol 
where it functions as a metabolic enzyme. Our data support the role of GADPH as a 
multifunctional protein within the cell and in particular as an alternative mechanism for iron 
acquisition. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 5. Bidimensional western blot of GADPH. A. GADPH isoforms expressed in macrophages after treatment with 
FAC in membrane and cytosol fraction. B.  GADPH isoforms physiologically expressed in macrophages in 
membrane and cytosol fraction. 
 
An incremented anion transport activity in presence of iron emerges from the up-regulation 
of the membrane voltage dependent anion channels (VDAC) 1, 2 and B-36. The voltage-
dependent anion channels (VDAC), located to the mitochondrial outer membrane, function 
as gatekeeper for the entry and exit of mitochondrial metabolites, and thus controls cross-
talk between mitochondria and the cytosol. VDAC was also identified as a site for the 
docking of cytosolic proteins, such as hexokinase, and was recognized as a key protein in 
mitochondria-mediated apoptosis in experiments conducted on tumor cells (Shoshan-
Barmatz et al., 2009). Key regions of VDAC1 functioning in apoptosis induction and 
regulation by hexokinase. It could be hypothesised that in macrophages challenged with iron 
the up-regulation of VDACs is consequence of the activation of intracellular defence 
mechanisms linked to iron homeostasis.  
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Cytoskeleton: possible implications in iron uptake and delivery 
Iron uptake activity of challenged macrophages seems to influence cytoskeleton 
reorganization. Close to the membrane the Fe stimulus up-regulates vimentin (↑ 4.54) and 
galectin-3 (↑ 1.97), as indicated by our investigation on the expression of membrane 
associated protein fraction (Fig. 3); both proteins are involved in phagocytosis and in 
internalization processes (Sano et al., 2006). Vimentin and galectin-3 localize on phagocytic 
structures, replacing actin (Sano et al., 2003). The hypothetical role of vimentin and 
galectin-3 could be to increase the phagocytic activity of macrophages, induced by the Fe 
stimulus, absolving one of the main physiological roles of macrophages: iron internalization. 
In parallel, es1 protein is down-regulated (↓ 2.94), its job relates with microtubule-
organization of the mammalian cell; es1 protein is involved in the centrosome and plays 
many important roles during cell growth and organization (Manning et al., 2008).  
The actin cytoskeleton has been reported to be required also for the regulation of ion 
channel activity and in the intracellular trafficking; in particular data reports on the binding 
of VDAC channel to actin (Noda et al., 2008) These findings are in agreement with our 
proteomic data on anion channel expression and on the actin increment next to 
membranes. 
A different picture emerges from the cytosol, where data indicate the down-regulation of 
proteins of the cytoskeleton induced by the Fe stimulus: beta-actin (↓ 2.15), gamma-actin-
like protein (↓ 2.88), A-X actin (↓ 1.56), actin (↓ 2.52). The down-regulation include also 
proteins with a role of control on signalling pathways the glia maturation factor gamma-
isoform 1 (↓ 2.42) and on the formation of vescicles, the vescicle mediated transport 
mKIAA3012 protein (↓ 1.54) and Rho GDP dissociation inhibitor (GDI) beta (↓ 1.56). The 
presence of higher iron levels seems to induce the de-structuration or the de-polymerisation 
of the cytosolic actin filaments.  
Comparing the proteomic data of the cytoskeleton proteins upon iron challenge in cytosol 
and those of the membrane & membrane associate 2D maps, two apparently contrasting 
effects seem to take place in the macrophage cell: an increase in cytoskeleton elements 
next to the membrane and a depolymerisation of the cytoskeleton within the cytosol. A 
possible explanation to such a phenomenon comes from recent observations on the role of 
transport of internal proteins attributed to the microtubules and in general to the structures 
of the cytoskeleton (Noda et al., 2008, Hasan et al., 2006). A confirm of the cytoskeleton 
function in the transport of proteins to critical sites which is also of particular significance for 
iron homeostasis is in the discovery of the association of ferritin to microtubules that 
suggested these interaction plays a role in regulating the intracellular localization and/or 
release of ferritin under different physiological circumstances (Hasan et al., 2005). Further 
works provided insights into the binding properties of ferritin with the microtubules in vitro, 
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indicating a dependence of the association on ferritin oligomerisation state (Hasan et al., 
2006). Our proteomic data are in agreement with the supposed microtubule-driven 
mechanisms for the intracellular distribution of ferritin, indicating the Fe stimulus induce 
incremented cytoskeletal proteins at the membrane, thus localized next to the iron transport 
structures. It could be foreseen that ferritin loaded with iron would be next delivered to 
destinations by an analogous mechanism (or driveway) of microtubules, which in this case 
would polymerize from the membranes across the cytosol to the recipient cell structures.  
Inflammatory  
Of particular interest is the newly induction (↑ >10) of the Mif protein, also called 
macrophage migration inhibitory factor, whose presence was always described pivotal to 
induce a response to inflammation. MIF is a highly conserved cytokine which was originally 
described as a soluble factor expressed by T cells in delayed-type hypersensitivity responses 
exerting inhibitory effects on macrophages migration (David, 1966). More recently MIF has 
been acknowledged to play pleiotropic roles in the control of inflammatory “set-point” 
(Calandra, 1995), being so involved in acute and chronic inflammatory diseases such as 
septic shock, rheumatoid arthritis, atherosclerosis and ischemic heart (Bernhagen et al., 
1993, Burger-Kentischer et al., 2002, Baugh et al., 2002, Miller et al., 2008). Moreover, MIF 
has gain great popularity especially  in vascular diseases and myocardial damage being 
under investigation as a therapeutic target for plaque regression (Zernecke et al., 2008, 
Noels et al., 2009).   
MIF was never found, before us, induced by iron exposure but, as iron can elicit oxidative 
stress, this result is also in agreement with recent reports; in fact MIF was  identified in 
some proteomic studies for having a role in the response to oxidative stress in epithelial 
cells, T cells and neurons (Cha et al., 2007, Nguyen et al., 2003, Harrison and Sumners, 
2009). In the context of macrophage cell, which is recognized as being at the interphase 
between iron and immunity for the control of infections (Theurl et al., 2005), this new finding 
of MIF prompt induction can be of pivotal importance for the understanding and eventual 
treatment of inflammation and inflammatory related diseases.   
 
5. CONCLUSIONS 
Comparative proteomic was a powerful tool for the analysis of iron regulated proteins in 
macrophage cells. The protein expression related to that stimulus can be very helpful for a 
better understanding of the role of this cell type in iron metabolism, immunity and infection.   
Moreover the information obtained on the molecular mechanism elicited can give new 
insight in the understanding of the pathophysiology of congenital and acquired disorders of 
iron homeostasis. It would be beneficial to compare the present results, in whose MDMs 
were stimulated with ionic iron at physiological concentrations, with data on MDMs 
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stimulated with senescent erythrocytes, in whose presumably a phagocytosis response 
would be elicited.  
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Table 1. Identification of the differentially espressed proteins of intracellular proteome in macrophages treated with iron. 
Protein name Gene name Spot no.  
NCBI 
acc. # 
Mr. (Da)  theor. pI theor. 
No. of 
peptides 
identified 
Mascot 
score 
Molecular 
function               
Fold of 
variation 
Cytoskeleton organization          
Gamma actin-like protein Actg1 0211 gi|6425087 44029 5.11 7 378 Protein binding Down 2.88 
Moesin Msn 6904 gi|70778915 67839 6.22 16 874 Protein binding Up 3.96 
Glia maturation factor, gamma isoform 1 Gmfg 1110 gi|11993950 16909 5.57 3 124 Actin binding Down 2.42 
A-X actin Actb 2501 gi|309090 42009 5.21 10 586 Protein binding Down 1.56 
Actin Actb 1403 gi|74187644 42053 5.23 10 536 Protein binding Down 2.52 
Gamma actin-like protein Actg1 2303 gi|6425087 44029 5.11 9 498 Protein binding Down 1.91 
Rho, GDP dissociation inhibitor (GDI) beta Arhgdib 2102 gi|33563236  22894 4.97 5 166 
GTPase activator 
activity 
Down 1.63 
Annexin A3 Anxa3 2402 gi|5902786 36520 5.33 9 483 
Calcium ion 
binding 
Down 3.44 
Rap1b Rap1b  3209 gi|595280 21201 5.37 5 270 GTP binding Down 1.91 
Beta actin Actb 2502 gi|74187644 42053 5.23 7 374 Protein binding Down 2.15 
Rho GDP dissociation inhibitor (GDI) alpha Arhgdia 1301 gi|31982030 23450 5.12 7 402 
GTPase activator 
activity Down 1.56 
Moesin Msn 6807 gi|70778915 67839 6.22 4 163 Protein binding Up 2.09 
Chain A, Solution Structure Of Coactosin-Like Protein (Cofilin 
Family) 
Cotl1 1105 gi|159163110 16621 5.13 9 348 Actin binding Down 1.57 
Lipocortin I Anxa1 5406 gi|198845 38952 6.56 6 458 
Calcium ion 
binding 
Down 1.67 
RAB1B, member RAS oncogene family Rab1b 1207 gi|21313162 27717 5.55 2 149 GTP binding Down 1.54 
Iron homeostasis          
Ferritin light chain 1 Ftl1 3104 
 
gi|120524 
 
20847 5.66 9 505 
Stores iron in a 
soluble, non-toxic, 
readily available 
form 
Up 3.03 
Ferritin heavy chain 1 Fth1 2204 gi|6753912 21224 5.53 11 498 
Stores iron in a 
soluble, non-toxic, 
readily available 
form 
Up 3.72 
Ferritin light chain 1 Ftl1 2104 gi|120524 20847 5.66 8 478 
Stores iron in a 
soluble, non-toxic, 
readily available 
form 
Up 3.50 
Ferritin heavy chain 1 Fth1 2206 gi|6753912 21224 5.53 13 618 
Stores iron in a 
soluble, non-toxic, 
readily available 
form 
Up 2.63 
Ferritin light chain 1 Ftl1 3203 gi|120524 20847 5.66 12 720 
Stores iron in a 
soluble, non-toxic, 
Up 4.41 
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readily available 
form 
mCG23169 Eukaryotic Ferritin cd01056 3202 gi|148690909 20845 5.66 12 759 
Stores iron in a 
soluble, non-toxic, 
readily available 
form 
Up 4.28 
Ferritin light chain 1 Ftl1 2205 gi|120524 20847 5.66 10 636 
Stores iron in a 
soluble, non-toxic, 
readily available 
form 
Up 3.79 
Cell redox homeostasis          
Peroxiredoxin 1 Prdx1 8204 gi|6754976 22390 8.26 14 722 
Peroxiredoxin 
activity 
Up 1.92 
SH3-binding domain glutamic acid-rich protein like Sh3bgrl 0008 gi|9910548 12917 4.87 6 301 Antioxidant activity Down 3.44 
type II peroxiredoxin 1 Prdx1 1209 gi|3603241 21949 5.20 2 80 
Peroxiredoxin 
activity 
Down 2.05 
Carbohydrate metabolism          
Phosphoglycerate kinase 1 Pgk1 8603 gi|40254752 44909 8.02 23 1189 ATP binding Up 15.59 
Hypothetical protein LOC433182 Eno1 5609 gi|70794816 47453 6.37 25 1419 
Phosphopyruvate 
hydratase activity 
Up 1.74 
Hypothetical protein LOC433182  Eno1 3604 gi|70794816 47453 6.37 11 630 
Phosphopyruvate 
hydratase activity 
Up 1.67 
Pyruvate kinase Pkm2 7802 gi|31981562  58378 7.18 17 942 
Pyruvate kinase 
activity 
Down 2.56 
Protein folding and turnover          
Proteasome 28 subunit, alpha Psme1 3304 gi|6755212 28826 5.73 11 511 
proteasome 
activator activity 
Up 2.59 
p100 co-activator Snd1 6904 gi|6009521 99934 6.64 5 288 Nuclease activity Up 3.96 
Proteasome subunit beta type-9 precursor Psmb9 0204 gi|130856 23496 5.11 7 394 
Threonine 
endopeptidase 
activity 
Down 1.68 
Heat shock protein Hspd1 3801 gi|74211667 60878 6.04 7 322 ATP binding Up 1.75 
Heat shock protein 1, beta Hspb1 1820 gi|40556608 83571 5.39 14 740 ATP binding Up 2.35 
Ubiquitin-conjugating enzyme E2N Ube2n 3101 gi|12838544 17228 5.71 4 221 
Ubiquitin-protein 
ligase activity 
Down 2.26 
Nitrogen metabolism          
UMP-CMP kinase Cmpk1 3205 gi|23821758 22379 5.68 8 414 ATP binding Down 2.17 
Arginase 1 Arg1 4510 gi|7106255 34957 6.51 7 346 Arginase activity Up 3.03 
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Table 2. Identification of the differentially espressed proteins of membrane proteome in macrophages treated with iron. 
Protein name Gene name Spot no. 
NCBI 
acc.  
Mr. (Da)  theor. pI exp./theor. 
No. of 
peptides 
identified 
Mascot 
score 
Molecular 
function               
Fold of 
variation  
Ion transport          
Voltage-dependent anion channel 2 Vdac2 7407 gi|6755965 32340 7.48 4 193 ion channel Up 1.68 
Voltage-dependent anion channel 1 Vdac1 8406 gi|6755963 30851 8.62 8 502 ion channel Up 1.60 
B-36 VDAC=36 kda voltage dependent anion channel Vdac2 5401 gi|299036 32327 7.44 9 489 ion channel Up 1.76 
ATP synthesis          
ATP synthase, H+ transporting, mitochondrial F1 complex, O 
subunit 
Atp5o 2205 gi|20070412 23406 10.00 4 174 Proton transport Up 2.81 
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha 
subunit, isoform 1 
Atp5a 8411 gi|6680748 59830 9.22 7 537 Proton transport Up 1.60 
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha 
subunit, isoform 1 
Atp5a 8701 gi|6680748 59830 9.22 21 1198 Proton transport Up 2.06 
F1F0 ATP synthase E subunit Atp5k 8007 gi|1491942 8198 9.39 2 60 Proton transport Down 2.70 
Ubiquinol-cytochrome c reductase binding protein Uqcrq 9007 gi|13385726 13553 9.10 7 313 Electron transport Down 5.55 
Chromatin and cytoskeleton organization          
Histone cluster 1, H2ah Hist1h2ab 7008 gi|30061327 13942 11.03 3 149 
Core component of 
nucleosome 
Up 2.19 
Histone H4 Hist1h4a 7001 gi|94378251 17513 10.59 6 340 
Core component of 
nucleosome 
Up 2.49 
Gamma actin-like protein Actb 2310 gi|6425087 44029 5.11 6 334 Protein binding Up 3.01 
Actin, gamma Actb 2301 gi|123298587 32941 5.15 8 443 Protein binding Up 1.68 
Vimentin Vim 0813 gi|55408 53746 5.06 6 214 Protein binding Up 4.54 
rab7 Rab7a 2201 gi|1050551 23829 7.53 5 239 Endocytic transport Up 1.78 
Iron homeostasis          
Heme-binding protein Hebp2 1201 gi|3724328 21165 5.18 2 109 heme binding Up 1.72 
Glyceraldehyde-3-phosphate dehydrogenase Gapdh 7517 gi|55153885 36093 7.59 4 209 Protein binding Up 2.36 
Glyceraldehyde-3-phosphate dehydrogenase Gapdh 8408 gi|55153885 36093 7.59 10 491 Protein binding Up 1.55 
Glyceraldehyde-3-phosphate dehydrogenase Gapdh 8404 gi|55153885 36093 7.59 7 305 Protein binding Up 1.60 
Glyceraldehyde-3-phosphate dehydrogenase Gapdh 8403 gi|55153885 36093 7.59 9 489 Protein binding Up 1.55 
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Glyceraldehyde-3-phosphate dehydrogenase Gapdh 8407 gi|55153885 36093 7.59 9 463 Protein binding Up 1.51 
Cell proliferation and differentiation          
RAS related protein 1b Rap1b 1209 gi|52138628 21013 5.65 4 127 GTP binding Up 2.23 
Galectin-3 Lgals3 9311 gi|52851 27469 8.57 8 531 Sugar binding Up 1.97 
Macrophage migration inhibitory factor Mif 7006 gi|6754696 12667 6.79 2 72 
phenylpyruvate 
tautomerase activity 
Newly 
induced 
Nitrogen metabolism          
Nit protein 2 Nit2 5403 gi|12963555 30825 6.44 8 410 Hydrolase activity Down 2.32 
Glutamate oxaloacetate transaminase 2, mitochondrial Got2 9502 gi|6754036 47780 9.13 11 601 
L-aspartate:2-
oxoglutarate 
aminotransferase 
activity 
Up 2.34 
Carbon metabolism          
Isocitrate dehydrogenase 2 (NADP+), mitochondrial Idh2 8604 gi|27370516 51358 8.88 10 610 NAD or NADH binding Up 1.71 
Phosphopyruvate hydratase Eno1 5603 gi|70794816 47453 6.37 13 822 Lyase Down 6.25 
Miscellaneous          
es1 protein D10Jhu81e 7304 gi|20070420 28415 9.00 7 284 unknown Down 2.94 
mCG15232, isoform CRA_b Eef1a1 8305 gi|148694454 38315 9.13 10 384 GTPase activity Down 3.45 
RIKEN full-length enriched mouse cDNA Rcan1 8402 gi|12848861 31398 7.72 2 134 Protein binding Up 1.68 
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Table 3. Identification of the differentially espressed proteins of membrane-associated proteome in macrophages treated with iron. 
Protein name Gene name Spot no. 
NCBI 
acc. # 
Mr. (Da) theor. pI theor. 
No. of 
peptides 
identified 
Mascot 
score 
Molecular function               
Fold of 
variation  
Iron homeostasis          
mCG23169 Fth 3102 gi|148690909 20845 5.66 12 746 
Stores iron in a 
soluble, non-toxic, 
readily available form 
Up 5.17 
Ferritin heavy chain 1F Fth 3104 gi|6753912 21224 5.53 8 399 
Stores iron in a 
soluble, non-toxic, 
readily available form 
Up 22.08 
Actin cytoskeleton organization          
Annexin A2 Anxa2 6405 gi|6996913 38937 7.55 16 865 
Cytoskeletal protein 
binding 
Up 1.96 
beta-actin Actb 2303 gi|74191564 42066 5.30 10 452 Protein binding Up 1.85 
Vimentin Vim 2702 gi|2078001 51590 4.96 14 765 Protein binding Up 1.90 
put. beta-actin (aa 27-375) Actb 1403 gi|49868 39446 5.78 12 382 Protein binding Up 1.59 
CAP, adenylate cyclase-associated protein 1 Cap1 7602 gi|157951604 51875 7.16 1 150 Actin binding 
Not 
detected 
Calreticulin Calr 0703 gi|6680836 48136 4.33 15 712 Actin binding Up 9.26 
Cell redox homeostasis          
Peroxiredoxin 1 Prdx1 7201 gi|6754976 22390 8.26 11 518 
Hydroperoxide 
oxidoreductase 
Up 2.01 
Protein disulfide-isomerase precursor (PDI) (Prolyl 4-hydroxylase 
subunit beta) (Cellular thyroid hormone-binding protein) (p55) 
(Erp59) 
P4hb 1605 gi|129729 57507 4.79 24 1170 
Disulphide isomerase 
activity 
Down 3.57 
Protein folding and turnover          
Cystatin B Cst2 5003 gi|6681071 11153 6.82 5 164 
Cysteine-type 
endopeptidase inhibitor 
activity 
Up 1.51 
Peptidylprolyl isomerase A Ppia 6104 gi|6679439 18131 7.74 7 345 Peptide binding Up 1.70 
Proteasome (prosome, macropain) subunit, alpha type 6, isoform 
CRA_b 
Psme1 5201 gi|148704781 28353 6.99 6 372 
Threonine-type 
endopeptidase activity 
Up 1.66 
Miscellaneous          
L-lactate dehydrogenase A Lhda 6304 gi|6754524 36817 7.62 10 543 Dehydrogenase Down 2.5 
Vacuolar adenosine triphosphatase subunit D Atp6v0a1 1401 gi|3955100 40749 4.39 10 517 Ion transport Up 1.70 
78 kDa glucose-regulated protein precursor (GRP 78) (Heat 
shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding 
protein) 
Hspa5 0704 gi|2506545 72492 5.07 32 1795 ATP binding Up 2.42 
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Hypothetical protein LOC433182 Eno1 5510 gi|70794816 47453 6.37 16 937 Lyase Up 4.27 
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CHAPTER 3 
PROTEOMIC RESPONSE TO HEME-IRON IN 
MURINE MACROPHAGES 
 
 
 
1. INTRODUCTION  
The importance of well-defined amounts of iron for the survival, replication and 
differentiation of animals, plants and almost all microrganisms is well established (Chricton, 
2001). Iron deficiency is a general problem in biology, and in human it is responsible for 
400-500 million cases of anaemia, among the one-third of the world‟s population. However, 
iron in excess is toxic, particularly in human, where Hemochromatosis is one of the most 
frequent genetic disorders, with an estimated carrier frequency of 1 in 200 in the Caucasian 
population of Northern European descent for C282Y homozygotes (greater than that of 
cystic fibrosis and phenylketonuria together). It is therefore not surprising that iron 
homeostasis is a major concern in human health and well-being. Excess iron accumulation 
in the tissues, in cells and even in organelles, can result in toxicity and is associated with 
pathological disorders. In addition to the classic iron loading found in genetic 
haemochromatosis and in secondary iron overload disorders, such as the thalassaemias, 
with their associated dysfunctions (Chricton, 2001), there are many other diseases 
associated with excess of iron. For example, iron accumulation in the brain has been 
associated with Parkinson‟s disease, Alzheimer‟s disease, Huntington‟s chorea and HIV 
encephalopathy (Rouault, 2001) and more recently in basal ganglia disease (Curtis et al., 
2001) and Hallervorden Spatz syndrome (Zhou et al., 2001), while Freidrich ataxia, 
excessive mitochondrial iron accumulation occurs particularly in brain and cardiac tissue 
(Kaplan, 1999). Thereby an adequate supply of iron is essential for good health. In human, 
more than 60% of total body iron is present in erythrocytes complexed with the heme of 
hemoglobin. After a life-span of 120 days, senescent red blood cells (RBCs) are specifically 
cleared from the circulation by tissue macrophages and  heme iron is efficiently recycled. In 
mammals, this process is critical in iron homeostasis (Knutson and Wessling-Resnick, 
2003). Macrophages play a critical role in body iron homeostasis by recovering iron from 
senescent red blood cells and returning it to the circulation for binding to transferrin, which 
delivers the metal to the cells that need it for various functions, thus contributing for more 
than 80% to the daily iron turnover (Recalcati et al., 2009). However, the molecular 
mechanisms involved in macrophage iron handling are still poorly documented. After RBCs 
engulfment by macrophages in phagosomes, hemoglobin is degraded and iron is released 
from heme through the action of heme oxygenase, the rate-limiting enzyme of heme 
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degradation (Maines, 1997, Tenhunen et al., 1969). Heme iron is subsequently recycled to 
the blood circulation to respond to the needs of the organism. Three isoforms of HO have 
been described in mammals, but only HO-1, an inducible form, appears to be largely 
responsible for heme catabolism in macrophage cells (Poss and Tonegawa, 1997). Due to 
the localization of HO-1 in the endoplasmic reticulum (ER) (Tenhunen et al., 1969), heme 
freed from RBC inside the phagolysosome is assumed to reach the cytosol by diffusing 
across the phagosomal membrane. However, the more recent discovery of Desjardins and 
colleagues showing participation of ER in phagosome formation (Gagnon et al., 2002) may 
suggest heme degradation inside the erythrophagolysosome. Iron transporters belonging to 
the Nramp family and localized in the phagosomal membrane may help subsequently to 
transport iron into the cytosol (Forbes and Gros, 2001). Heme iron is then either stored in 
macrophages, or exported into the circulation to respond to body iron needs. Ferritin seems 
to play an important role in macrophage iron storage secondary to the catabolism of red cell 
heme. In fact, ferritin has been shown to be strongly upregulated after erythrophagocytosis 
(Knutson and Wessling-Resnick, 2003). Interestingly, in splenic macrophages, iron 
deposition was observed in paracrystallin arrangements surrounded by membranes that 
likely correspond to intralysosomal formation of hemosiderin, an insoluble aggregated form 
of partially digested ferritin (Ferreira et al., 2001). Ferroportin, the first cellular iron exporter 
identified in mammals (Abboud and Haile, 2000, McKie et al., 2000, Donovan al., 2000), is 
high expressed in tissue macrophages (Abboud and Haile, 2000, Donovan al., 2000, Yang 
et al., 2002) and plays a key role in iron release from macrophages after EP (Pietrangelo, 
2004, Donovan et al., 2005, Knutson et al., 2005, Knutson et al., 2003). Recently, insight 
into ferroportin function came from the observation that hepcidin, a major systemic 
regulator of iron metabolism (Ganz, 2005), is able to bind to ferroportin and to lead to 
internalization and degradation of the iron exporter (Nemeth et al., 2004). The iron export 
from macrophages seems to be also dependant of the activity of a ferroxidase, the 
ceruloplasmin (Harris et al., 1999). However, despite several evidences that point out the 
importance of HO-1, ferritin, ferroportin or hepcidin in heme iron recycling, little is known 
about the molecular mechanisms involved in iron recovery from heme. The absence of a 
clear description regarding the process of heme iron recycling in macrophages may be due 
in part to the inherent difficulties in studying EP in vivo and of reproducing in vitro the 
natural clearance of RBCs by macrophages.  
To date information on RBCs recognition, trapping and destruction from macrophages are 
highly complex and not completely understood (Bratosin et al., 1998, Bratosin et al., 1997). 
Two erythrophagocytosis pathways have been described in the literature: an 
immunoglobulin-dependant pathway that relies on opsonization of effete RBCs by natural 
antibodies as a primary signal for clearance and an immunoglobulin-independent pathway 
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that involves non-immune mediators for recognition and destruction of old RBCs. The 
importance of the latter pathway has been clearly demonstrated by the observation that 
erythrophagocytosis can occur in the absence of immunoglobulins (Bratosin et al., 1997). A 
classical model of EP is the phagocytosis of IgG-coated erythrocytes by macrophages. 
However, it has to be kept in mind that this model does not take into account the major 
cellular changes observed in old RBC membranes. Indeed, numerous changes including 
appearance of new molecules (e.g. externalization of phosphatidylserine), modification of 
preexisting molecules (desialylation, exposure of h-galactosyl residues), occurring in the 
erythrocyte membrane have been identified as markers for phagocytes to bind and 
phagocytose a senescent RBC (Bratosin et al., 1998). Here, we carried out a comparative 
proteomic analysis using artificially aged rabbit RBCs and primary culture of murine 
(C3H WT) bone marrow-derived macrophages (BMDMs) that tends to mimic the natural 
clearance of senescent RBCs. We report the mapping of heme-stimulated protein expression 
versus un-stimulated in its entire complexity. The comparison of the two proteomes helped 
in defining stimulus-expressed or stimulus-suppressed proteins, to precise the molecular 
mechanisms involved in heme iron recycling. 
 
2. MATERIALS AND METHODS 
2.1. Cell culture and protein extraction  
Mouse Bone Marrow macrophages isolated from C3H WT mice were maintained in culture 
for 7 days. Macrophages were incubated with senescent RBCs accordingly to Delaby et al. 
(2005). Intracellular, membrane, membrane associated fractions were obtained as 
described by Polati et al. (2009) and analysed on 2-DE. 
 
2.2. 2-DE and statistical analysis 
Differential proteomics analyses were performed as described by Polati et al. (2009) 
(session 3, chapter 1, paragraphs 2.2-2.5, 2.7-2.8). 
 
2.3. Mass Spectrometry Analysis 
Differential proteomics analyses were performed as described by Polati et al. (2009) 
(session 3, chapter 1, paragraph 2.9). 
 
3. RESULTS 
3.1. Proteic pattern before and after iron stimulus: 2-DE 
Proteins extracted from 10x106 cells were fractionated with a method set up for obtaining 
high resolution 2D maps from monocytes/macrophages  (Polati et al., 2009). Two discrete 
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fractions, indicated as intracellular proteins and membrane proteins were recovered, 
quantified and analysed by 2-DE (5 replica gels for each fraction).  
 
3.1.1. Intracellular proteome 
2-DE gels of the intracellular fraction of cells treated with senescent RBCs and control cells 
(i.e. non-treated) were run each in five replicas. The images of the gels, analysed by the 
software PDQuest 7.3.0 (BioRad), were used to develop a master map (Fig. 1) on which 
were counted a number of 360 protein spots representative of all the proteins of the two 
experimental groups analyzed. The comparative analysis highlighted the spots differentially 
expressed with statistical significance (minimum ratio accepted >2.0 fold) on the master 
map. The comparison of the cytosol fraction of treated cells versus control cells evidenced 
27 proteins over-expressed and 26 proteins under-expressed. 
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Fig 1. A. Replica maps of intracellular proteome of macrophages treated with RBC (+RBC) and not treated (-RBC). 
B. Master map of intracellular proteome of macrophages. Blue squares highlight proteins differentially expressed 
in macrophages. C. Protein GO categorization. Distribution of the identified proteins according to the biological 
function. Assignments were made on the basis of information provided by gene ontology (GO) lists downloaded 
using the tool FatiGO30 from Babelomics (http://fatigo.bioinfo.cipf.es/). The absolute number of proteins to 
which the distribution is referred is 17 proteins (11 up and 6 down) (cytoskeleton organization), 8 (4 upand 4 
down) (protein folding and turnover), 13 (4 up and 9 down) (carbohydrate metabolism),3 (3 up) (cell 
differentiation), 3 (2 up and 1 down) (cell redox homeostasis), 4 (1 up and 3 down) (transport), 5 (3 up and 2 
down) (miscellaneous). 
 
 
3.1.2. Membrane proteome 
Similarly to 3.1.1., the master map of membrane proteins was elaborated (Fig. 2). A total of 
336 spots were counted, of which 33 were over-expressed and 28 were under-expressed 
upon RBCs treatment. 
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Fig 2. A. Replica maps of membrane proteome of macrophages treated RBC (+RBC) and not treated (-RBC). B. 
Master map of membrane proteome of macrophages. Blue squares highlight proteins differentially expressed in 
macrophages. C. Protein GO categorization. Distribution of the identified proteins according to the biological 
function. Assignments were made on the basis of information provided by gene ontology (GO) lists downloaded 
using the tool FatiGO30 from Babelomics (http://fatigo.bioinfo.cipf.es/). The absolute number of proteins to 
which the distribution is referred is 23 proteins (14 up and 9 down) (cytoskeleton organization), 4 (1 up and 3 
down) (cell redox homeostasis), 6 (3 up and 3 down) (cell cycle and transcription), 5 (3 up and 2 down) 
(metabolism), 2 (2 up) (translation), 3 (1 up and 2 down) (miscellaneous). 
 
 
B 
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3.2. Identification of regulated proteins 
Proteins that resulted significantly varied on the 2D-maps were identified by nano-HPLC/MS-
MS and the complete lists are reported in Table 1 (intracellular proteins) and Table 2 
(membrane proteins). 
 
4. DISCUSSION 
In this study, we were able to improve the understanding of the molecular effects produced 
by erythrophagocytosis on macrophage cells by analyzing the differential protein expression 
in control and in macrophages treated with artificially aged rabbit RBCs to mimic the natural 
clearance of senescent RBCs and to observe how heme-iron is recycled.  
Cytosol and membranes were analysed independently with comparative proteomics, 
because the analysis of homogeneous sub-fractions of the proteome allows to optimise the 
2D separations, thus favouring a better insight of the protein population induced by RBC 
phagocytosis. 
The proteins found regulated are reported in Table 1 and 2. Results indicate that numerous 
proteins in the two fractions are regulated >10 folds (ratio of normalized optical densities of 
treated samples vs. Controls), such regulation threshold is conventionally defined as 
completely switched on/off. The list of spots switched on/off is reported in Figure 3.  
 
 
 
 
 
 
 
 
 
 
 
Fig 3. List of SSP switched on (green background) and switched off (red background) after treatment of 
macrophages with senescent RBC. A. Spots swiched on/off in cytosol fraction, B. spots switched on/off in 
membrane fraction. 
 
It is interesting to note thatthe newly induced proteins are located mainly in the cytosolic 
fraction, while the majority of proteins switched off were found in the membrane fraction . All 
the other proteins differentially expressed, were regulated with quantitative ratios  10 
folds. The localization/function of the regulated proteins is shown in panels C of Fig. 1-2 
where proteins are ordered for similar categories and are indicated with the respective % of 
regulation upon iron stimulus. 
B A 
  SESSION 3, Chapter 3 
120 
 
Cytoskeletal alterations: implications of the erythrophagocytosis  
In mammals, macrophages are multifunctional cells. Apart from their crucial role in the 
regulation of both innate and acquired immunity,  they play a fundamental role as scavenger 
in the clearance of non-self materials such as microorganisms and altered-self materials 
such as apoptotic cells, immune complexes, inflammatory products and senescent 
erythrocytes. Thus, whereas the immune-activity is based on phagocytosis and intracellular 
degradation, the clearance-activity largely depends on the production and secretion of a 
panel of regulatory molecules such as cytokines, chemokines, and nitrogen oxide (NO). The 
phagocytic activity involves substantial remodeling of the cytoskeleton. Our proteomics 
results highlighted changes in the cytoskeletal proteins involved in erythrophagocytosis. The 
majority of cytoskeletal proteins that we found regulated during erythrophagocytosis belong 
to the class of actin. Four different isoforms of beta-actin were up-regulated (SSP8705, 
↑3.5; SSP4304, ↑4.99; SSP3302, ↑2.43; SSP1204, newly induced) and also gamma-actin 
(SSP2204, ↑3.54; SSP2101, ↑5.44; SSP2502, ↑2.85; SSP7604, ↑2.13) both in the cytosol 
fraction and in the membrane fraction. It was demonstrated by Stossel (1993) that the 
dynamic shifts in the concentration and length of actin filaments provide the force and 
structure for non-muscle cell motility and phagocytosis. It was estimated that phagocytosis 
is associated with a 40% increase in the content of filamentous actin in phagocytic cells 
(Greenberg et al., 1991). In addition there are a myriad of actin-binding proteins that relate 
to temporal and spatial regulation of actin filaments assembly.  
Actin filaments assemble with a fast-growing or barbed end. Which refers to  the end of 
filaments decorated with fragments of myosin. Proteins capable of blocking exchange at the 
barbed end can prevent indiscriminate growth of actin filaments and control the localization 
of newly assembled actin filaments. Among the proteins assolving the function of actin 
regulatory proteins there are polypeptides of thethe gelsolin family (Kwiatkowski, 1999). 
Here, we found an up-regulation of gelsolin at the cytoplasmic level (SSP4803, ↑4.05; 
SSP5801, ↑4.50) and a simultaneous down-regulation of this protein (SSP6504, ↓5.53) in 
the membrane fraction of macrophages treated with senescent RBCs.  
Another protein belonging to gelsolin family appears down-regulated at membrane level: the 
macrophage capping protein (CapG) (SSP6506, ↓2.16). CapG is the only member of gelsolin 
family that does not sever actin filaments (Southwick, 1995). It was proposed that active 
remodeling of the actin cytoskeleton by gelsolin family proteins might regulate the 
endo/exocytic activities in phagocytic cells (Beaulieu et al., 2005). The regulation of actin 
family and gelsolin family proteins goes hand in hand with the differential expression of 
other cytoskeletal proteins such as coronins (SSP4402, ↓2.45; SSP4603, ↓3.73; SSP4708, 
↑2.67), an ARP3 actin-related protein (SSP4505, newly induced) and a chaperonin 
containing TCP-1 (CCT) (SSP6602, ↑4.40). A classical function of coronins is in regulating 
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the actin cytoskeleton and the microtubule system. Furthermore coronins act in intracellular 
vesicle formation and trafficking (Rybakin and Clemen, 2005). In particular Yan and 
collegues (2005) examined the role of coronin in the phagocytic process of macrophages. 
They demonstrated that coronin-1 transiently accumulates at the nascent phagosome in a 
temporal sequence similar to that of actin. Moreover they observed significant changes in 
macrophages adhesion properties and in phagocytic potential, with impaired accumulation 
of ARP3 and actin at the phagocytic cup. These results provide the first evidence for a 
requisite function of coronin-1 in macrophage phagocytosis and are perfectly in agreement 
with our proteomic data. Furthermore the complex ARP2/3 is considered the main driving 
force for the formation of pseudopod protrusions (i.e. phagocytic cup) around the target 
(May et al., 2000). Interestingly CCT, that was here found up-regulated after 
erythrophagocytosis, is a molecular chaperone assisting protein folding in the cytosol of 
eukaryotes. CCT facilitates the folding of actin and tubulin in the presence of ATP and is 
bound to newly synthesized actin, tubulin and some other unidentified polypeptides (Yokota 
et al., 2000). Ultimately, high and sudden energy demand is seen during cell-shape change: 
a process in which ATP fuels the cytoskeletal machinery that drives cell-morphology 
alteration. Indeed, due to the evidences, various studies now argues in favor of a model in 
which up to 50% of cellular energy expenditure via ATP hydrolysis is required for acto-myosin 
dynamics in cell types with a constantly changing morphology, like neurons, astrocytes and 
immune cells (Hertz et al., 2007). Regarding ATP requirements, in macrophages treated with 
senescent RBCs we found over-expression of an ATP synthase (SSP7705, ↑2.29) and brain 
creatine kinase (CK-B), this latterresults over expressed of 2.12 folds in the cytoplasm and 
completely switched off at the membrane level. Our data are in agreement with the results 
of Kuiper and colleagues (2008) who demonstrated that the metabolic ATP-supply activity of 
CK-B is of local importance and facilitates specific phagocytosis steps via effects on actin-
based events early in the binding-ingestion process.  
ER stress: implications in inflammation, in attenuation of metabolism and in translation 
Interestingly our proteomics data suggest that erythrophagocytosis causes in macrophages 
the stress of endoplasmic reticulum (ER). ER stress is of particular interest because is 
involved in inflammation, neurodegeneration, diabetes mellitus, heart diseases, and kidney 
diseases (Han et al., 2008, Lin et al., 2008, Marciniak and Ron, 2006). ER stress has also 
been related to autoimmune diseases including rheumatoid arthritis (Gao et al., 2008, 
Purcell et al., 2003) and autoimmune myositis (Nagaraju et al., 2005). Accordingly to these 
authors aberrant ER stress responses can contribute to disease. 
ER stress is caused by perturbation of its homeostatic functions: accumulation of unfolded 
proteins in the ER lumen is a shared hallmark of the perturbation the physiological functions 
of the ER and results in the activation of a common response to such stress situation. The 
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ER chaperone BiP serves as a master controller of the stress response (Quinones et al., 
2008).  
In unstressed cells, BiP is associated with the ER luminal domains of the stress sensors, 
thanks to the low concentration of unfolded proteins under these conditions. Accumulation 
of unfolded proteins triggers their interaction with BiP, which results in depletion of the free 
BiP pool, and sequestering of BiP from the ER luminal domains of the stress sensors, 
resulting the activation of these latter (Schröder, 2008). In our proteomics analysis we found 
the simultaneous down regulation of BiP (SSP5704, ↓6.37) and cathepsin D (SSP4503, 
↓2.64), an aspartyl protease involved in the degradation of BiP (Shi et al., 2009). 
Furthermore murine valosin-containing protein (SSP3901) results up-regulated of 2.45 folds 
in macrophages treated with senescent RBCs. The valosin-containing protein, also termed 
p97, belongs to the AAA superfamily, ATPases associated with a variety of cellular activities. 
In particular Wojcik et al. (2006) demonstrated a significant up-regulation of transcripts 
encoding for this protein associated with apoptosis, ER stress and oxidative stress.  
To maintain ER homeostasis, cells initiate processes that augment the ER capacity of 
protein folding by evoking transient attenuation of protein translation, transient attenuation 
of metabolism, ER-associated degradation of misfolded proteins, the induction of molecular 
chaperones and inflammation (Shi et al., 2009). In our results of macrophages that 
phagocyted RBCs, we observed the attenuation of protein translation, the attenuation of 
metabolism and the inflammatory response. In fact, regarding the attenuation of protein 
translation, both Tu translational elongation factor (SSP5506, ↓2.58) and ribosomal protein 
L9 (SSP1201, ↓2.7) appears down-regulated. Aalso many enzymes belonging to 
carbohydrate metabolism, such as transaldolase 1 (SSP5408, ↓2.71), triosephosphate 
isomerase (SSP7202, ↓2,28), enolase 1 (SSP7402, ↓9.02; SSP7404, ↓2.00), beta-
glucoronidase (SSP6701, ↓4.27; SSP6703, ↓2.34), pyruvate kinase (SSP7402, ↓9.02; 
SSP7404, ↓2.00; SSP7404, ↓2.00), glutamate dehydrogenase 1 ( SSP7706, ↓3.26) and 
phosphoglycerate mutase (SSP6301, ↓3.73) are down-regulated. 
In terms of inflammation, numerous proteins resulted regulated upon RBCs exposure. The 
first signal of macrophages activation is the over expression of Ca2+ binding proteins. In fact 
agonist-stimulated changes in intracellular Ca2+ serve as ubiquitous second messenger 
signals in eukaryotic cells. The effect of changes in intracellular Ca2+ are transduced within 
cells by Ca2+–binding proteins. Macrophages have been seen to be particularly responsive 
to extracellular signals, the reaction to extracellular stimuli are often mediated by changes in 
the intracellular  Ca2+ concentration (Johnston et al., 1990). Here we observed the up-
regulation of the tumor protein translationally controlled 1 (SSP1201, ↑2.95) and of the 
calgizzarin (S100 calcium binding protein A11) (SSP1003, ↑2.14) both involved in acute and 
chronic inflammatory responses and in cancer (Odink et al., 1997, Ma et al., 2010). The 
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expression of secondary inflammatory mediators such as cytokines, chemokines, 
complement proteins, and co-stimulatory molecules is fundamental to modulate cellular 
responses by the activation and recruitment of immune cells mediating host cellular and 
tissue remodeling (Glaros et al., 2009). Regarding cytokines production we found regulated 
some key proteins such as α-fetoprotein (SSP4704, ↓7.23; SSP5001, ↓5.26), which down-
regulation allows the expression of inflammatory cytokines in activated immune cells by an 
NFkB-dependent mechanism (Potapovich et al., 2009); ubiquitin-conjugating enzyme E2N 
(SSP5003, ↓6.82) that is key in the process of 'tagging' target proteins with lysine 63-linked 
polyubiquitin chains, which are essential for the transmission of immune receptor signals 
culminating in activation of the transcription factor NF-kB (Yamamoto et al., 2006); and 
endoplasmin (gp96) (SSP1804, newly induced) that is the master chaperone for TLRs and 
the dominant inducer of pro-inflammatory cytokines synthesis by macrophages (Yang et al., 
2007).  
The beta-galactoside binding protein (galectin-3) (SSP2004) is also up-regulated of 4.49 
folds, this protein, which is secreted from monocytes/macrophages and epithelial cells, has 
also been demonstrated to function as an extracellular molecule in activating various types 
of cells, including monocytes/macrophages, mast cells, neutrophils, and lymphocytes (Sano 
et al., 2000). The expression of this lectin is up-regulated during inflammation (Flotte et al., 
1983), cell proliferation (Moutsatsos et al., 1987, Agrwal et al., 1989), and cell 
differentiation (Liu et al., 1995, Nangia-Makker et al., 1993) and through trans-activation by 
viral proteins (Hsu et al., 1996). Its expression is also affected by neoplastic transformation 
(Konstantinov et al., 1996): up-regulated in certain types of lymphomas  and thyroid 
carcinoma (Fernadez et al., 1997, Xu et al., 1995), while down-regulated in other types of 
malignancies, such as colon (Lotz et al., 1993, Castronovo et al., 1992), breast (Castronovo 
et al., 1996), ovarian (van den Brule et al., 1994), and uterine carcinomas (van den Brule et 
al., 1996). Finally the hepatocyte growth  factor (HGF) results up-regulated of 3.49 folds. 
HGF is known as scatter factor and described as a multifunctional cytokine. It has a potent 
mitogenic activity for a wide variety of epithelial and endothelial cells and it is involved in 
organ growth and regeneration. HGF enhances cell migration and inhibits cells proliferation 
and may play a role in regulating immune cell function and inflammatory responses (Chen et 
al., 1996). 
 
5. CONCLUSIONS 
Comparative proteomic confirms a powerful tool for the analysis of regulated proteins in 
macrophage cells after erythrophagocytosis. The protein expression related to RBCs 
stimulus would offer a better understanding of the process of heme-iron metabolism in 
macrophages and would help to clarify heme-iron role in  immunity and infection.  In 
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summary this work highlights the proteins regulated in macrophages after the phagocytosis 
of senescent red blood cells. In addition to the numerous proteins involved in cytoskeletal 
changes, particular attention should be given by proteins indicating the ER stress, as such 
condition strictly relates to inflammatory responses. Still an important piece of the puzzle is 
missing: what is the destiny of the thousands heme-groups bound to haemoglobins of the 
phagocyted RBCs? There are no trace of them, nor there is trace of heme-oxigenase nor 
ferritins, both protein classes well involved in heme dismantling and in iron storage.  
Experimental results clearlyindicated that the phagocytosis of senescent RBCs and their 
consequent degradation took place, as supported by the expression of proteins upon RCBs 
stimulus and by the lack of rabbit proteins on 2D maps. But surprisingly, there was no 
evidence of the activation of a molecular response addressed to heme-recycling. Thus in 
order to clarify the heme-metabolism and in order to draw a comprehensive picture of the 
responses triggered by iron on macrophages, a wider experimental plan needs to be 
set.Further experimental case to be studied comprise the challenging of  macrophages 
treated with nude heme-groups.   The comprehensive analysis of these results would allow 
to fill the gap in iron homeostasis and would help in understanding better the important 
relations between iron and inflammatory processes. 
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Table 1. Identification of the differentially espressed proteins of intracellular proteome in macrophages treated with senescent RBCs. 
Protein name Gene name 
Spot no. 
a) 
 
NCBI 
acc. # 
Mr. (Da)  
exp./theor. 
pI exp./theor. 
No. of peptides 
identified 
Mascot 
score 
b)
 
Molecular 
function              
GO term 
Fold of 
variation on 
+RBC 
d)
 
Cytoskeleton organization          
tumor protein, translationally-controlled 1 Tpt1 1201 gi|6678437  19450 4.76 6 82 Calcium ion binding Up 2.95 
Rho, GDP dissociation inhibitor (GDI) beta Arhgdib 1203 gi|33563236  22836 4.97 8 82 
GTPase activator 
activity 
Up 2.06 
put. beta-actin (aa 27-375) Actb 1204 gi|49868  39161 5.78 19 228 Protein binding 
Newly 
induced 
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation 
protein, eta polypeptide 
Ywhah 1304 gi|6756037  28194 4.81 17 549 
Monooxygenase 
activity 
Up 2.99 
put. beta-actin (aa 27-375) Actb 2202 gi|49868  39161 5.78 56 358 Protein binding Up 3.21 
gamma actin-like protein Actb 2204 gi|6425087  43572 5.11 51 404 Protein binding Up 3.54 
annexin A5 Anxa5 2303 gi|6753060  35730 4.83 13 110 Calcium ion binding Down 2.36 
transgelin Tagln 3002 gi|5007032  23582 6.59 13 293 Actin cross-linking Down 2.15 
Rho, GDP dissociation inhibitor (GDI) beta Arhgdib 3102 gi|33563236  22836 4.97 10 198 
GTPase activator 
activity 
Down 3.79 
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation 
protein, eta polypeptide 
Ywhah 3107 gi|6756037  28194 4.81 13 139 
Monooxygenase 
activity 
Down 4.49 
rab7 Rab7 4101 gi|1050551  23544 7.53 9 371 GTP binding Up 2.78 
annexin A3 Anxa3 4304 gi|5902786  36348 5.33 41 416 Calcium ion binding Down 2.12 
ARP3 actin-related protein 3 homolog B Actr3b 4505 gi|148671124  37861 6.11 9 245 
Regulation of actin 
filament 
polimerization 
Newly 
induced 
unnamed protein product  4703 gi|26326929  70119 5.24 45 433 Actin binding  Down 2.13 
Gsn protein Gsn 4803 gi|38014369  80712 5.52 30 748 Actin binding Up 4.05 
Gsn protein Gsn 5801 gi|38014369  80712 5.52 37 861 Actin binding Up 4.50 
annexin A5 Anxa5 7002 gi|6753060  35730 4.83 1 81 Calcium ion binding 
Newly 
induced 
Protein folding and turnover          
tumor rejection antigen gp96 (endoplasmin) Hsp90b1 1804 gi|6755863  92418 4.74 26 831 
Unfolded protein 
binding 
Newly 
induced 
heat shock protein 1, alpha Hsp90aa1 2802 gi|6754254  84735 4.93 50 484 
Unfolded protein 
binding 
Newly 
induced 
unnamed protein product Hsp70 4702 gi|74211667  60764 6.04 74 962 
Unfolded protein 
binding 
Down 5.70 
ubiquitin-conjugating enzyme E2N Ube2n 5003 gi|4507793  17127 6.13 9 260 
Ubiquitin-protein 
ligase activity 
Up 6.82 
BiP Hspa5 5704 gi|2598562  72433 5.10 9 100 Protein binding Down 6.37 
CCT (chaperonin containing TCP-1) beta subunit Cct2 6602 gi|468546  57411 5.97 12 186 
Unfolded protein 
binding 
Up 4.40 
proteasome subunit MC13 Psmb8 7108 gi|673450  23032 6.89 12 372 
Threonine-type 
endopeptidase 
activity 
Down 6.58 
proteasome subunit alpha type-2 Psma2 7201 gi|1709759  25909 8.39 21 258 
Threonine-type 
endopeptidase 
activity 
Down 2.13 
  
 
1
2
6 
 
Carbohydrate metabolism          
transaldolase 1 Taldo1 5408 gi|33859640  37363 6.57 15 404 
Transaldolase 
activity 
Down 2.71 
hypothetical protein LOC433182 Eno1 5506 gi|70794816  47111 6.37 48 537 
Phosphopyruvate 
hydratase activity 
Up 2.73 
hypothetical protein LOC433182 Eno1 6505 gi|70794816  47111 6.37 53 773 
Phosphopyruvate 
hydratase activity 
Up 2.71 
triosephosphate isomerase Tpi1 7202 gi|1864018  22492 5.62 26 251 
Triose-phosphate 
isomerase activity 
Down 2.28 
hypothetical protein LOC433182 Eno1 7402 gi|70794816  47111 6.37 48 349 
Phosphopyruvate 
hydratase activity 
Down 9.02 
EG433182 protein Eno1 7404 gi|13278412  38276 5.60 29 336 
Phosphopyruvate 
hydratase activity 
Down 2.00 
hypothetical protein LOC433182 Eno1 7510 gi|70794816  47111 6.37 70 1305 
Phosphopyruvate 
hydratase activity 
Up 2.43 
beta-glucoronidase Hpse 6701 gi|193723  74206 6.16 14 261 Calcium ion binding Down 4.27 
beta-glucoronidase Hpse 6703 gi|193723  74206 6.16 11 77 Calcium ion binding Down 2.34 
M2-type pyruvate kinase Pkm2 8605 gi|1405933  57878 7.18 65 848 Ion binding Down 2.11 
pyruvate kinase Pkm2 8609 gi|31981562  57808 7.18 35 1167 Ion binding Down 2.31 
hypothetical protein LOC433182 Eno1 9001 gi|70794816  47111 6.37 12 485 
Phosphopyruvate 
hydratase activity 
Up 6.53 
unnamed protein product Pkm2 9302 gi|74212815  43138 5.88 8 113 Ion binding Down 4.35 
Cell redox homeostasis           
peroxiredoxin 1 Prdx1 4101 gi|6754976  22162 8.26 15 67 
Removal of 
superoxide radicals 
Up 2.78 
peroxiredoxin 1 Prdx1 6107 gi|6754976  22162 8.26 86 403 
Removal of 
superoxide radicals 
Not detected 
peroxiredoxin 1 Prdx1 7803 gi|6754976  22162 8.26 25 583 
Removal of 
superoxide radicals 
Up 4.04 
Cell differentiation          
S100 calcium binding protein A11 (calgizzarin) S100a11 1003 gi|21886811  11075 5.28 6 127 Calcium ion binding Up 2.14 
thioredoxin 1 Txn1 1004 gi|6755911  11668 4.80 17 263 Electron transport 
Newly 
induced 
beta-galactoside binding protein Lgals1 2004 gi|193442  14796 5.32 15 226 Galactose binding Up 4.49 
Transport          
murine valosin-containing protein Vcp 3901 gi|55217   89252 5.14 16 610 
Activation of 
caspase activity 
Up 2.45 
alpha-fetoprotein Afp 4704 gi|191765  47195 5.47 4 121 Ion binding Down 7.23 
alpha-fetoprotein Afp 5001 gi|191765  47195 5.47 2 72 Ion binding Down 5.26 
albumin Afamin 5701 gi|158138568  68714 6.09 5 129 Transport Down 7.45 
Miscellaneous          
brain creatine kinase Ckb 3405 gi|10946574  42686 5.40 11 216 ATP binding Up 2.12 
hypothetical protein LOC239673  7001 gi|29244176  58230 8.47 1 87  Down 3.52 
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hypothetical protein LOC239673  7009 gi|29244176  58230 8.47 1 67  Down 3.67 
heterogeneous nuclear ribonucleoprotein A2/B1 Hnrpa2b1 7104 gi|3329498  35971 8.67 4 153 RNA binding 
Newly 
induced 
unnamed protein product Ef2 7805 gi|26324898  95197 6.51 31 784 Elongation factor Up 3.22 
 
  
 
1
2
8 
Table 2. Identification of the differentially espressed proteins of membrane proteome in macrophages treated with senescent RBCs. 
Protein name Gene name Spot no. 
NCBI 
acc. # 
Mr. (Da)  
theor. 
pI 
theor. 
No. of 
peptides 
identified 
Mascot 
score  
Molecular 
function               
Fold of 
variation  
Cytoskeleton organization          
A-X actin Actb 4601 gi|309090  41667 5.21 4 122 ATP binding  Down 2,06 
gelsolin Gsn 6504 gi|74144652  38646 6.28 10 397 actin binding  Down 5.53 
coronin-1 Coro1a 4402 gi|4895037  50943 6.05 2 57 actin filament binding  Down 2.45 
gamma-actin  Actg1 2101 gi|809561  40992 5.56 19 522 ATP binding  Up 5.44 
put. beta-actin (aa 27-375)  Actb 2201 gi|49868  39161 5.78 2 96 ATP binding  Not detected 
gamma actin-like protein  Actg1 2502 gi|74195718  41709 5.46 58 529 ATP binding  Up 2.85 
hypothetical protein LOC239673  Actb 3203 gi|29244176  58230 8.47 9 118 ATP binding  Up  2.48 
put. beta-actin (aa 27-375)  Actb 3302 gi|49868  39161 5.78 50 423 ATP binding  Up 2.43 
A-X actin Actb 3401  gi|309090  
 
41667 5.21 37 599 ATP binding  Up 2.99 
annexin A4 Anxa4 3402 gi|2492905  35967 5.43 1 68 calcium ion binding  Not detected 
alpha-tubulin isotype M-alpha-2 Tuba1b 3602 gi|202210  50134 4.94 5 64 GTP binding  Up 2.92 
beta-actin  Actb 4304 gi|110226713  41645 5.15 7 228 ATP binding  Up 4.99 
alpha-tubulin isotype M-alpha-2 Tuba1a  4603 gi|202210  50134 4.94 2 79 GTP binding  Down 3.73 
coronin-1  Coro1a 4603 gi|4895037  50943 6.05 4 79 actin filament binding  Down 3.73 
coronin-1 Coro1a 4708 gi|4895037  50943 6.05 3 134 actin filament binding  Up 2.67 
unnamed protein product Actc1 3604 gi|12835802  47287 5.54 12 239 ATP binding  Up 3.16 
macrophage-capping protein  Capg  6506 gi|729023  39216 6.73 
5 
 
135 actin binding  Down 2.16 
unnamed protein product  Actb 7303 gi|74195718  41709 5.46 5 159 ATP binding  Up 2.01 
gamma-actin Actb 7604 gi|809561  40992 5.56 6 190 ATP binding  Up 2.13 
tubulin beta 5 Tubb5 2501 gi|74204140  49616 4.75 32 690 GTP binding  Down 3.18 
binder of Rho GTPases 5 Cdc42ep1 6803 gi|26324898  95197 6.51 3 97 protein binding  Up 8,88 
binder of Rho GTPases 5 Cdc42ep1 6804 gi|26324898  95197 6.51 4 154 protein binding  Newly induced 
put. beta-actin (aa 27-375)  Actb 8705 gi|49868  39161 5.78 5 135 ATP binding  Up 3.5 
Cell redox homeostasis          
peroxiredoxin Prdx1  5202  gi|6435547  
 
22079 8.34 8 207 heme binding  Not detected 
peroxiredoxin 1 Prdx1 6201 gi|6754976  22162 8.26 12 288 peroxiredoxin activity  Down 3.38 
peroxiredoxin 1  Prdx1 6202 gi|6754976  22162 8.26 13 341 peroxiredoxin activity  Up 2.9 
  
 
1
2
9 
voltage-dependent anion-selective channel protein 1 Vdac3 6402 gi|109479457  35014 8.86 3 60 nucleotide binding  Not detected 
Cell cycle and transcription          
cell division cycle 5-related protein Cdc5l 3803 gi|74198702  89315 5.14 18 517 DNA binding  Down 3.75 
hepatocyte growth factor receptor Met 4504 gi|12843046  26390 8.22 1 48 growth factor activity Up 3.49 
Dhx36 protein Dhx36 6304 gi|50815  42158 6.56 3 112 ATP binding  Newly induced 
purine nucleoside phosphorylase Pnp 4302 gi|388923  32239 6.08 5 193 
purine-nucleoside 
phosphorylase 
activity 
Down 2.32 
tyrosine 3/tryptophan 5 -monooxygenase activation protein Ywhab 1301 gi|5803225  29155 4.63 3 83 
monooxygenase 
activity 
Up 2.12 
centromeric protein E Cenpe 3901 gi|47847498  154779 5.43 48 360 ATP binding  Down 5.29 
Metabolism          
glutamate dehydrogenase 1  Glud1 7706 gi|148692928  54185 7.66 12 360 ATP binding  Down 3.26 
transketolase Tkt 7707 gi|6678359  67588 7.23 5 121 calcium ion binding  Up 8.62 
transketolase Tkt 7709 gi|1729977  67601 7.23 3 92 calcium ion binding  Up 5.94 
enolase Eno3 5609 gi|55491  47095 6.37 5 161 
magnesium ion 
binding  
Up 4.48 
phosphoglycerate mutase 1  
 
Pgam1 6301 gi|10179944  28919 6.19 7 244 
2,3-bisphospho-D-
glycerate 2-
phosphohydrolase 
activity 
Down 3.73 
Translation          
Tu translation elongation factor, mitochondrial isoform 1  Tufm 5506 gi|27370092  49477 7.23 6 153 GTP binding  Down 2.58 
ribosomal protein L9 Mrpl9 1201 gi|14149647  21868 9.69 3 104 
structural constituent 
of ribosome  
Down 2.7 
Miscellaneous          
creatine kinase B-type Ckb 6203 gi|148698457  34014 5.85 3 77 ATP binding  Not detected 
cathepsin D precursor  Ctsd 4503 gi|6753556  44925 6.71 3 53 
aspartic-type 
endopeptidase 
activity 
Down 2.64 
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit, 
isoform 1 precursor  
Atp6v1a 7705 gi|6680748  59716 9.22 19 503 ATP binding  Up 2.29 
 
 
 
  
  
  
 
1
3
0 
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